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Summary 
To respond to exogenous and endogenous stimuli, organisms have developed a variety of 
mechanisms to modulate the quantity, duration and the type of response to these stimuli. Of these 
mechanisms, one of the most important is the regulation of gene expression. This regulation of gene 
expression occurs at various levels but especially by the employment of different transcription 
factors and cofactors. Transcription factors interact with specific sequences within the regulated 
genes. The way in which co-factors act can be very diverse and are generally less known. 
The present work aims to analyse the mechanisms used by cells to regulate gene expression for 
reactive oxygen species (ROS) detoxification genes, and in particular, the mechanisms controlling the 
activity of the two co-factors SirT1 and PGC-1α on those genes. PGC-1α was first discovered as a 
regulator of biogenesis and mitochondrial activity. Later, it was demonstrated that PGC-1α operated 
as an expression coordinator of a group of genes controlling ROS levels and therefore prevented the 
accumulation of oxidative stress due to its binding to the transcription factor FoxO3a. Moreover, 
SirT1 was first discovered as a Histone deacetylase, involved in the regulation of genomic stability. 
Later on, SirT1 was shown to regulate activity of other proteins, specifically transcription factors or 
cofactors such as PGC-1α.  
The first aim of the work presented in this thesis was to determine if SirT1 collaborates with PGC-1α 
in regulating antioxidant genes and to find out through which mechanisms this regulation is 
mediated. The results demonstrate not only that SirT1 deacetylates PGC-1α and FoxO3a, but also 
that all three proteins together form an efficient ternary transcription elongation complex recruited 
to the regulating regions of the target antioxidant genes. After recruitment to the regulating regions, 
SirT1 deacetylates the nearby histones; this specific deacetylation does not lead to a gene silencing. 
However the exact mechanism of regulation is still not clear and remains to be elucidated. These 
results show for the first time that SirT1 can not only lead to a general silencing of chromatin, but can 
also induce specific gene expression when involved in a specific transcription complex. 
PGC-1α has a RNA recognition motif (RRM) whose deletion abolishes some of the transactivation 
capacity of PGC-1α. The second aim of this work was to study the functionality of this motif in the 
specific context of regulating antioxidant genes. The results showed that some genes are more 
sensitive to the absence of RRM than others. To have a global overview of the genomic functionality 
of the RRM, a complete genome microarray expression analysis comparing wild-type PGC-1α protein 
to the PGC-1α protein lacking the RRM was performed. The observation that the deletion of the PGC-
1α RRM differentially affects genes regulated by PGC-1α suggests that the RRM could be involved in 
selection of 3’UTR and as a consequence modify RNA transcripts. 
The final aim of this study was to confirm and identify RNA species binding to PGC-1α RRM. The 
technique applied to confirm and identify these RNA species was high throughput cross-linked 
immuno-precipitation (HITS-CLIP). The use of HITS-CLIP confirmed binding of RNA to PGC-1α. The 
presence of RRM suggests preferential transcription of some protein isoforms. The combination of 
the obtained results from array and RNA sequencing support this hypothesis. 
In summary, this study not only gives detailed information about ROS detoxification gene regulation 
by PGC-1α but also allowed the identification of new mechanisms of action for SirT1 and PGC-1α.  
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Presentación 
Para responder de manera adecuada a estímulos exógenos y endógenos, los organismos han 
desarrollado diversos mecanismos los cuales permiten variar tanto la cantidad como el tipo de 
repuestas. Entre estos mecanismos se encuentran aquellos que permiten regular la expresión génica. 
Esta ocurre a varios niveles y a través de distintos tipos de factores, siendo los más importantes los 
factores de transcripción y los cofactores. Los factores de transcripción actúan reconociendo 
secuencias específicas en los genes regulados. Los cofactores operan a través de mecanismos muy 
variados y, en general, estos son más desconocidos. 
La presente Tesis analiza los mecanismos por los cuales la célula regula la expresión de los genes 
implicados en la destoxificación de especies reactivas de oxígeno (ROS). En primer lugar se 
determinaron los mecanismos que median la actividad de los cofactores SirT1 y PGC-1α sobre estos 
genes. Inicialmente el cofactor PGC-1α se describió como regulador de la biogénesis y de la actividad 
mitocondrial. Posteriormente, se demostró que PGC-1α regula de manera coordinada la expresión 
de un grupo de genes encargados de controlar los niveles de ROS y prevenir la aparición de estrés 
oxidativo a través de su interacción con el factor de transcripción FoxO3a. Por otra parte, el cofactor 
SirT1 se describió primeramente como una desacetilasa de histonas, responsable de la regulación de 
la estabilidad genómica, pero después se determinó que SirT1 puede también regular la actividad de 
otras proteínas, y en concreto, de factores de transcripción como PGC-1α. El primer objetivo de este 
trabajo fue determinar si SirT1 colaboraba con PGC-1α en la regulación de genes antioxidantes y a 
través de que mecanismo.  
Este estudio ha permitido demostrar que SirT1 no solo desacetila PGC-1α y FoxO3a, sino que forma 
con ellos un complejo ternario de elongación transcripcional más eficiente que es reclutado a las 
regiones reguladoras de los genes diana. Tras su reclutamiento, SirT1 desacetila las histonas 
próximas, pero esta desacetilación no va asociada a silenciamiento génico, el cual ocurre a través de 
un mecanismo desconocido. Estos resultados muestran por primera vez que más allá de la capacidad 
de SirT1 de inducir un silenciamiento general de la cromatina, puede además tener un efecto 
inductor en la expresión de genes específicos cuando forma parte de complejos de regulación 
transcripcional. 
PGC-1α contiene un dominio de unión a RNA (RNA recognition motif; RRM) cuya deleción 
compromete la capacidad transactivadora de PGC-1α. El segundo objetivo de este trabajo fue 
estudiar la funcionalidad de este dominio en el contexto específico de la regulación de genes 
antioxidantes. Se concluyó que algunos genes son más sensibles a la deleción de este dominio y que 
el coactivador TLS es capaz de activar PGC-1α solo en algunos de ellos.  
Con el fin de tener una visión global a nivel genómico de la funcionalidad del RRM, se realizó un 
análisis de expresión con microarrays de genoma completo, comparando la actividad de la proteína 
WT con el mutante en la region RRM. Se observó que la deleción del dominio afecta de forma 
diferencial a los genes regulados por PGC-1α, sugiriendo así que el dominio RRM podría afectar a la 
selección del 3‘UTR y alterar la estabilidad del transcrito.  
El último objetivo de esta Tesis fue el de confirmar e identificar qué especies de ARN se unen al RRM 
de PGC-1α. Para ello, se utilizó la inmunoprecipitación con entrecruzamiento covalente apareada de 
alto rendimiento (HITS-CLIP), la cual confirmó la unión del ARN a la  proteína PGC-1α. La presencia 
del RRM sugiere la transcripción preferencial de ciertas isoformas de la proteína. La combinación de 
los resultados obtenidos mediante arrays de ARN y la secuenciación de ARN apoyan esta hipótesis. 
En conclusión, los resultados obtenidos en este trabajo no solo proporcionan información detallada 
sobre la regulación de la expresión de genes antioxidantes, sino que también han permitido 
identificar dos nuevos mecanismos de acción para los cofactores SirT1 y PGC-1α. 
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Introduction 
1. Regulation of chromatin structure and gene expression 
In 1958 Francis Crick introduced the Central Dogma of Molecular Biology as the key concept behind 
gene expression regulation (Crick F 1970; Thieffry D  and Sarkar S 1998, Figure 1.1). 
 
Figure 1.1: Concept of gene expression 
Deoxyribonucleic acid (DNA), the blueprint of life, produces molecules called ribonucleic acid (RNA) 
by a mechanism called transcription. RNA translates the genes encoded in DNA (genotype) into 
proteins and regulation of RNA levels is determinant in the modulation of protein levels and the 
cellular response to extracellular and intracellular stimulus. 
There are several classes of RNA, all of which undergo transcription via specific transcription 
complexes in which RNA polymerases play a central role. In eukaryotic cells there are different RNA 
polymerases, of which RNA polymerase II (RNAP II) is responsible for the transcription of a class of 
RNAs called messenger RNAs (mRNA) that include most protein coding RNAs.  The concept of mRNA 
as the intermediate carrier of information in protein synthesis was first proposed by F. Jacob and J. 
Monod (Jacob 1961) and experimentally confirmed by S. Brenner, F. Jacob and M. Meselson (Brenner 
et al. 1961).  
The complete process of gene expression regulation is complex, highly dynamic and discontinuous 
involving modulation of three main checkpoints, transcription initiation, elongation, and termination. 
The transcription cycle will be described in detail in Introduction Section 1.2.3. Due to the complex 
nature of DNA packaging (chromatin structure), a multitude of transcription factors (that bind 
specific DNA sequences) and co-activators (do not bind DNA or do so in a non-sequence specific 
manner) with a multitude of different activities are needed for efficient and specific transcription. 
The presented work will focus on the mechanisms of transcriptional regulation by two transcriptional 
co-activators, peroxisome proliferator-activated receptor gamma (PPARγ)-co-activator 1 alpha (PGC-
1α), and sirtuin SirT1, and their role in the regulation of target gene expression via transcription 
factors, histone code regulation and their interactions with the transcriptional machinery. 1.1. Chromatin structure 
The enormous length of the eukaryotic genome requires for its stability that it is packaged in 
structures that can be replicated and propagated during mitosis. Furthermore, it is essential that this 
packaged structure remains sufficiently malleable and modifiable to enable access to genetic 
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information. Such a structure is acquired by the formation of chromatin, which contains DNA and its 
associated proteins. 
The structured DNA is packed into a cellular structural unit located in the nucleus called the 
nucleosome. The nucleosome is a nucleoprotein complex consisting of 147 base pairs of DNA 
wrapped in a left-handed superhelix 1.7 times around an octamer of core canonical histones proteins 
H2A, H2B, H3 and H4 (2 molecules of each, Richmond TJ et al. 1984), arranged as an octamer in a 
“bead-on-a string” configuration (11 nm fiber) and stabilised by linker histones (H1, H1a, and H5, 40-
70 bp of linker DNA). Nucleosomes are fundamental in gene expression control (Kornberg RD 1974). 
The different degrees of compaction are shown in Figure 1.2. 
It is known that nucleosomes form a chromatin fiber (Finch J.T. and Klug A 1976), which can further 
compact into structures increasingly complex. Compactation reaches its peak during cell division with 
the formation of mitotic chromosomes (Felsenfeld and Groudine 2003).  
Cytological examination of mitotic chromosomes distinguishes two types of chromatin known as 
euchromatin and heterochromatin. Heterochromatin is thought to be tightly condensed and thus 
inaccessible to DNA binding factors, unlike euchromatin which adopts a more relaxed conformation 
(Grewal SI and Moazed D 2003). Most highly transcribed genes are found in euchromatin regions.  
 
Figure 1.2: Hierarchical organisation of nuclear DNA structure in eukaryotes. 
Chromatin structure can be altered by nucleosome remodeling enzymes, replacement of the core 
histones with specialised histone variants or by covalent modification of histones within the 
nucleosome. Covalent modification of histones will be discussed in further detail below. 
The term “Epigenetic”, first used by Conrad H. Waddington (1905–1975), as the junction of 
epigenesis and genetics has become a central concept of gene regulation in more recent years. The 
term “Epigenetic modifications” is now used to define all functionally-relevant modifications to the 
genome that do not alter the underlying DNA sequence, and which aim mainly to regulate gene 
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expression, but also DNA stability, replication and repair, and include not only histone modifications 
but also DNA modifications such as methylation.  
1.1.1. DNA Modification: DNA methylation, CpG island, DNA methylases 
Methylation is the main and first described DNA modification in vertebrates. DNA methylation occurs 
on the fifth carbon position of cytosine residues to yield 5-methylcytidine. This occurs almost 
exclusively within CpG dinucleotides. In the mammalian genome, approximately 70–80% of CpG 
dinucleotides are methylated. However, stretches of CpG-rich sequences with low levels of DNA 
methylation, known as CpG islands, do exist (Blackledge NP and Klose R 2011, Deaton AM and Bird A, 
2011). DNA methylation is typically associated with epigenetic gene repression and many targets of 
de novo DNA methylation during differentiation (Weber M et al. 2007, Mohn F  et al. 2008, Farthing 
CR  et al. 2008). DNA methylation also recruits methyl-CpG-binding proteins, which recruit additional 
proteins that add silencing modifications to neighboring histones.  
Interestingly, CpG islands make up only 0.7% of the human genome but contain 7% of the CpG 
dinucleotides. CpG islands often are highly enriched in gene promoters. For example, approximately 
60% of all mammalian gene promoters are CpG-rich. CpG islands are typically unmethylated, open 
regions of DNA with low nucleosome occupancy. As such, CpG islands promote relaxed chromatin 
structure that favors active transcription, known as euchromatin, and increases accessibility of RNAP 
II and other components of the basal transcription machinery to the transcription start site (see 
Section 1.2.3.).  
The mechanisms that keep CpG islands free of methylation appear to involve binding of transcription 
factors and transcriptional machinery itself. However, according to recent studies, CpG islands can 
become hypermethylated (Meissner A et al. 2008; Mohn F et al. 2008) to silence specific genes 
during cellular differentiation, genomic imprinting and X chromosome inactivation. DNA methylation 
is catalyzed by DNA methyltransferases (DNMTs). Two DNMTs, DNMT3A and DNMT3B, are involved 
in de novo methylation (Okano M et al. 1999) and are targeted to particular genomic regions by 
specific histone modifications (Pradhan S et al. 1999).  
1.1.2. Nucleosomes positioning and modifications  
Nucleosome  remodeling 
In addition to its central structural role, nucleosomes are also key regulators of gene expression 
(Peterson CL and Laniel MA 1994, Imbalzano AN 1994). Generally speaking nucleosomes inhibit 
transcription by limiting the access of transcription complexes to DNA. Individual nucleosomes can 
be disrupted by ATP-dependent chromatin remodelling complexes which use the energy derived 
from ATP hydrolysis to perform their task (Smith CL and Peterson CL, 2005). A central activity in ATP-
dependent chromatin remodelling complexes is performed by a helicase-like protein of the SWI/SNF 
(switch genes/sucrose non-fermentors) family. This class of helicases has also been divided into three 
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subfamilies based on primary sequence homology as well as the individual characteristics of the 
corresponding remodelling complexes: the SWI2/SNF2, ISWI and Mi-2/CHD families (Figure 1.3.; 
Smith and Peterson, 2005).   
o The SWI2/SNF2 complexes have been implicated in the regulation of gene transcription in 
yeast but also mammalian organisms. The catalytic components contains bromodomains, which 
mediate interaction with acetylated histone tails. Mutations of SWI2/SNF2 complex components 
have been associated with tumor progression, in particular lung and gastric cancers. Aside from their 
role in transcriptional regulation, SWI2/SNF2 complexes have also been implicated in global 
chromatin structure control during mitosis when chromosomes undergo major structural changes.  
o The ISWI (imitation SWI)-based complexes contain ATPases, which are characterised by a 
different histone-binding domain than SWI/SNF complexes, namely the SANT domain. Although they 
participate in transcriptional regulation, they have been implicated in global nucleosome assembly 
and positioning. This is likely to be coupled to replication as ISWI components co-localise with 
replication foci in mammalian cells. Furthermore, ISWI complexes are thought to be involved in 
transcriptional repression, as well as the formation of silenced regions on chromatin (Smith CL and 
Peterson CL, 2005).  
o The ATPases of the third class of remodeling complexes, the Mi-2 family, contain another 
histone binding domain, the chromodomain. Many of the Mi-2 complexes are thought to participate 
in transcriptional repression by virtue of their association with histone deacetylases (Section 
1.1.3.1.). 
Histone variants  
Gene regulation is controlled by changes in histones isoforms that make up the nucleosome. The 
several different histone isoforms can vary by a small number of amino acids or include large 
insertions (Sarma K and Reinberg D, 2005). Variants for all histones except H4 have been identified 
and are thought to have occurred through gene duplication (Gilbert N and Ramsahoye B 2005). 
1.1.3. Covalent histone modifications 
The covalent modification of the N-terminal tails of histones is an important mechanism used to 
regulate eukaryotic transcription and to fine-tune chromatin structure.  
The Grunstein group lay the first cornerstone in the eventual description of this mechanism by 
showing that histone tails have specific functions. They found that between 14 and 38 amino 
terminal residues of each core histone extend outside the disk-shape complex as N and C terminal 
`tail' domains of histones.  Various studies have shown that these tails are substrates for a collection 
of posttranslational modifications that determine whether a gene is on or off or whether its activity is 
high or low, including acetylation (Ac) and methylation (Me) of lysines (K) and arginines (R), 
phosphorylation (Ph) of serines (S) and threonines (T), ubiquitylation and sumoylation of lysines, and 
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ribosylation. At least three of these posttranslational modifications (Ac, Me, Ph) are believed to exert 
their function primarily by disrupting histone/DNA contacts in the nucleosome, thus altering 
chromatin structure directly; while there is evidence that modified histone tails serve as platforms 
for other DNA regulatory complexes via the recruitment of proteins (Jenuwein T and Allis CD 2001). 
The term “histone code” is used to describe the complex pattern of histone modifications and how 
different combinations of histone modifications affect transcription levels (Strahl BD and Allis CD 
2000, Turner BM 2000, Jenuwein T and Allis CD 2001, Nakayama J et al. 2001). Identification of 
proteins that read, write or erase these marks is critical to help unravel the complexities of 
epigenetic regulation.  
 
Figure 1.3. Chromatin structure regulates transcriptional activity. 
The “Openness” of the chromatin, described as absence of nucleosomes or weak/unstable 
nucleosome binding, is crucial to allow and modulate the transcription rate of all genes (Figure 1.3.). 
When the chromatin is in an “open” conformation, the DNA is accessible to transcription factors and 
polymerase complexes, being a pre-requisite for effective transcription.  1.1.3.1.  Histone acetylation and deacetylation 
Lysine acetylation occurs on the N-terminal tails of core histones and is controlled primarily by two 
enzyme families: histone acetyl transferases (HATs) and histone deacetylases (HDACs).  
o HATs use acetyl CoA as a cofactor to transfer an acetyl group to the epsilon amino group of 
the lysine side chain. HATs constitute a remarkably diverse class of enzymes that play significant roles 
in transcriptional regulation (Roth SY et al. 2001). Numerous studies have highlighted that this 
modification is strongly correlated with active gene transcription (Clayton AL et al. 2001). They are 
recruited to specific sites of the genome by sequence-specific transcription factors to regulate gene 
expression. 
These enzymes are grouped into three sub-families: GNAT (Gcn5-related N-acetyltransferases), 
p300/CBP (CREB binding protein) and MYST (named after its founding members MOZ, Ybf2/Sas3, 
Sas2, and Tip60). The best characterised being p300/CBP.  
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o HDACs reverse histone acetylation and promote gene silencing. HDACs are often 
components of large protein complexes. Similarly to HATs, they are recruited to specific sites of the 
genome by sequence-specific transcription factors to regulate gene expression.  
Four classes of deacetylases have been described. Class I, which includes HDAC 1, 2, 3 and 8; 
Class, II, which includes HDAC 4, 5, 6, 7, 9 and 10; Class III, which includes the NAD+-dependent 
sirtuins (SIRTs, (Eckwall K 2005, de Ruijter AJ et al. 2003); and Class IV, which includes HDAC11. 
Sirtuins will be addressed extensively in Section 2.3. Class I HDACs are ubiquitously expressed, 
whereas Class II HDACs are restricted to specific tissues and thus may be involved in differentiation. 
Despite their name, it is now clear that deacetylation of proteins other than histones can be 
catalysed by HDACs, as is the case of HDAC6 which is associated with microtubules and deacetylates 
tubulin (Hubbert C et al. 2002).   
Both HATs and HDACs act in the context of multicellular complexes, which target them to specific 
genomic sites where they participate in the regulation of gene transcription. Importantly, and in 
contrast to HATs, recombinant HDACs by themselves do not exhibit robust deacetylase activity, and 
rely on additional co-factors to catalize deacetylase reactions (de Ruijter AJ et al. 2003).  
A plethora of studies have highlighted the connection between histone acetylation and 
transcriptional regulation and facilitated a deep understanding of how histone modifications control 
chromatin structure and gene expression. (Brownell JE et al.  1996, Kuo MH 1996, Taunton J et al. 
1996). Generally speaking, euchromatin, which is associated with transcriptionally competent regions 
of the genome, contains high levels of acetylated histones whereas heterochromatin is characterised 
by histones in a hypoacetylation state (Grewal SI and Moazed D 2003). Importantly, misregulation of 
HATs and HDACs is often associated with development and progression of cancer and other diseases 
such as neurodegenerative disorders and cardiovascular diseases, making these enzymes attractive 
therapeutic drug targets. 1.1.3.2.  Histone methylation  
Unlike acetylation, which generally correlates with transcriptional activation, histone lysine 
methylation can signal either activation or repression (Martin C and Zhang Y 2005). Histone 
methylation occurs at lysine (K) residues, which can be mono-, di- or trimethylated, and arginine (R) 
residues, which can be mono- or dimethylated (Gilbert N and Ramsahoye B 2005). 
To date, researchers have identified over 30 demethylating enzymes (Tsukada Y et al. 2006), over 50 
protein lysine methyltransferases and over 10 protein arginine methyltransferases, suggesting that 
protein methylation is a dynamic and complex process (Janzen WP et al. 2010).  
Histone methylation has different effects on transcriptional activity, depending on the number of 
methyl groups and on the position of the amino acid being modified. Although H3-K9, H3-K27, H4-
K20 methylation usually correlates with silent chromatin, whereas H3-K4, H3-K36, H3-K79 mark 
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transcriptionally active chromatin, this general rule is subject to exceptions (Sims RJ 3rd et al. 2003, 
Vaquero A  et al. 2003).  
In general, the H3K9me1 mark is activating, whereas H3K9me2 and H3K9me3 are repressive; 
H3K4me3 and H3K36me3 are associated with active chromatin, whereas H3K9me3, H3K27me3, 
H3K36me2 and H4K20me1 are often found in transcriptional repressed heterochromatin. H3K4me3 
recruits proteins that promote euchromatin formation, whereas H3K9me1, H3K9me2 and H3K27me3 
interact with proteins that promote heterochromatin formation.  
The downstream effects of histone methylation are largely determined by proteins that bind the 
modified histones.  1.1.3.3. Other Histone modifications:  phosphorylation, ubiquitination, sumoylation, ADP-ribosylation 
All histones, including H1, have been shown to be modified by phosphorylation. In particular, 
histones can be phosphorylated on serine, threonine and tyrosine residues. Many of the serine and 
threonine phosphorylation events play a role in DNA repair or DNA condensation, segregation and 
decondensation during mitosis, but some including H3T3ph, H3T6ph, H3T11ph, H2.AS1ph, H3S10ph 
and H4S41ph are involved in epigenetic regulation of transcription (Pérez-Cadahía et al. 2010). In 
addition to its DNA-restructuring responsibilities during mitosis, H3S10ph seems important for 
chromatin decondensation associated with transcriptional activation of target genes.  
Compared to phosphorylation, histone ubiquitination is a less understood modification. Unlike 
previous modifications, ubiquitination occurs in the C-terminus of histones and consists of the 
conjugation of ubiquitin, a 76-amino acid protein, to lysine residues of histone proteins. This can 
affect transcription activity as well as nucleosome stability and, as a result, gene accessibility. The 
consequences of histone ubiquitination depend on the histone substrate and on the degree of 
ubiquitination (Weake VM and Workman JL 2008). Moreover, histone deubiquitination has been 
associated with both transcription activation (Nakagawa M et al. 2008, Draker R et al. 2011, 
Gutierrez-Marcos JF and Dickinson HG 2012) and repression (van der Knaap JA et al. 2005, van der 
Knaap JA et al. 2010). Ubiquitination of histones can be reversed by cleaving the peptide bond 
between ubiquitin and the ubiquitinated protein. Several deubiquitinases (DUBs) have been reported 
to deubiquitinate histones 2A, 2A.Z and 2B, including USP3, USP10, USP21, USP22 and Bap1.  
An additional posttranslational modification that plays an important role in epigenetic regulation is 
sumoylation, which is the addition of the small ubiquitin-related modifier SUMO (Ouyang J and Gill G 
2009). This modification can stabilize proteins, alter subcellular localization, affect enzyme activity 
and mediate interactions with other proteins. Many transcription factors and cofactors can be 
sumoylated, which is generally indicative of transcription repression. Many histone-modifying 
enzymes, nucleosome-remodeling complexes and their associated enzyme cofactors contain one or 
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more SUMO interaction motifs (SIMs). These motifs allow these proteins to interact with sumoylated 
transcription factors and cofactors, which can direct these enzymes to specific promoters.  
Histone ADP-ribosylation occurs in glutamic acids in a polyglutamate stretch of single arginines 
(Vaquero A et al. 2003). Although mono-ADP-ribosylation can also occur, poly-ADP-ribosylation is 
relevant to histone function and can comprise more than 100 ADP-ribosyl moieties with extensive 
branching (Jacobson MK and Jacobson EL 1999). Poly ADP-ribosylation is a highly dynamic process 
catalyzed by poly-ADP-ribosyltransferases (PARPs) and removed by poly-ADP-ribose glycohydrolases 
(PARGs). PARP activity requires NAD+ and one of its enzymatic products is nicotinamide both are 
features of the enzymatic reaction catalysed by sirtuin deacetylases and related to energy demand 
(Sections 1.1.3.1. and 2.3.).  1.1.3.4. Histone code 
Most of the histones modifications mentioned above work in a coordinated manner. In fact, it has 
been demonstrated that site-specific combinations of histone modifications correlate well with 
particular biological functions (Peterson CL and Laniel MA 2004). Histone modifications serve as 
recognition moieties for specific protein domains that recruit additional chromatin-modifying 
complexes that regulate gene expression control. Thus, the modification status of histone tails and 
sequence elements encoded on the DNA can dictate chromatin structure and consequently 
transcriptional activity. The recognition of this organization lead to the coinage of the term "histone 
code" which postulates that covalent chromatin modifications are carriers of information that 
significantly contribute to gene expression control (Jenuwein T and Allis CD 2001). It is therefore of 
great interest to identify links between specific epigenetic phenomena and associated phenotypes as 
it becomes apparent that information other than the DNA nucleotide sequence is contained within 
chromatin. 
Examples that highlight the functional relevance of epigenetic control are plentiful, among them 
aberrant regulation of epigenetic mechanisms occurs in the absence of one of the recognition 
domains through gene mutation or rearrangement that can cause serious gene misregulation and 
diseases such as Angelman syndrome and Prader-Willi syndrome.  In addition, absence of recognition 
domain may contribute to the heritability of many forms of cancer; asthma; Alzheimer’s disease and 
autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis and multiple 
sclerosis (Hirst M and Marra MA 2009, Hewagama A and Richardson B 2009, Handel AE et al. 2010). 
Recently, researchers have characterized a translocation in an acute myeloid leukemia patient, 
involving histone demethylase KDM5A that results in fusion of the H3K4me3-binding PHD finger of 
KDM5A to the transcriptional activator NUP98, a common leukemia translocation partner (Islam S et 
al. 2011). Mutations that can interfere with epigenetic regulation can occur at many levels, some are 
inherited, but many accumulate due to environmental factors or with age.  
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1.2. Gene expression 
1.2.1. RNA polymerases 
The earliest evidence for the existence of DNA-dependent RNA polymerases (RNAP) was the 
discovery that the base composition of newly synthesized RNA is complementary to that of the DNA 
template. Additionally, hybridization experiments revealed that the RNA sequences are 
complementary to their DNA template (Hall BD and Spiegelman S 1961). The enzyme that produces 
RNA using a DNA template was discovered independently by Jerard Hurwitz (Hurwitz J et al. 1961) 
and Samuel Weiss (Weiss SB and Nakamoto T 1961). Both researchers named the enzyme “RNA 
polymerase”. 
While in prokaryotes, all RNA molecules are synthesized by a single type of RNA polymerase, in 
eukaryotes, where transcription takes place in the nucleus, there are three types of functionally- and 
structurally-related RNA polymerases (RNAPs) (Brueckner F et al. 2008). The three distinct eukaryotic 
RNAPs, designated RNAP I, RNAP II and RNAP III, were first distinguished according to their variable 
sensitivity to α-amanitin, a toxic cyclic octapeptide from the mushroom Amanita phalloides (Roeder 
RG et al. 1974, Schwartz LB and Roeder RG 1974).  
o RNAP I, which is preferentially localized in the nucleolus, transcribes the abundant array of 
tandem rRNA genes to produce a long transcript named the precursor ribosomal RNA (pre-rRNA) 
which is processed into 28S, 5.8S, and 18S rRNAs. 
o RNAP II, is located in the nucleoplasm and may cluster in “transcriptional hotspots”, 
transcribes all protein-encoding genes (mRNA), many noncoding RNAs, including all spliceosomal 
small nuclear RNAs (snRNAs) except U6, as well as small nuclear RNAs (snoRNAs), microRNA (miRNA) 
precursors and cryptic unstable transcripts (CUTs) (Iborra FJ et al. 1996).  
o RNAP III, like RNAP II, is located in the nucleoplasm (Lassar AB et al. 1983). It transcribes the 
genes encoding tRNAs, other ribosomal RNA molecules, 5S rRNA and other small, stable RNAs, 
including U6 RNA (involved in RNA splicing) and the 7S RNA of the signal recognition particle 
(involved in the transport of proteins into the endoplasmic reticulum).  
All DNA-dependent RNA polymerases are able to generate RNA from a DNA template in the 5’→3’ 
direction and do not require primer. The transcription process is generally divided in three main 
phases, known as initiation, elongation and termination.  Each of them can be regulated by 
transcription factors (Bregman DB et al. 2000, Panning B and Taatjes DJ 2008, Arndt KM and Kane CM 
2003, Hirose Y and Ohkuma Y 2007, Fuda NJ et al. 2009, Nechaev S and Adelman K 2011). 
1.2.2. Specificity of the carboxyl terminal domain of  RNA P II (CTD) 
A unique feature of RNAP II that distinguishes it from the other polymerases is the extended 
carboxyl-terminal domain (CTD) of its largest subunit, Rpb1. The CTD is essential for cell viability and 
plays a central role in the regulation of mRNA synthesis in vivo. The CTD of Rpb1 consists of a varying 
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number of tandemly repeated heptapeptides with the consensus sequence YSPTSPS Y1-S2-P3-T4-S5-
P6-S7 (Stiller JW and Hall BD 2002, Svejstrup JQ and Reid J 2004). The consensus repeat has been 
conserved in evolution, although the number of repeats seems to increase with the complexity of the 
organism, being 26 in yeast, 32 in C. elegans, 45 in Drosophila and 52 in mammals (Hampsey M 1998, 
Stiller JW and Hall BD 2002). The unstructured CTD serves as a platform for the assembly and 
recruitment of various factors involved in initiation, elongation, mRNA maturation, surveillance, and 
export (Hirose Y and Manley JL 2000, Orphanides G and Reinberg D 2002, Proudfoot NJ et al. 2002). 
Crystal structures indicate a highly versatile nature of CTD folding, depending on its phosphorylation 
status and binding partner. The CTD can be thought of as a nucleation centre for the multitude of 
factors that regulate mRNA processing events.  Specific modifications of the CTD allow RNAP II to 
proceed through the transcription cycle (see 1.2.3). These CTD modifications include phosphorylation 
(mostly on Ser2 and Ser5), glycosylation, and cis/trans isomerization of prolines (Lin PS et al. 2003). 
1.2.3. The eukaryotic RNA polymerase transcription cycle 
Transcription is a fundamental step in gene expression. As such, it is one of the most regulated and 
complex processes requiring the functioning of numerous auxiliary factors (Arndt KM and Kane CM 
2003, Hirose Y and Ohkuma Y 2007, Fuda NJ et al. 2009). The generation of mature mRNA by RNA 
polymerase involves a myriad of events, some of which occur sequentially and others in parallel. As 
mentioned above, transcripts are generated through a transcription cycle comprising the following 
steps: pre-initiation, initiation, elongation, termination and re-initiation (Figure 1.4.  Hahn S 2004).  
Pre-initiation 
DNA sequences located upstream (5') of the gene coding region recruit RNAP II to initiate gene 
transcription and constitute the pre-initiation complex (PIC). These sequences constitute the core 
promoter element, which is able to sustain transcriptional initiation by RNAP II. This sequence has to 
be accessible and must contain a specific epigenetic code as described in the previous chapter. The 
most common initiation sequence in eukaryotes is the TATA-Box. Initiation by RNAP II-catalysed 
transcription begins with the recognition of the TATA box element by the TATA-binding protein (TBP) 
of the transcription factor IID (TFIID) complex. TBP binding causes a dramatic conformational change 
in the DNA which is thought to contribute to the downstream transcriptional activation events 
(Orphanides G et al. 1996, Orphanides G and Reinberg D 2002).  RNAP II transcription initiation can 
also occur in the absence of TATA elements where other sequences such as the initiator (Inr) or the 
downstream core promoter element (DPE) take up its role (Butler JE and Kadonaga JT 2002).  
A major role in the pre-initiation step is played by sequence specific binding transcription factors to 
DNA recognition elements that can affect the recruitment and stability of the basal transcriptional 
complex and may facilitate the unwinding or “opening” of the DNA around the transcription start 
site. Recognition elements concentrate in the near proximity of the transcription start site, 
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preferentially in the upstream region, but can be found in other locations, generally grouped in the 
so called “enhancer” elements (Cosma MP et al. 1999, Nechaev S and Adelman K 2011). While in the 
proximal promoter regions the orientation, relative to the initiation elements, is important, distal 
enhancers do not have these topological constraints and can promote transcription in a position- and 
orientation-independent manner.  
Transcription factors and associated factors such as GAGA associated factor (GAF) recruit chromatin 
remodeling complexes, facilitating disruption nucleosome positioning and opening of the DNA 
double helix to form a “transcription bubble”, rendering it competent as a transcription template 
(Chen LI et al. 1994, Tsukiyama T et al. 1994, Cosma MP et al. 1999, Peterson CL and Workman JL 
2000, Boehm AK et al. 2003, Boeger H et al. 2004). This process is ATP dependent and requires the 
action of TFIIE and TFIIH (Goodrich JA and Tjian R 1994, Holstege FC et al. 1996, Kim TK et al. 2000) in 
eukaryotes. A large number of factors have been shown to be involved in the initiation of 
transcription and recruitment of polymerase and the list of members of the pre-initiation complex 
(PIC) might not be complete yet (Imbalzano AN et al. 1994, Ohkuma Y 1997, Wilkins RC and Lis JT 
1997, Esnault C et al. 2008). Upon DNA binding, RNAP II is phosphorylated at the serine 5 residue of 
its C-terminal tail by TFIIH, driving the formation of a transcription elongating complex (Akoulitchev S 
et al. 1995, Nechaev S and Adelman K 2011). 
 
Figure 1.4: Transcription cycle 
Pre-initiation/initiation  
The earliest stages of transcription are marked by instability of the transcription complex and a 
pronounced tendency to release short pieces of RNA (2-5mers) in a phase, named “abortive 
initiation”. Synthesis of about 23 bases renders the complex maximally stable (Wu CH et al. 2003). 
RNAP II then proceeds into productive transcription elongation and completes transcription of the 
gene (Figure 1.4.). The mechanism involves tight connection with chromatin modulation and RNAP II 
CTD.  
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Promoter clearance and early elongation 
The transition to elongation goes along with partial PIC disassembly. A subset of common TFII 
proteins, and the mediator complex, stays at the promoter, serving as a scaffold for the formation of 
the next transcription initiation complex (Pal M and Luse DS 2003, Yudkovsky N et al. 2000, Zawel L 
et al. 1995). Therefore, re-initiation of transcription is a much faster process compared to the initial 
round (Jiang Y and Gralla JD 1993, Orphanides G and Reinberg D 2000, Ranish JA et al. 1999). Of all 
the general components of the PIC, only TFIIF can be found associated to RNAP II during the 
elongation phase (Sims RJ 3rd et al. 2004).  
Transcription elongation factors 
Transcription elongation by RNAP II is regulated at different stages by auxiliary factors (Saunders A et 
al. 2006). There are three main categories of transcription elongation factors. A classic example of 
the first is TFIIS. It re-activates elongation complexes that have paused or stopped during elongation 
(Wind M and Reines D 2000). The second class, which includes the CTDK-I and the Bur1/2 kinase 
complexes, facilitates the escape of the elongation complex from the promoter (Cho EJ et al. 2001, 
Jona G et al. 2001, Keogh MC et al. 2003). Finally, in the third class, we find proteins like Spt4/Spt5 
and the THO complex that have been shown to increase elongation efficiency (Hartzog GA et al. 
1998, Jimeno S et al. 2002, Strasser K et al. 2002, Rondon AG et al. 2003). 
Termination and mRNA processing 
The choreography of termination and mRNA processing is intimately linked in eukaryotes. Before a 
gene transcript leaves the nucleus as mature mRNA, it has to undergo three major processing events:  
o Capping, a GMP molecule is fused to the 5’-terminus of nascent RNA via an unusual 5’-5’ 
triphosphate linkage and then methylated at position N7. This cap protects the nascent RNA from 
exonucleolytic 5’→3’ degradation and is recognised during nuclear export of mature mRNA. 
o Splicing removes non-coding sequences (introns), which are present in most mammalian 
genes and some yeast genes. This subject will be addressed as a result of the present work. 
o Polyadenylation, the 3’-terminus of mRNAs comprises a poly(A) tail of about 200 nucleotides. 
This poly(A) tail is attached to the pre-mRNA following cleavage by a specific RNA nuclease at 
polyadenylation sites, followed by incorporation of the poly A tail by the polyadenylation complex or 
by an intrinsic ribozyme (Teixeira A et al. 2004).  
All three processes are known to be interconnected and co-regulated with the transcriptional 
initiation and termination (Proudfoot N 2004, Proudfoot NJ et al., 2002). However, control of 
eukaryotic termination is still not well understood. During termination, the transcript is released 
from the transcription site and RNAP II gets detached from the DNA template.  
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1.2.4. Noncoding RNAs 
In the year 2000, sequencing of nearly the entire human genome revealed approximately 20 000 
protein-coding genes (approximately 1.5% of the genome).  The rest of the genome is made up of 
noncoding RNA molecules, regulatory DNA sequences, introns and sequences to which no function 
has been assigned. There is increasing evidence that expression of noncoding RNAs, such as 
microRNAs, small RNAs and large RNAs, plays a role in gene regulation at all levels, including those 
dependent on epigenetic modifications (Costa FF 2008, Chuang JC and Jones PA 2007). Noncoding 
RNAs can direct both cytosine methylation and histone modification to silence DNA repeats in the 
genome. 
Since the discovery of the first small silencing RNA in 1993, a remarkable number of small RNA 
classes have been discovered, including microRNAs (miRNAs), small interfering RNAs (siRNAs), and 
Piwi-associated small RNAs (piRNAs), which have important roles in various biological processes. The 
discovery of new classes of small RNAs and new members of existing classes substantially expands 
our knowledge of small RNAs. For instance, a class of small RNAs originated from small nucleolar 
RNAs (snoRNAs) have been identified to function like miRNAs. Notably, a new type of siRNA, known 
as qiRNAs (QDE-2-interacting small RNAs), originates mostly from the rDNA locus and has roles in 
DNA damage response in the filamentous fungus Neurospora crassa. Moreover, other novel classes 
of small RNA are being revealed, including cis-acting siRNA (casiRNA), trans-acting siRNA (tasiRNA), 
natural antisense transcript siRNA (natsiRNA), exogenous siRNA (exo-siRNA) and endogenous siRNA 
(endo-siRNA). Besides, there are also a number of small RNA classes, such as heterochromatic siRNA 
(hc-siRNA), stem bulge RNA (sbRNA), vault RNA (vtRNA), small scan RNA (scnRNA), Y RNA and DSB-
induced small RNA (diRNA). Nevertheless, many small RNAs identified in high-throughput sequencing 
analysis do not belong to any of these classes, suggesting there are still more uncharacterized types 
of small RNAs. 
2. Environmental adaptation 
Living environments are dynamic rather than static. The ability of organisms to adapt to these 
environmental changes allows them to increase their survival potential and contribute to the 
evolution of the species. In single-cell eukaryotes, elaborate networks are in action to sense and 
respond to environmental changes. These principles of adaptive responses are conserved in 
multicellular organisms. Multiple regulatory inputs convert to implement the transcriptional 
program, i.e. the regulation and expression of new genes supporting specific cellular functions. An 
intimate connection between basic homeostatic pathways is necessary to ensure the coordinate 
control of cellular activities in response to environmental factors. 
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2.1. Signaling pathways regulating responses to metabolite availability 
Transcriptional activity is modulated through several different classes of coregulators that do not 
bind to specific DNA sequences but are rather recruited to the PIC by classical transcription factors. 
Many of these co-regulators, commonly described as coactivators and corepressors, were initially 
identified following two hybrid approaches that aimed to identify interacting proteins of classical 
transcription factors (Glass CK and Rosenfeld MG 2000, McKenna NJ et al. 1999, Naar AM et al. 
2001). Generally coregulators interact with members of the PIC to regulate transcription, and/or are 
responsible for epigenetic modifications elicited by themselves or by other factors recruited in a 
sequential or a combinatorial manner, generally forming large multiprotein complexes. Taking into 
account that each coregulator can interact with multiple transcription factors and vice versa, 
understanding the mechanisms that lead to specific protein complexes and the biological roles of 
these specific partnerships is fundamental. The large number of coactivators and coactivator 
complexes already identified show a large functional and mechanistic diversity, and integration of 
multiple signal clues in order to confer for example tissue and promoter-specific regulation of target 
genes. Two main types of coactivator complexes have been described based on their mechanism of 
action: ATP-dependent chromatin-remodeling complexes and histone-modifying complexes.  2.2. PGC-1 alpha family: inducible tissue specific coactivators 
2.2.1. Structure features 
Peroxisome Proliferator-Activated Receptor Gamma-Coactivator-1α (PGC-1α) is the founding 
member of the PGC-1 family of coactivators. They lack enzymatic activities and show several 
characteristic features (Figure 1.5).  
 
Figure 1.5: Peroxisome Proliferator-Activated Receptor Gamma-Coactivator-1α (PGC-1α) 
The N-terminus of PGC-1α harbors a potent acidic transactivation domain and three leucine rich 
LXXLL motifs--L1, L2 and L3 that reside in predicted α-helices. These motifs are conserved among all 
the PGC-1α family members (Kressler D et al. 2002). Motif L2, in particular, serves as the major 
interaction surface for several transcription factors of the nuclear receptor superfamily, including GR 
ER, PPARs, RXR, LXR and probably others (Delerive P et al. 2002, Knutti D et al. 2001, Oberkofler H et 
al. 2003, Tcherepanova I et al. 2000, Vega RB et al. 2000). PGC-1α has additional interaction domains 
that have been proposed to bind PPARγ, NRF-1 and the muscle-specific transcription factor MEF2C 
(Michael LF et al. 2001, Puigserver P et al. 1998, Wu Z et al. 1999, Rodgers JT 2008). Two coactivators 
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(SRC-1 and CBP/p300) dock on the N-terminus activation domain with acetyl transferase activity. This 
interaction can promote chromatin opening thereby allowing initiation of the transcription through 
RNAP II binding (PIC-CTD; Monsalve M et al. 2000). 
At the C terminus, PGC-1α harbors two atypical motifs a serine/arginine rich (RS) domain and a RNA 
recognition motif (RRM) (Knutti D et al. 2000). Strikingly, both RRM and RS domains are characteristic 
features of SR splicing factors, components and/or regulators of the spliceosome (Graveley BR 2000, 
Hastings ML and Krainer AR 2001, Reed R and Magni K 2001). The C-terminal PGC-1α is proposed to 
interact with the elongation form of polymerase II (RNAP II ph), and to regulate mRNA processing 
(Monsalve M et al. 2000). The RS domains are shown to be important for protein-protein 
interactions, especially transcription factors like FoxO3a. The RRM motif has been shown to be 
relevant for PGC-1α activity but so far it was unknown whether it actually bound RNA and the 
regulatory function of the ligand RNA. Since the ligated RNA would be expected to regulate PGC-1α 
activity, its identification as well as the determination of its regulatory activity might serve to 
modulate PGC-1α activity in vivo. The work presented has as one of its main aim to characterize the 
role of the RRM of PGC-1α. 
Post-translational mechanisms regulating PGC-1α  
PGC-1α undergoes several posttranslational modifications (PTMs) including phosphorylation, 
methylation, acetylation and ubiquitination. The phosphorylation by the MAPK, p38 at Thr262-
Ser265-Thr298 correlates with a more active and stable protein (Puigserver P et al. 2001). AMP 
kinase (AMPK) targets residues Thr 177 and Ser 38 resulting in a more active protein. Moreover, 
Akt/PKB phosphorylation of Ser 570 in the SR domain leads to a more unstable protein (Figure 1.5.). 
GCN5 acetylates and inactivates PGC-1α while the deacetylated active status of PGC-1α is 
maintained by the class III NAD+ dependent deacetylase SirT1. 
 
Figure 1.6: Peroxisome Proliferator-Activated Receptor Gamma-Coactivator-1α (PGC-1α) Family 
PGC-1-related coactivator (PRC) was the first homologue of PGC-1α to be identified based on its N-
terminus sequence homology (Andersson U and Scarpulla RC 2001, Figure 1.6). Even though the PRC 
overall sequence similarity with PGC-1α is fairly low, the domain pattern is highly similar. Both 
coactivators contain the N-terminal acidic transactivation domain, the nuclear receptor interaction 
(LXXLL) motif, the proline rich region, the RS domain and the RNA binding domain. 
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Later, a second, more closely related homologue was cloned, named PGC-1β (mouse) (Kressler D et 
al. 2002, Lin J et al. 2002). Sequences of PGCP 1α, β and PRC display around 45 to 46 % (over 450 
amino acids) similarity in the C-terminus; whereas all three proteins contain an RNA recognition 
motif, PGC-1β does not contain an RS domain. PGC-1β displays a marked specificity in the interaction 
with nuclear receptors (Kressler D et al. 2002), showing a strong regulatory activity of ERα. PGC-1α 
and PGC-1β have been shown important additional functional differences, indicating that the two 
coactivators have overlapping but not identical functions (St-Pierre J et al. 2003).  
2.2.2. Implications of PGC-1 alpha in environmental changes, regulation of PGC-1 alpha 
activity Activation of PGC-1α 
 PGC-1α is a transcriptional coactivator identified as an upstream regulator of lipid catabolism, 
mitochondrial number and function. PGC-1α is expressed in a tissue-specific manner and induced by 
specific metabolic signals. Consistent with its emerging role as a central regulator of energy 
metabolism, PGC-1α is abundantly expressed in tissues with high metabolic rates that have a high 
density of active mitochondria, like heart, skeletal muscle, brown adipose tissue (BAT), kidney, liver 
and brain (Esterbauer H et al. 1999, Knutti D et al. 2000, Puigserver P et al. 1998). In addition, PGC-1α 
is induced in physiological states that have high energy demands, such as exposure to cold and 
physical exercise (Goto M et al. 2000, Herzig S et al. 2001, Lehman JJ et al. 2000, Puigserver P et al. 
1998) PGC-1α is tightly regulated in a temporally and spatially defined manner since both increased 
and decreased levels could potentially contribute to diseases.  PGC-1α regulates mitochondrial biogenesis in response to specific signals  
Mitochondria provide cellular energy in the form of ATP. The mitochondrial content and respiration 
efficiency vary greatly from cell type to cell type and reflect the energy demand defined by the 
physiological status of the cell (Moyes CD and Hood DA 2003). The modulation of mitochondrial 
functions is a complex process, which requires the coordinate expression of mitochondrial and 
nuclear encoded proteins. A number of studies have shown that PGC-1α works as a master regulator 
of mitochondrial biogenesis. Ectopic expression of PGC-1α in adipocytes, myocytes and 
cardiomyocytes induces the biosynthesis of mitochondria and increases cellular respiration (Goto M 
et al. 2000, Lehman JJ et al. 2000, Puigserver P et al. 1998, Wu Z et al. 1999). Significantly, PGC-1α up 
regulation is detected in the heart of mice directly after birth, shortly before a strong increase of 
mitochondrial biogenesis and oxidative metabolism (Lehman JJ et al. 2000) and PGC-1α levels are 
increased in muscle after exercise, a situation of high energetic demand (Goto M et al. 2000).  
ROS (reactive oxygen species) are by-products of several metabolic reactions in the cell and primarily 
in mitochondria. An excess of ROS in mitochondria is able to cause oxidative stress. To prevent the 
oxidative damage of cellular machineries and in particular of the DNA, cells have developed a 
complex antioxidant defense system consisting of superoxide dismutases and glutathione 
Introduction 
17 | P a g e  
  
transferring enzymes among others (Figure 1.7.). PGC-1α, a potent regulator of mitochondrial 
biogenesis, has been involved in the cellular response to oxidative stress.  Oxidative stress 
ROS (reactive oxygen species) are by-products of several metabolic reactions in the cell and a by-
product of mitochondrial oxidative metabolism. An excess of mitochondrial ROS production results in 
cellular oxidative stress. To prevent the oxidative damage of cellular machineries and in particular of 
the DNA, cells have developed a complex antioxidant defense system consisting of superoxide 
dismutases and glutathione transferring enzymes. PGC-1α, a potent regulator of mitochondrial 
activity, has been shown to coordinately regulate the expression of antioxidant genes preventing 
oxidative stress upon mitochondrial activation through its interaction with the transcription factor 
FoxO3a. 
 
Figure 1.7: Antioxidant defense system PGC-1α role in adaptive thermogenesis 
Adaptive thermogenesis is a process closely associated with the function of mitochondria and energy 
expenditure. This program is switched on in response to exposure to cold and overfeeding, and leads 
to the production of heat instead of energy through the uncoupling of the respiratory chain 
(Puigserver P and Spiegelman BM 2003). PGC-1α is strongly induced in the brown fat and muscle (i.e. 
thermogenic tissues) of mice upon exposure of the animals to cold. Overexpression studies reveal 
that PGC-1α is capable of up regulating molecular components of the adaptive thermogenesis, e.g. 
the UCPs (uncoupling proteins), a process likely to depend on the interaction of PGC-1α with PPARα, 
PPARγ, RAR and TR (Puigserver P et al. 1998).  
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PGC-1α function in glucose metabolism 
Fasting induces a strong upregulation of PGC-1α in the liver and the heart (Lehman JJ et al. 2000, 
Yoon JC et al. 2001). The main regulators of the fasting state are glucagon, which is acting through 
the cAMP pathway, and glucocorticoids. After cAMP levels rise, protein kinase A (PKA) exerts 
increased activity and activates the cAMP-response element binding protein (CREB). The treatment 
of hepatic cells with cAMP leads to an upregulation of PGC-1α (Yoon JC et al. 2001). The PGC-1α 
promoter harbors binding sites for CREB and seems to be regulated by this factor (Herzig S et al. 
2001). In the fasting state, gluconeogenesis is increased in the liver to ensure glucose availability to 
tissues like the brain. Overexpression of PGC-1α induces the expression of PEPCK and glucose-6-
phosphatase, two key enzymes of gluconeogenesis, through the coactivation of HNF4, GR and FOXO1 
(Herzig S et al. 2001, Puigserver P and  Spiegelman BM 2003, Yoon JC et al. 2001).  2.3. Implication of Sirtuins in environmental changes 
2.3.1. Sirtuins and caloric restriction 
SirT1 belongs to a NAD+ dependent histone deacetylase family of enzymes known as sirtuins, first 
described in yeast (Frye RA 1999, Howitz KT et al. 2003, Denu JM 2005). In C. elegans, overexpression 
of the homolog Sir2 increases lifespan, which requires DAF-16, the homolog of mammalian FOXO and 
the induction of antioxidant genes like sod2 (Tissenbaum HA and Guarente L 2001).  
In humans and rodents, seven genes share the Sir2 conserved domain (sirtuin (SIRT) 1 to 7). SirT1 is 
the major effector of increased NAD+, making it a key sensor of the cellular redox status.  It is located 
in the nucleus and is involved in chromatin remodeling, inducing gene silencing and genomic stability 
and also in the regulation by deacetylation of transcription factors like p53 (Kang J et al. 2005). SirT1 
promotes cell survival by negatively regulating the pro-apoptotic activity of the tumor suppressor 
p53 (Vaziri H et al. 2001).  
Caloric restriction induces SirT1 expression and activity in a wide array of tissues, which shifts the 
balance away from cell death towards cell survival. SirT1 regulates the gluconeogenic/glycolytic 
pathways in the liver in response to fasting signals through the transcriptional co-activator PGC-1α. 
Once SirT1 is induced, it interacts with and deacetylates PGC-1α at specific lysine residues in an NAD+
 
dependent manner (Rodgers JT et al. 2005). SirT1 has also been shown to coregulate PGC-1α in the 
induction of oxphos genes, increasing oxygen consumption in response to fasting and exercise in the 
muscle. 
SirT1 also regulates cell fate in response to oxidative stress by regulating FOXO transcription factors. 
FOXO are a family of transcription factors that in response to changes in the insulin signalling 
pathway regulates cell metabolism and stress response, being as already mentioned key mediators of 
increased organism longevity in response to CR. In mammalian cells, in response to oxidative stress, 
SirT1 deacetylase forms a protein complex with the Forkhead transcription factor FoxO3a and 
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deacetylates it. SirT1 differentially affects the function of FoxO3a, increasing FOXO3a’s effect on cell 
cycle arrest and DNA repair target genes, but attenuating FoxO3a-dependent apoptosis in the 
presence of stress stimuli (Brunet A et al. 2004). Furthermore, under non-restricted nutrient 
availability conditions, p53 represses SirT1 expression. In contrast, under starvation conditions, the 
ability of activated FoxO3a to stimulate SirT1 expression requires p53. This suggests that in the 
absence of p53, the basal expression level of SirT1 might marginally respond to FoxO3a, while the 
starvation-induced increase would be more pronounced (Nemoto S et al. 2004). Our group has 
further demonstrated that PGC-1α, SirT1 and FoxO3a form a complex involved in the regulation of 
antioxidant gene expression. 
2.3.2. Sirtuins enzymatic properties 
The sirtuin family of enzymes is characterized by a highly conserved core domain which carries a 
catalytic activity and is flanked by N- and C-terminal regions of variable length.  The flaked regions 
are particularly prevalent in the more recent additions of the evolutionary time-scale. Two enzymatic 
activities have been associated with sirtuins, ADP-ribosyltransferase and NAD+ dependent protein 
deacetylase. Using computer-based homology searches, Frye provided the first comprehensive 
description of the sirtuin family, discovering the first five human orthologues. He provided 
experimental evidence that some bacterial, yeast and human sirtuin members harbor ADP-
ribosyltransferase activity (Frye RA 1999). Interestingly, this activity seems to depend on 
nicotinamide adenine dinucleotide (NAD+). Mammalians SirT6 was shown to be an ADP-
ribosyltransferase (Liszt G et al. 2005). Further studies have confirmed the same enzymatic activity 
for other sirtuins in yeast, Drosophila and mammals.  
2.3.3. Nicotinamide and NAD+ biosynthesis pathway 
Biochemical studies, along with structural data, have provided sound evidence that two naturally 
occurring metabolites, NAD+ and nicotinamide, may regulate SirT1 activity.  
In both prokaryotic and eukaryotic cells two pathways participate in NAD+ biosynthesis, the de novo 
pathway and the salvage pathway. Both pathways share, as a common intermediate, the nicotinic 
acid mononucleotide (NaMN). NAD+ is involved in many metabolic, primarily catabolic, processes 
such as glycolysis and the tricarboxylic acid (TCA) cycle, where it participates as a proton acceptor 
leading to its reduction to NADH+. It is also very important in DNA metabolism since enzymes like 
DNA ligase and poly(ADP) ribose polymerase (PARP) depend on NAD+ for their activity. 
The ratio of NAD+ to NADH+ mirrors the redox state of the cell and fluctuates in response to 
metabolic changes. As a result, it modulates the activity of enzymes like glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) of the glycolysis pathway and pyruvate dehydrogenase (PDH), which 
converts pyruvate to acetyl-CoA, driving the oxidative catabolism of glucose. Thus, homeostatic 
mechanisms exist ensuring constant re-oxidation of NADH to NAD+, of which the most important is 
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the mitochondrial respiratory chain. Therefore, when mitochondrial activity is not enough to 
replenish the NADH+ pool, elevated NAD+ activate SirT1, that in turn enhances PGC-1α activity on 
mitochondrial genes. 2.4. Involvement of forkhead transcription factors in environmental changes 
2.4.1. Forkhead transcription factors and caloric restriction 
The insulin receptor (IR) pathway has been described as a phylogenetically conserved signaling 
module that determines life-span in Drosophila and C. elegans. The forkhead transcription factor daf-
16, which is negatively regulated by the insulin pathway, is a key mediator of increased longevity in 
the absence of IR or its downstream effectors, PI3K and AKT (Giannakou ME and Partridge L 2004). In 
mammals, the functional orthologues of daf-16 are represented by the “O” class of the forkhead or 
winged helix family of transcription factors (FoxOs), with four members, FoxO1 (or FKHR), FoxO3a (or 
FKHRL1), FoxO4 (or AFX) and FoxO6. AKT dependent phosphorylation of these factors leads to their 
exclusion from the nucleus under conditions of growth factor availability. FoxO1 binds PGC-1α to 
induce gluconeogenesis, while FoxO3a binds PGC-1α to induce antioxidant genes. 
The acetyltransferase CBP/p300 enhances acetylation of FoxO1, FoxO3a and FOXO4. PCAF has the 
same effect on FoxO3a. These acetyltransferases have also been shown to acetylate PGC-1α.  SirT1, 
as already mentioned, deacetylates FoxO1, FoxO3 and FoxO4 factors as well as PGC-1α.  
Regulation of cell cycle arrest genes by FoxO factors in response to oxidative stress depends on SIRT1 
activity (Brunet A et al. 2004). In response to oxidative stress FoxO factors becomes first acetylated 
by the acetylase p300 and then deacetylated by SirT1 (van der Horst A et al. 2004, Kobayashi Y et al. 
2005). Acetylation impairs the capacity of FoxOs to regulate cell cycle arrest but keeps intact or 
enhances its capacity to induce pro-apoptotic genes. That implies that in response to oxidative stress 
FoxO will induce apoptosis unless it becomes deacetylated.  
Importantly, acetylation of FoxO factors in response to oxidative stress increases their sensitivity to 
phosphorylation by the phosphatidylinositol 3-kinase (PI3K)/AKT pathway (Jing E et al. 2007, 
Matsuzaki H et al. 2005) which in turn promotes their ubiquitination and degradation (Plas DR and 
Thompson CB 2003) while deacetylation by SirT1 promotes protein stabilization (Olmos Y et al. 
2013). Intriguingly, deacetylation has also been shown to drive FoxO3 degradation (Wang F et al. 
2012) and resveratrol, an activator of SirT1, has been proposed to be able to regulate FoxO in a SirT1 
and AKT independent manner (Qiang L et al. 2010). 
The first antioxidant gene that was demonstrated to be regulated be regulated by FoxO in a SirT1 
dependent manner was sod2, coding for the mitochondrial Mn2+ superoxide dismutase (MnSOD) (van 
der Horst A et al. 2004). The relevance of this regulation was later demonstrated in mouse models of 
oxidative stress induced heart failure (Tanno M et al. 2010, Alcendor RR et al. 2007). The report by 
Alcendor RR et al. (2007) also showed that SirT1 regulated the expression of another antioxidant 
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gene previously characterised as a FoxO target gene, catalase. A later study demonstrated the 
relevant of catalase regulation by the FoxO/Sirt1 complex in, renal tubular cells (Hasegawa K et al. 
2008). More recently, it was shown that SirT1 acts as a coactivator of FoxO in the regulation of the 
ROS detoxification enzymes, peroxiredoxins 3 and 5 (Prx3, Prx5), thioredoxin 2 (Trx2), thioredoxin 
reductase 2 (TR2), and also uncoupling protein 2 (UCP-2), a protein that protects mitochondria from 
excessive O2- generation in the electron transport chain (ETC, Olmos Y et al. 2013). All these results 
stress the crucial interplay between SirT1 activity and FoxOs in the response to oxidative stress. 
Importantly, it has been recently shown that FoxOs are indispensable for SIRT1-dependent cell 
survival against oxidative stress (Hori YS et al. 2013). 
2.4.2. Forkhead transcription factors: structure and cellular expression 
The FoxO class has been shown to recognize two distinct types of DNA binding elements (DBE) the 
insulin response element (IRE), and the Daf-16 binding element. The DBE was defined as TTGTTTAC, 
which overlaps with the IRE: CACTAGCAAAACAAACTTATTTTGAACAC. The consensus sequence is 
generally regarded to be (G/A)(T/C)(C/A)AA(C/T)A. FoxOs can also regulate target gene expression in 
a DNA-binding independent manner through their interaction with other transcription factors such as 
CCAAT/enhancer binding protein β (CEBPB), and Creb/binding protein (CBP), several nuclear 
receptors (NRs) and Smads. FoxO3a  
FoxO3a protein is encoded by foxO3 gene, which is located in chromosome 6q21 and is 124.7kb. The 
transcription factor FoxO3a is a downstream target of several signalling pathways. FoxO3a can 
shuttle between the cytoplasm and the nucleus and many PTMs impact its subcellular location. 
FoxO3a target genes are involved in the cellular stress responses. FoxO3a can induce either cell 
survival or cell death genes depending on the activity of other TF, coactivators, or PTMS. Target 
genes include genes that play a role in DNA repair, cell cycle arrest, cell death, tumor suppression, 
cellular differentiation and proliferation, ROS detoxification and metabolism. FoxO3a works as a 
tumor suppressor inducing apoptosis of terminally damaged cells. Other oncogenic kinases have also 
been related to FoxO3a inactivation in tumors, including SGK and ERK. However, FoxO3a can also 
promote tumorogenesis, enhancing chemoresistance of cancer cells.  
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Objectivos  
 
Identificar los mecanismos transcripcionales implicados en la regulación de la expresión de los genes 
antioxidantes, esencialmente: 
 
1) Valorar la contribución del factor SirT1 a la regulación génica e identificar los mecanismos 
implicados 
• Determinar si la histone desacetilasa SirT1 actúa como regulador de la expresión de genes 
clave en la defensa antioxidante, especialmente a nivel mitocondrial, tales como MnSOD, 
CAT, Prx3, Prx5, Trx2, TR2, UCP-2 así que los cofactores FoxO3a y PGC-1α. 
• Analizar el efecto de SirT1 sobre la formación de un complejo FoxO3a/PGC-1α. 
• Determinar los sitios de reclutamiento de SirT1 en las regiones reguladoras de los genes 
diana. 
• Determinar el entorno de estas regiones al nivel de acetilación. 
• Analizar la secuencia del proceso de activación de la transcripción por estos genes diana en 
situación de estrés oxidativo. 
 
2) Analizar la función del dominio RRM de PGC-1α a la actividad de este factor y los mecanismos 
implicados 
 2.1) Caracterización funcional del dominio RRM 
• Identificar los genes afectados en ausencia de PGC-1α en los hepatocitos usando análisis a 
nivel genómico (WGE). 
• Analizar el efecto funcional de la ausencia del dominio RRM en los hepatocitos usando nivel 
genómico (WGE). 
• Determinar el efecto regulador del RRM sobre la maturación de los RNAs. 
2.2) Identificación de los posible RNAs ligados 
• Estudiar si PGC-1α es capaz de interaccionar con ácidos nucleicos y determinar de qué tipo. 
• Identificar los ácidos nucleicos  que se unen a PGC-1α en los hepatocitos utilizando la técnica  
de HITS-CLIP. 
  
 
 
  
  
Objectives  
 
Identify transcriptional mechanisms involved in regualtion of antioxidant gene expression, 
essentially: 
 
1) Assess the SirT1 contribution in gene regulation and identify the implied mechanisms  
• Determine if the histone deacetylase SirT1 regulates expression of key antioxidant genes, 
essentially at mitocondrial level, as MnSOD, CAT, Prx3, Prx5, Trx2, TR2, UCP-2 and the 
cofactors: FoxO3a y PGC-1α. 
• Analize SirT1 implication on the establishment of a complex FoxO3a/PGC-1α. 
• Determine SirT1 recruitment sites within the regulatory regions of the target genes.  
• Determine the acetylation level of the regulatory regions of the target genes.  
• Analize the transcription activation sequence of the target genes when submitted to 
oxidative stress.  
 
2) Analize PGC-1α RRM domain fonction ,  its activity and the regulatory mechanisms involved   
 2.1) Characterize the RRM fonctional domain  
• Identify genes affected in absence of PGC-1α in hepatocytes when performing whole gene 
expression analysis (WGE).  
• Analize the functional effect when the PGC-1α RRM domain is missing in hepatocytes when 
performing whole gene expression analysis (WGE).  
• Determine the RRM regulatory effect on RNAs maturation. 
2.2) Identification of possible bound RNAs   
• Investigate if PGC-1α is able to interact with nucleic acids and determine the specific type.  
• Identify the nucleic acid  bound to PGC-1α in hepatocytes applying the HITS-CLIP technique.  
  
 
  
  
  
 
 Materials and Methods 
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Materials and Methods 
1. Mice 
C57BL6 PGC-1α-/- mice were part of a colony established within the CNIC and IIB animal facilities by 
embryonic transfer. The funder PGC-1α-/- mice were originally provided by Dr. Bruce Siegelman 
(DFCI, USA), head of the lab were the animals were initially generated (Lin J et al. 2004). 
C57BL6 SirT1+/- mice used were part of a colony established within the CNIC and IIB animal facilities. 
The funder Sirt1+/- mice were originally provided by Dr. Manuel Serrano (CNIO, Spain), who 
established a colony from mice donated by the laboratory of Dr. David Sinclair (HMS, USA), where 
they were initially generated (Pfluger PT et al. 2008). 
Animal care protocols are in accordance with Spanish legislation on care of experimental animals 
(Real Decreto 1201/2005 and Law. Law 6/2013 of the 11th of July, 2013 that modifies the previous 
Law 32/2007 of the 7th of November, 2007 for animal care for animal exploitation, transport, 
experimentation and sacrifice. And it also conforms to European Council Directive 86/609/EEC on the 
protection of Animals used for Experimental and other scientific purposes. Housing and handling 
procedures are in accordance with the recommendations of the European Commission of the 18th of 
June, 2007 that provides guidelines on housing and care of experimental animals. 
Animals were maintained free of disease and specific parasites and under controlled conditions of 
light, pressure and temperature with access ad libitum to water and food. Colonies were maintained 
with a standard CHOW diet from Harlam. 
The animal experimental protocols were approved by the Institutional Animal Care and Use 
Committee of the CNIC and the CISC. All protocols used conform to the Declaration of Helsinki and to 
the Guide for the Care and Use of Laboratory Animals published by the US National Institute of 
Health (NIH publication No. 85-23). 
2. Cell culture 2.1. Primary Cells 
Bovine aortic endothelial cells (BAEC) were isolated and cultured as previously described (Lamas S et 
al. 1991, Lopez-Ongil S et al. 1996). In brief, aorta sections from under one-year-old cows were 
donated for scientific use by an authorized slaughter house, “El Matadero” (Colmenar Viejo, Madrid). 
The aortic sections were washed with PBS and endothelial cells were recovered following incubation 
with 0.1% collagenase A in PBS for 20 min at 37ºC. Recovered endothelial cells were collected in 
Hank’s solution, decanted by centrifugation and resuspended in culture medium [RPMI 
supplemented with 10% FBS (Gibco), and antibiotics (100 µg/ml pen/strept (Biowhittaker)]. Cells 
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were grown in gelatin coated plates in a humidified cell incubator at 5% C02. BAEC were used from 
passages 3-6.  
Mouse Embryonic Fibroblasts (MEFs) were prepared from day 13.5 embryos derived from crosses 
between Sirt1+/- mice and cultured as described (Serrano M et al. 1997). The SirT1+/- mice used were 
part of a colony established within the CNIC animal facility. In brief, embryos were extracted from the 
placenta and washed with PBS. The head and the internal organs were removed and the remaining 
tissues where fractionated and incubated in a trypsin solution (0.25% 1mM EDTA, Gibco) at 37ºC 
during 45 minutes. The mixture was repeatedly passed through a 1ml micropipette every 15 min to 
facilitate tissue rupture. Dispersed MEFs were grown DMEM tissue culture media (Sigma) 
supplemented with 10% FBS (Gibco), 2 mM L-glutamine,  1% non-essential amino acids and 
antibiotics (100 µg/ml penicillin/streptomycin (Biowhittaker). 24 h post seeding, media was renewed 
to remove cellular debris. Cells were in a humidified cell incubator at 5% C02. MEF were used from 
passages 2-5.  
Mouse Primary Hepatocytes were isolated by hepatic perfusion and digestion with collagenase as 
described (Bahjat FR et al. 2000, Rana B et al. 1994). In brief, anesthetized mice were subjected to 
laparotomy and prefunded through the caudal cava vein with a constant flux of 7 ml/ml generated by 
a perfusion pump Masterflex L/S modelo 7518-00 (Cole-Parmer instrument Company). Mice were 
first perfused with a wash solution for 10 min containing NaCl 150 mM; KCl 5.5 mM; HEPES 10 mM, 
pH 7.5; NaHCO3  25 mM  and EGTA 0.5 mM. Then the mise were prefunded with a digestion solution 
containing NaCl 150 mM; KCl 5.5 mM; HEPES 10 mM, pH 7.5; NaHCO3  25 mM;  CaCl2  0.5 mM and 
collagenase  (150 Units/ml, Roche) at 0.05% (p/v). Following digestion the liver is deposited in a 
ceramic bowl and mechanically disaggregated with a pestle. The resulting preparation is passed 
through a 70 µm filter (Becton Dickinson) and centrifuged at a 50 g during 5 minutes at 4ºC to 
remove the digestion solution. The cells are then resuspended in Williams E (Gibco) cell culture 
media supplemented with 10% FBS, and filtered again. The ratio of viable hepatocytes in the 
preparation is estimated by trypan blue staining followed by manual counting in a Neubauer 
chamber. The hepatocytes are seeded in tissue culture dishes on a gelatin and collagen matrix (0.2% 
gelatin, 1% collagen) and grown in Williams E media supplemented with 10% FBS, 2 mM de L-
glutamine, 100 nM dexametasone (Sigma), 100 nM insulin (ROCHE) and 100 µg/ml 
penicillin/streptomycin (Biowhittaker). Fresh medium was added 4 h after plating to remove cellular 
debris. Cells were in a humidified cell incubator at 5% C02. 
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2.2. Cell lines 
The rat hepatoma cell line FAO was grown in RPMI (Sigma) cell culture medium supplemented with 
10% FBS, 2 mM L-glutamine and 100 µg/ml penicillin/streptomycin. Cells were in a humidified cell 
incubator at 5% C02. 
The human embryonic kidney cell line HEK-293A (Invitrogen) were grown in DMEM cell culture 
medium supplemented with 10% FBS and 100 µg/ml penicillin/streptomycin. Cells were in a 
humidified cell incubator at 5% C02. 
3. Plasmid constructs 
The pShuttle-HA-PGC-1α shuttle vector has been described (Valle et al. 2005). Versions containing 
the PGC-1α mutants PGC-1α-∆SR (∆564-634), PGC-1α-∆RRM/SR (∆564-710), PGC-1α-∆CTD (∆564-
797) and PGC-1α-∆RRM (∆677-710) (Monsalve M et al. 2000) were generated using the same cloning 
strategy. The shuttle vectors were used to generate pAdEasy-1 (Quantum) derivatives by 
recombination. Adenoviruses (Ad) were amplified as previously described (Valle I et al. 2005). 
Plasmids pcDNA3.1-Flag-PGC-1α and pcDNA3.1-Flag-PGC-1α-∆CTD have been described (Monsalve 
M et al. 2000), and plasmids pcDNA3.1-Flag-PGC-1α-∆SR, PGC-1α-∆RM/SR and PGC-1α-∆RRM were 
generated using the same cloning strategy.  
TLS cDNA was cloned in the KpnI-XhoI sites of pShuttle-CMV to generate pS-TLS. The following 
plasmids are as described: pSG5-FL-TLS (Yang et al. 2000), pShuttle-TLS, pcDNA3.1-TLS (Sanchez-
Ramos C et al. 2011, Table 1). 
To create pDR-1-luc, three copies of the UCP-1 DR-1 element and a TATA box were subcloned into 
the BamH1 and Hind III sites of pGL3 (Promega).  Plasmid p3k consisted of the rat fibronectine 
genomic fragment comprising the alternative IIIB exon and the two flanking exons 7b and 8a inserted 
in-frame into the BstB1 site of pDR-1-luc. pSV-RXRα and pSV-PPARγ2 have been described 
(Mangelsdorf DJ et al. 1990, Tontononoz P et al. 1994).  3.1. Adenoviral vectors  
3.1.1. Generation 
Recombinant adenoviruses Ad-PGC-1α, Ad-SirT1, Ad-FoxO3a, Ad-shFoxO3a and corresponding 
control adenoviruses have been previously described (Olmos Y et al. 2009, Rodgers JT et al. 2005, 
Skurk C et al. 2004, Valle I et al. 2005, Ueki N et al. 1998). Versions containing TLS and the PGC-1α 
mutants PGC-1α-∆SR (∆564-634), PGC-1α-∆RRM/SR (∆564-710), PGC-1α-∆CTD (∆564-797) and PGC-
1α-∆RRM (∆677-710) (Monsalve M et al. 2000) were generated using the same strategy and 
amplified as previously described (Valle I et al. 2005). 
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Plasmids Characteristics References 
pShuttle-CMV - Quantum 
Shuttle pS-HA-PGC-1α HA tag 5' (SalI-EcoRV) Valle I et al. 2005 
pS-HA-PGC-1α -∆SR 
HA tag 5' (SalI-EcoRV) 
∆ 564-634 sequence PGC-1α  
Monsalve M et al. 2000  
Sanchez-Ramos C et al. 2011 
pS-HA-PGC-1α-∆RRM/SR 
HA tag 5' (SalI-EcoRV) 
∆ 564-710 sequence PGC-1α  
Monsalve M et al. 2000  
Sanchez-Ramos C et al. 2011 
pS-HA-PGC-1α-∆CTD 
HA tag 5' (SalI-EcoRV) 
∆ 564-797 sequence PGC-1α  
Monsalve M et al. 2000  
Sanchez-Ramos C et al. 2011 
pS-HA-PGC-1α-∆RRM 
HA tag 5' (SalI-EcoRV) 
∆ 677-710 sequence PGC-1α  
Monsalve M et al. 2000  
Sanchez-Ramos C et al. 2011 
pShuttle-TLS cDNA TLS KpnI-XhoI Sanchez-Ramos C et al. 2011 
pcDNA3.1 - Invitogen 
pcDNA3.1-Flag-PGC-1α - Monsalve M et al. 2000  
pcDNA 3.1-Flag-PGC-1α-∆CTD - Monsalve M et al. 2000  
pcDNA3.1-Flag-PGC-1α-∆SR 
Flag tag 5' (AgeI-EcoRV) 
∆ 564-634 sequence PGC-1α  Sanchez-Ramos C et al. 2011 
pcDNA 3.1-Flag PGC-1α-∆RRM/SR 
Flag tag 5' (AgeI-EcoRV) 
∆ 564-710 sequence PGC-1α  Sanchez-Ramos C et al. 2011 
pcDNA 3.1-Flag PGC-1α-∆RRM 
Flag tag 5' (AgeI-EcoRV) 
∆ 677-710 sequence PGC-1α  
Sanchez-Ramos C et al. 2011 
pcDNA3.1V5-TLS - Sanchez-Ramos C et al. 2011 
pAdEasy-1 - Quantum 
pAd- Shuttle Recombination pAdEasy-1  and pShuttle-CMV Valle I et al. 2005 
pAd- PGC-1α - Olmos Y et al. 2009 
pAd-PGC-1α-∆RRM/SR - Sanchez-Ramos C et al. 2011 
pAd-SirT1 Dr. P. Puigserver Olmos Y et al. 2013 
pAd-FoxO3a Dr. K. Walsh Olmos Y et al. 2009 
pAd-TLS - Sanchez-Ramos C et al. 2011 
p-Shuttle silencer 1.0-CMV - Ambion 
pAd-shPGC-1α - Sanchez-Ramos C et al. 2011 
pAd-shFoxO3a - Olmos Y et al. 2009 
pAd-shSirT1 - Olmos Y et al. 2013 
p-Ad-shControl - Sanchez-Ramos C et al. 2011 
p-Adenoviral LacZBackbone - Ambion 
pGEX-6P-2 - GE Healthcare 
pGEX-PGC-1α-CTD CTD domain aa558-797 (XhoI-NotI) Sanchez-Ramos C et al. 2011 
pSG5-FL-TLS Dr. D. Hickstein Chen Y et al. 2011 
Table 1: Vector summary 
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Silencing adenoviruses Ad-shPGC1α, and Ad-shSirt1 were constructed using the pSilencerTM Adeno 
1.0 Cytomegalovirus Promoter System from Ambion. In brief, ssDNA oligonucleotides were designed 
that contained specific direct and reverse sequences for a specific shRNA targeting the gene of 
interest (Table 2). The oligonucleotides were hybridized and ligated to the linearized vector Shuttle 
1.0 CMV. The ligation products were used to transform competent Escherichia coli (E.coli) DH5α. 
Transformed bacteria were selected by growth on agar plates supplemented with ampicillin. Selected 
clones were grown to obtain plasmid preparations. Inserts were verified by DNA sequencing. 
Silencing efficiency was tested by transfection of the plasmid into relevant cell lines and ratio of 
decreased mRNA and protein levels was monitored by RT-qPCR and western blot respectively. Finally 
viral particles were generated by co-transfection of the Shuttle 1.0 CMV-shRNA and Adenoviral LacZ 
Backbone vectors in HEK-293A.  
shPGC-1α 
5'-TCGAGTTCATGGAGCAATAAAGCGTTCAAGAGACGCTTTATTGCTCCATGAATTA-3' forward 
5'-CTAGTAATTCATGGAGCAATAAAGCGTCTCTTGAACGCTTTATTGCTCCATGAAC-3' reverse 
shSirT1 
5'-TCGAGCATGAAGTATGACAAAGATTTCAAGAGAATCTTTGTCATACTTCATGGCA-3' forward 
5'-CTAGTGCCATGAAGTATGACAAAGATTCTCTTGAAATCTTTGTCATACTTCATGC-3' reverse 
Table 2: Adenoviral silencing oligonucleotides 
Cells were infected with the adenoviral vectors at a multiplicity of infection of 10-25 for 12-16 hours. 
The viruses were washed off 3 times with PBS, and the cells were harvested 24 or 48 h post-infection. 
mRNA and protein were analysed by real time PCR of reverse transcribed cDNA (qRT-PCR) and 
Western blot.   
3.1.2. Viral amplification, preparation of adenoviral stocks and titration 
Viruses were generated and amplified in the cell line HEK-293A, that provides in trans the 
constitutively expressed E1 viral elements, absent from the replicative deficient adenoviral vectors. 
Expansion is carried out by the consecutive infection of continuously large amounts of HEK-293A and 
generation of consecutively higher titre preparations. When infected HEK-293A cells show cytopathic 
effects, they are harvested by scraping, centrifuged, and resuspended in PBS. Viral particles are then 
released by repeated cycles of freezing (in dry ice) and thawing (at 37ºC) followed by intense 
vortexing. Finally, the preparation is centrifuged for 5 min at 4.000 rpm to remove cellular debris.  
Determination of viral titre followed the terminal dilution method. In short, HEK-293A cells were 
seeded at confluence in 96 well plates. Each well in a given row was incubated with 1 µl of a dilution 
of the virus preparation. Dilutions rates increased 10 times for each consecutive row. Cells were 
maintained in culture for two weeks and then the number of wells showing lysis halos was 
determined. Titres were in the 1011PFU/ml range.  
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3.1.3. Adenoviral Infections 
FAO cells, MEF and hepatocytes were infected overnight with adenoviral vectors at a multiplicity of 
infection (moi) of 1-50. Viruses were washed off and cells were harvested 48h post-infection. In all 
cases we compared the effect of an adenovirus driving the expression or knock down of a particular 
gene with the effect of a control, non-targeting adenovirus.  
Ad-Shuttle was used as control for Ad-PGC1α, its mutant derivatives and Ad-SIRT1; Ad-shControl was 
used as control for Ad-shSIRT, Ad-shFoxO3a and shPGC-1α.  
mRNA and protein were analysed by qRT-PCR of retro-transcribed cDNA (qRT-PCR) and western blot 
(WB). The primers and antibodies used were as described (Valle I et al. 2005, Borniquel S et al. 2006, 
Olmos Y et al. 2009, Sanchez-Ramos C et al. 2011).  3.2. Cell transfections  
70-80% confluent cells were transfected with Lipofectamine 2000 (Invitrogen). DNA and 
Lipofectamine 2000 were diluted in Opti-MEM 1 medium in the absence of serum. Following 5 min 
incubation at RT the two preparations were mixed and incubated for another 20 min at RT. 
Complexes DNA-Lipofectamine were formed at a ratio 1 µg DNA -2 µl Lipofectemine. The mixture 
was added to the cells wells containing cell culture media without antibiotics. The transfection was 
allowed to proceed for 4-6 h at 37ºC in a cell culture incubator. The cells were washed with PBS and 
fresh media was added to the cell culture. Cells were harvested 24-48 h later. 
4. RNA and protein assays 4.1. Determination of luciferase activity  
Luciferase activity was determined using the Dual-luciferase Reporter Assay System from Promega, 
following the manufacturer instructions. Signals were monitored in Orion Microplate luminometer 
(Berthold Detection Systems). 4.2. RNA extraction and quantitative RT-PCR 
Total RNA was isolated using TRIzol® reagent (Invitrogen) according to the manufacturer’s protocol. 
Cells were washed twice with cold PBS and lysed with TRIzol®. Following chloroform (MERCK) 
addition and centrifugation, RNA was recovered from the aqueous phase by precipitation with 
isopropyl alcohol (Sigma-Aldrich). The precipitated material was washed with 70% ethanol (MERCK) 
and resuspended in RNAse free water. Purity and concentration of the recovered material was 
analysed using a spectophotometer (Nanodrop). The RNA was also analysed in ethidium bromide 
(EtBr) stained agarose gel to confirm the preservation of the integrity of the material. RNAs that were 
being prepared for microchip hybridization were also analysed in a Bio-analyser (Agilent). 
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Complementary DNA (cDNA) was generated by Moloney Murine Leucemia Reverse Transcriptase 
(MMLV-RT, Invitrogen) using 1 µg of total mRNA previously heated 2 min at 72ºC. Random hexamers 
(GE Healthcare) were used to prime the reaction that was allowed to proceed for 45 min.  4.3. Determination of relative mRNA levels, real time PCR (qRT-PCR) 
The resulting cDNA was analysed by quantitative RT-PCR using Power SYBR Green and Taqman PCR 
Mixes from Applied Biosystems in Sequence Detection Systems (SDS) 7900 and 7000FAST from 
Applied Biosystems. Amplification conditions were: 2 min at 50ºC, 10 min. at 95ºC, and 40 cycles of 
15 s at 95ºC, 30 s at 55-60ºC and 30 s at 72ºC.  
Data were analysed using the software Sequence Detection System (Applied Bioystems) using the 
relative quantification system of CT (threshold cycle) comparison. All data were normalized to 18S 
expression (18S rRNA VIC-MGB, Applied Biosystems). Primers were as previously described (Valle I et 
al. 2005, Borniquel S et al. 2006, Olmos Y et al. 2009, Sanchez-Ramos C et al. 2011). 
The primers were designed in the laboratory and tested in a gradient temperature PCR for optimal 
amplification temperature and absence of double peaks. Before we run our assays, we run a test 
qPCR with serially diluted DNA to make sure we have no secondary amplifications and the 
amplification curve follows the predicted exponential. We analyse the data using the ∆∆Ct method. 
We run triplicates for each DNA sample. For each one of the triplicates, we first we correct for 
loading using the 18S signal as reference for each one of the samples, then we choose a reference 
sample and calculate the ∆∆Ct and then calculate the 2∆∆Ct. Finally, we calculate mean and 
standard deviation for the triplicates. This procedure is followed for every experiment; all 
experiments were carried out at least twice. A final analysis of all the experiments included 
determination of statistical significance. 4.4. RNA pull-down from cell extracts 
70% confluent FAO cells in 10 cm Ø plates were infected at an moi of 5 with recombinant 
Adenovirus. Cells were harvested 48 h posttransfection, and whole cell extract (WCE, DNase I 
treated) were diluted to 1 µg/µl. 250µl of WCE were then incubated for 20 min at RT with 2 ng of 32P 
labeled in vitro transcribed RNA and 50 µg or tRNA that was added as non-specific competitor. Finally 
1 µg of heparine was added and the samples were placed on ice. PGC-1α was immunoprecipitated 
with HA-agarose beads (Babco), RNA was extracted from the immunoprecipitates, and loaded on an 
8% polyacrylamide gel containing 8 M urea. 4.5. RNA Immunoprecipitation and RT-PCR amplification 
70% confluent 293T cells (two 15 cm Ø plates per lane) were transfected with 3.1-Flag-PGC-1α, 3.1-
Flag-PGC-1α-∆RRM, or the corresponding empty vector. Whole cell extract (DNase I treated) and 
immunoprecipitation reactions were carried out as in (Monsalve M et al. 2000). RNA was isolated 
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from the immunoprecipitate with Trizol (Invitrogen). RT was performed using primer Round A as 
template, followed by 20 cycles of PCR amplification with primer Round B (Table 3). 
5'-GTTTCCCAGTCACGATCNNNNNNNNNN-3' Round A 
5´-GTTTCCCAGTCACGATC-3´ Round B 
Table 3: RNA Immunoprecipitation oligonucleotides 4.6. GST-pull down assays 
The fusion protein GST-PGC-1α-CTD (GST, Glutation S-transferase) was generated by cloning of the 
PCR amplified CTD domain (aa 558-797) of PGC-1α between XhoI and NotI sites of the expression 
vector pGEX-6P-2 (GE Healthcare). The recombinant GST-PGC-1α-CTD protein was expressed in E.coli 
Bl21DE3 following IPTG induction and purified by affinity chromatography using glutathione-agarose 
beads (GE Healthcare). 0.8 µg of purified GST-CTD immobilized on glutation beads were incubated in 
binding buffer (20 M Tris-HCl (pH 8.0), 10% glycerol, 400 mM KCl, 5 mM MgCl2, 0.5 mM EDTA, 0.5 
mM EGTA, 2 mM DTT, 0.4% NP-40, 0.2 units RNasin). The following RNA:  processed mRNA of LR-1 
(coding region only, 1.2 kb, RNA1) or the 3’ 1.7 kb of the pre-mRNA (RNA2) were the 2 ng of 32P-
labeled probe used for the test. This fragment was selected because it contained the E2 coding intron 
together with putative regulatory mRNA processing sequences. The binding of the 2 ng of 32P-labeled 
probe was competed with 0, 1 or 10 µg or tRNA, used as non-specific competitor. Incubation was for 
1h at room temperature in binding buffer, 200 µl final volume. Beads were washed three times with 
1 ml binding buffer. 32P labelled polynucleotides were extracted with phenol-chloroform, ethanol 
precipitated, and detected by autoradiography following separation on 1% agarose gels. 4.7. In vivo RNA crosslinking assay 
In vivo cross-linking of PGC-1α to polynucleotides was performed basically as described (Kelley RL 
and Kuroda MI 2000) except that whole cell extracts (WCE) were prepared essentially as in 
(Monsalve M et al. 2000), with two modifications, the lysis buffer contained 1% NP-40 and the 
freezing-thawing step was omitted. 4.8. Preparation of cellular extracts and immunodetection (Western Blot)  
Whole-cell lysates were obtained as described (Monsalve M et al. 2000). Cells were washed twice 
with cold PBS, centrifuged and resuspended in lysis buffer containing 20 mM HEPES pH 7.9, 125 mM 
NaCl, 1% NP-40, 1 mM EDTA, 5 mM β-glycerol phosphate, 0.2 mM NaV, 0.2 mM NaF, 10 mM NaP and 
protease inhibitors (Protease Inhibitor Cocktail, Sigma). The suspension was vortexed vigorously and 
centrifuged at 13.000 rpm in a minifuge to remove insoluble materials. Protein concentration in the 
extract was determined by a modified Lowry method (Bio-Rad DC Protein Assay). 20-25 µg of whole-
cell protein extracts were denatured resolved on 8-15% sodium dodecyl sulfatepolyacrylamide gel 
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electrophoresis (SDS-PAGE), transferred onto PVDF Hybond-P membranes (Amersham Biosciences) 
using a semi-dry transfer system from Bio-Rad and incubated with specific antibodies.  
PGC-1α Cayman Chemical (WB) Santa Cruz H-300 (IP) FoxO3a Cell Signalling Santa Cruz SirT1 Santa Cruz (WB-IP) Bethyl laboratories (ChIP) Prx5 Santa Cruz Prx3 LabFrontier Trx2 LabFrontier TR2 LabFrontier Catalase Chemicon International MnSOD Stressgen UCP-2  Santa Cruz  Biolegend Acetylated-Lysine Cell Signaling 
β-actin Sigma HA  Hybridoma 12CA5 TLS BD biosciences (IP) Novus Biologicals (WB) normal immunoglobulin G (mouse or rabbit) Santa Cruz  PGC-1α  Santa Cruz H-300 HA-tagged FoxO3a  Hybridoma 12CA5 Sirt1 Santa Cruz SirT1 Bethyl laboratories H4K16Ac Millipore RNAP II  monoclonal antibody 8WG15: COVANCE CTD-S2P-RNAP II  monoclonal antibody H5: COVANCE 
Table 4: Antibodies summary 
Membranes were incubated for 1h in blocking solution (5% 
w/v fat-free dry milk in saline tris buffer (TBS) and 0.1% 
Tween 20 (TBS-T) to prevent non-specific antibody 
interactions with the membrane. 
Then, membranes were incubated 
with specific antibodies diluted in 
TBS-T against specific primary 
antibodies for 2h at room 
temperature or overnight at 4ºC. 
β-actin was used as a loading 
control. 
Membranes were then washed 
twice with TBS-T with shaking for 
10 min, incubated with 
corresponding secondary 
antibodies conjugated with 
horseradish peroxidase (HRP, 
Table 4) for 45 min at room 
temperature, washed again twice 
with TBS-T for 10 min and signal 
developed following exposure to 
the chemodetection system ECL 
(Amersham Biosciences), that was 
captured by exposure to an 
autoradiography film (AGFA).  4.9. Protein immunoprecipitation (IP) 
Protein-protein interactions were analysed by co-immunoprecipitation experiments essentially as 
previously described (Monsalve et al., 2000). Cells were scraped from the dish, washed twice with 
cold PBS and resuspended in lysis solution (20 mM HEPES pH 7.9, 125 mM NaCl, 0.1% NP-40, 1 mM 
EDTA, 5 mM β-glicerolfosfato, 0.2 mM NaV, 0.2 mM NaF, 10 mM NaP and proteinase inhibitors. 
Following a fast freezing-thawing cycle (freezing in liquid nitrogen and thawing at 37ºC), samples 
were vortexed vigorously, and centrifuged at 13.000 rpm for 10 min in a microfuge to remove non-
soluble material. Following protein quantitation as indicated for whole cell extract preparations, 1mg 
of protein in 1ml of buffer was incubated with the corresponding immunoprecipitated antibody 
overnight at 4ºC in an orbital rotator. Then, 40 µl of 50:50 A/G-agarose slurry was added to the 
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sample and following 2 h incubation, the immune-complexes were collected by centrifugation (1 min 
at 1.000 rpm), washed twice with cold PBS and finally resuspended in denaturing buffer, heat 
denatured and loaded on SDS-PAGE gels, for western blot analysis. Control immunoprecipitation 
samples were analysed in parallel that used normal immunoglobulin G (mouse or rabbit) instead of a 
specific antibody (Table 4).  
5. Genomic analysis 5.1. Chromatin Immunoprecipitation (ChIP) 
ChIP experiments were carried out essentially as previously described (Valle I et al. 2005) with some 
modifications. In brief, cells were first cross-linked with 1% formaldehyde, and lysed (lysis buffer: 50 
mM Tris HCl pH8.0, 150 mM NaCl, 5 mM EDTA, 1 %, Triton-X 100, 0.5 % NP-40). The resulting 
chromatin preparation was sheared by sonication and incubated overnight at 4ºC with antibodies 
against specific proteins, and then with Dynabeads® A/G for 2h. The magnetic beads were collected, 
and washed extensively. To isolate the immunoprecipitated DNA, the crosslinks were reversed (6h 
65ºC), the protein was digested with proteinase K, and the RNA degraded with RNAse A. The nucleic 
acid fraction was extracted with phenol:chlorophorm and ethanol precipitated using glycogen as 
carrier. The resulting co-precipitated DNA preparations were analysed by qPCR with specific primers.  
Oligonucleotides designed against the coding sequence of β-actin were used as negative control 
(Table 5).  5.2. Genome-wide microarray analysis 
For each experiment three independently-isolated cultures of primary hepatocytes from PGC-1α+/+ 
and PGC-1α-/- mice were infected with the indicated adenovirus. RNA was extracted by TRIzol® 
extraction, re-purified with RNAeasy (Invitrogen), and checked for integrity and quantity with the 
Agilent Bio-Analyser QC. RNA was amplified and labelled with the One-Color Microarray-Based Gene 
Expression Analysis Protocol (Agilent Technologies, Palo Alto, CA, USA). Briefly, 800 ng total RNA 
were reverse transcribed using T7 promoter primer and the Moloney murine leukemia virus (MMLV) 
reverse transcriptase (RT). cDNA was then converted to anti-sense RNA (aRNA) with T7 RNA 
polymerase, which amplifies target material and simultaneously incorporates cyanine 3 (Cy3)-labeled 
CTP. Samples were hybridized to a G4122F 4x44K whole mouse genome microarray (Agilent 
Technologies). Cy3-labeled aRNA (1.65 µg), in a final concentration of 1x GEx HIRPM hybridization 
buffer (Agilent Technologies), was hybridized for 17 h at 65ºC in an G2545A hybridization oven 
(Agilent Technologies) set to 10 rpm.  
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β actin (Mm, Rn, Bt) 
5'-GTTCCTCTTCGCCTGACTGTT-3' forward 
5'-CTGAACCGTTTCCGTTGCTT-3' reverse 
MnSOD (-200) 
5'-GAGCCGTACCATCTCTTTCG-3' forward 
5'-CTCGGCACTGTGGTCGG-3' reverse 
MnSOD (ATG) 
5'-AGTTGGAAGCGGCGCGCGCA-3' forward 
5'-GCCGCGCTGACCTGAGACGA-3' reverse 
catalase (-300) 
5'-AGAGCTGAAAGCATGTTAACAG-3' forward 
5'-CTGCAAACGCCCGATTAACTA-3' reverse 
catalase (ATG) 
5'-GAAGTCGCCTATTTCAGCTG-3' forward 
5'-GCTCCTTCCAGTGTTTCATC-3' reverse 
prx3 (-1400) 
5'-TCCCACATGCCGTAACTAAGAGT-3' forward 
5'-ACTGGGTTGGTGGGTGTGGA-3' reverse 
prx3 (-1100) 
5'-CAAAGTACCGTGCTCACCAC-3' forward 
5'-CACCAATAAGCCAAGTGGGTC-3' reverse 
prx3 (-800) 
5'-GACCCACTTGGCTTATTGGT-3' forward 
5'-CAACTAAGACTTGGTGCAATC-3' reverse 
prx3 (-148) 
5'-TCTTGCCACCCTGGATTGGA-3' forward 
5'-ACG TGG AAG AGC TAC GAC CT-3' reverse 
prx3 (ATG) 
5'-AGGTCGTAGCTCTTCCACGT-3' forward 
5'-ACCGAAGCCCGAAACAACCT-3' reverse 
prx3 ( + 250) 
5'-GGGCAGCGTCTAAGGCAGGC-3' forward 
5'-AACCGGGACCAGGGGACAGG-3' reverse 
prx3 ( + 500) 
5'-GGGTTTCCGTGAGCATCCCCT-3' forward 
5'-GTTTGCTCAATTTCAGGGTTCTGC-3' reverse 
prx3 ( + 1700) 
5'-AGGAACAAGGCCAGCGGAGG-3' forward 
5'-AGA AGC AGC AGG CCT AAG GGC-3' reverse 
prx5 (-300) 
5'-TGGCTGAGCTAAACCTCAG-3' forward 
5'-CGAGTTGCCGCTGTTTCGA-3' reverse 
prx5 (ATG) 
5'-TCTTCCGCAGGATTGCGTC-3' forward 
5'-TGTCGTTGACGCACCCTCA-3' reverse 
ucp-2 (-2800) 
5'-CTGAAAGAGCAATGTGTGATAC-3' forward 
5'-CATTAGCGTATTCAGTCCTTG-3' reverse 
ucp-2 (-2500) 
5'-GCTCTACAGGACACATAGTATG-3' forward 
5'-CTCCTTTAGACTGGACTCTTAC-3' reverse 
ucp-2 (-2200) 
5'-AGGCCCCAATGGGACAGTGA-3' forward 
5'-TCGCAGTCTCAGGGACAGTCC-3' reverse 
ucp-2 (-500) 
5'-TGGGCTGGTGAGCTCTGAGA-3' forward 
5'-AGAGGGCAGGCAGATGAGGG-3' reverse 
ucp-2 (ATG) 
5'-GTTCGGCTGCTGATGGACCT-3' forward 
5'-GTAGGGGGCACATCTGTGGC-3' reverse 
ucp-2 ( + 250) 
5'-CAAGGAGAAAGGCAGGGGCC-3' forward 
5'-CGGAGGCGAAGCTCATCTGG-3' reverse 
ucp-2 ( + 700) 
5'-AGCAGGAGAGGCTGAGGCTT-3' forward 
5'-GGGTGAACGTGGCATGCTGA-3' reverse 
pgc-1α (-300) 
5'-TCATTCAGGAGCTGG ATGGC-3' forward 
5'-TCACCCAAACCCAAGCCCT-3' reverse 
pgc-1α (ATG) 
5'-AGCGTTACTTCACTGAGGCA-3' forward 
5'-ACAGTCCCCAGTCACATGA-3' reverse 
FoxO3a promoter 
5'-ACCTAGCCCAGGAGAGACCT-3' forward 
5'-AGCAGGCAGACCTGGAGAC-3' reverse 
Table 5: ChIP oligonucleotides summary 
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Arrays were washed and dried by centrifugation as indicated in the manufacturer's protocol. Arrays 
were scanned at 5 mm resolution with a G2565BA DNA microarray scanner (Agilent Technologies) at 
the default settings for 4x44k format one-color arrays. Images were analysed using Feature 
Extraction software v10.1.1.1 (Agilent Technologies). Raw signals were thresholded to 1 and 
normalization by quantile (Bolstad BM et al. 2003) was performed using GeneSpring software. Data 
were considered in the log2 scale. Default flags were considered as absent, except saturated spots 
that were flagged as marginal. From the initial 41081 probes present in the Agilent 4x44K chip, 25280 
remained if (i) they exhibit a signal within the higher 80th percentile in at least 50% of the replicates 
in one condition; (ii) at least 50% of the replicates in one condition were flagged as present or 
marginal (iii) are not control probes and (iv) have a standard deviation across samples larger than 
0.25. Quality Control checks based on the bioconductor package Array Quality Metrics 
(www.bioconductor.org) did not detect any sample as statistical outlier. All samples were hence used 
for statistical analysis using the limma bioconductor package (Smyth et al. 2004). The data were 
adjusted to a paired two factorial lineal model, considering as fixed factors the genotype (PGC-1α+/+ 
and PGC-1α-/-) and the adenovirus, and the animal as random factor. For each contrast of interest 
genes with a Benjamini-Hochberg corrected p-value smaller than 0.05 were considered as 
differentially expressed (Smitten AL et al. 2008). To identify relevant functions regulated by PGC-1α 
and their dependency on PGC-1α-RRM we carried out gene functional analysis of regulated genes 
using the Ingenuity software (Table 6). 
Inpp5j 1 F 5'-GGGATGATGTTCCTCTGGTG-3' forward 
Inpp5j 1 R 5'-ATCCACTTCCTCATGCTTGG-3' reverse 
Inpp5j 2 F 5'-CCCCAAACTCAGTCCTGGTA-3' forward 
Inpp5j 2 R 5'-ATGGATGACCTCCAAGATGG-3' reverse 
Cxcl1 1 F 5'-TGTTGTGCGAAAAGAAGTGC-3' forward 
Cxcl1 1 R 5'-ACAAAATGTCCAAGGGAAGC-3' reverse 
Slc17a3 a F 5’-TCCAAGGTATGCCAGCTTTC-3' forward 
Slc17a3 a R 5'-GCTTTCCCAAACACGAGGTA-3' reverse 
Slc17a3 b F 5'-GGAAGCTCACTCGTTTGTGA-3' forward 
Slc17a3 c F 5'-CAGTGAAGTAGGGCTCATAGCA-3' forward 
Slc17a3 c R 5'-TTTCCCACCCCTCTTCTCTT-3' reverse 
CamK2b a F 5'-CTCTCCCACCCACCTTGTTA-3' forward 
CamK2b a R 5'-TGCGAACACCTAGCCAGTTA-3' reverse 
CamK2b b F 5'-TGGCCAGTGCTGTAGTGTGT-3' forward 
CamK2b b R 5'-GCAGTTTCCCGAGACAGAAC-3' reverse 
CamK2b c F 5'-ACTTTGAGGCCTATGCGAAA-3' forward 
CamK2b c R 5'-TTCAGGATGGTGGTGTGGAT-3' reverse 
Cyp24a1 a F 5'-AGTCACAGCTTCGAGGGATG-3' forward 
Cyp24a1 a R 5'-GGCTCAAGCCCCACTATACA-3' reverse 
Cxcr7 a F 5'-AGCACCAGGACAGGCTCTTA-3' forward 
Cxcr7 a R 5'-CAGCCTTACACCTCCCATACA-3' reverse 
Table 6: Array target oligonucleotides 
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5.3. Crosslinking Immunoprecipitation (CLIP) 
The rat hepatoma cell line FAO and mouse primary hepatocytes (PGC-1α-/-) expressing HA-tagged 
PGC-1α, PGC-1-∆RRM were prepared in 20 cm Ø dishes as described under cell culture. Living cells 
were irradiated with 365 nm UV light for 2 min after removal of the medium and replacement with a 
thin layer of PBS. Cells were harvested and lysed in lysis buffer (as decribed in ChIP and Monsalve M 
et al. 2000). The cleared cell lysates were treated with RNase T1. HA-tagged proteins were 
immunoprecipitated with anti-HA antibodies bound to Protein A/G Dynabeads. RNase T1 was added 
to the immunoprecipitate. Beads were washed and resuspended in dephosphorylation buffer. Calf 
intestinal alkaline phosphatase was added to dephosphorylate the RNA. Beads were washed and 
incubated with polynucleotide kinase and radioactive ATP to label the crosslinked RNA. The protein-
RNA complexes were separated by SDS-PAGE. The specific protein/RNA band was cut from the SDS-
PAGE gel and electroeluted. The electroeluate was proteinase K digested. The RNA was recovered by 
acidic phenol/chloroform extraction and ethanol precipitation. Importantly, use siliconised tubes for 
all manipulations of the small RNAs. The minute amounts of small RNAs to be recovered after gel 
purification will readily adsorb to the walls of standard tubes. 
The protocol from Tushl was first applied as follows. 
The specific RNA was prepared to form a library labelled by distinct oligonucleotides on 3’ and 5’ end 
named barcode. These steps were applied to PGC-1α bound RNA and control oligomers 19 mer and 
24 mer (Table 7).  
Collect the small RNA pellet after ethanol precipitation in a tabletop centrifuge for 15 min at 
maximum speed (~14,000×g) at 4°C. Remove the supernatant and collect the residual liquid at the 
bottom of the tube by an additional 5 s centrifuge spin. Remove the residual liquid completely using 
a small pipette tip without perturbing the pellet. The additional spin is needed to collect all residual 
liquid. If necessary air-dry the RNA pellet to evaporate residual ethanol. Be sure that the ethanol has 
been evaporated as it may inhibit the subsequent enzymatic steps. All subsequent RNA precipitations 
are performed similarly. 
19-nt  5'-CGUACGCGGGUUUAAACGA-3' 
24-nt  5'-CGUACGCGGAAUAGUUUAAACUGU-3' 
Adapter set 3' 5'-AppTCGTATGCCGTCTTCTGCTTG-L-3' 
Adapter set 5' 5'-rGrUrUrCrArGrArGrUrUrCrUrArCrArGrUrCrCrGrArCrGrArUrC-3' 
A,C,G,T, DNA residues; rA, rU, rC, rG, RNA residues; L, 3'OH blocking group 
Table 7: CLIP oligonucleotides 
Adapters need to be joined to the small RNA pool to allow for Reverse transcription PCR 
amplification (RT-PCR). The adapters used to introduce the constant regions and their corresponding 
PCR primers vary, depending on the sequencing method that is being used. The adapter and the 
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primer sets for Solexa high-throughput sequencing-by-nucleotide are different because this method 
did not yet allow for reads similar in size to 454. Therefore, the sequencing primer-binding site has to 
be already present in the 5' adapter.  
The 3' adapter ligation is performed using chemically pre-adenylated oligodeoxynucleotides.  
Dissolve the RNA pellet in 10.5 µl water. Prepare a reaction mixture for ligation of the 3' adenylated 
adapter by combining the following components: 2 µl of 10× RNA ligase buffer without ATP (0.5 M 
Tris-HCl, pH 7.6; 0.1 M MgCl2; 0.1 M 2-mercaptoethanol; 1 mg/ml acetylated BSA (Sigma, B-8894), 
6µl 50% aqueous DMSO, 0.5 µl 100 µM adenylated 3' adapter oligodeoxynucleotide. Add the 8.5 µl of 
the mixture to the sample. 
Denature the RNA by incubating the tube for 30 s at 90°C. Place the tube immediately on ice for 20 s. 
Add 1 µl of Rnl2 (1–249) (1 µg/µl), mix gently, and incubate overnight at 0°C. Rnl2(1–249) is 
commercially available from New England Biolabs.  
Add 20 µl of gel loading solution [formamide loading solution (50 mM EDTA, 0.05 % (w/v) 
bromophenol blue in formamide)] and load the samples in two adjacent wells of a 20-well 15% 
acrylamide gel (15 cm×17 cm×0.8 mm; 30 ml gel volume). Make sure to space different samples 
appropriately, typically at a two-well distance, to avoid cross contamination. Run the gel for 1 h at   
30 W using 0.5× TBE buffer until the bromophenol blue dye is close to the bottom of the gel. Image 
the gel by exposure to a phosphorimaging screen for at least 45 min depending on the amount of 
RNA ligated. Excise the ligation product. Elute the ligation product from the gel slices overnight at 4°C 
with constant agitation with at least 3 to 4 volumes of 0.4 M NaCl. Ethanol-precipitate and collect the 
RNA.  
Dissolve the pellet in 9 µl water. Prepare the following reaction mixture by combining 1 µl of 100 µM 
5' adapter oligonucleotide, 2 µl of 10× RNA ligase buffer with ATP (0.5 M Tris-HCl, pH 7.6; 0.1 M 
MgCl2; 0.1 M 2-mercaptoethanol; 1 mg/ml acetylated BSA (Sigma, B-8894); 2 mM ATP) and 6 µl 50% 
aqueous DMSO. Add the 9 µl of this mixture to the sample. Denature the RNA by incubation for 30 s 
at 90°C. Place the tube immediately on ice for 20 s. Add 2 µl of T4 RNA ligase 1 (Rnl1) (Fermentas), 
mix gently, and incubate for 1 h at 37°C.  
Add 20 µl of gel loading solution (see above) and load the samples in two adjacent wells of a 20-well 
15% acrylamide gel (15 cm×17 cm×0.8 mm; 30 ml gel volume). Run the gel for 1 h at 30 W using 0.5× 
TBE buffer until the bromophenol blue dye is close to the bottom of the gel. Image the gel and excise 
the new ligation product. Elute the ligation product from the gel slices overnight at 4°C with constant 
agitation using at least 3 to 4 volumes of 0.4 M NaCl. Add 1 µl of 100 µM 3' primer during the elution 
as carrier to facilitate the recovery of the ligation product. Ethanol-precipitate and collect the RNA 
(Hafner M et al. 2008). 
Materials and Methods 
 
 45 | P a g e  
 
As this approach was not successful, we ligate the recovered RNA applying the TruSeqTM Small RNA 
kit from Illumina. 3’ Adapter and 5’ Adapter ligation was performed as described, followed by a RT-
PCR amplification and gel purification of the fragment. The obtained library was validated on gel and 
Bioanalyser. High-throughput sequencing was performed with an Illumina Genome Analyser. 
For each of the datasets mentioned above, the Illumina-Solexa small RNA sequencing data was 
filtered by eliminating low quality reads, adaptor sequences and adaptor contaminants in order to 
generate clean reads using Cutadapt 1.0. 
In order to identify clusters of sequences, the ClustalW software was used. The identified sequences 
(Table 8) were aligned to the mouse reference genome (NCBI v37, mm9) using Integrative Genomics 
Viewer (IGV).  
CLIP17/6 a F 5'-CGGAACTGAGGCCATGATTA-3' forward 
CLIP17/6 a R 5'-GCCGGTCCAAGAATTTCAC-3' reverse 
CLIP17/6/10 b F 5'-CGAAAGCATTTGCCAAGAAT-3' forward 
CLIP17 b R 5'-AGTCGGCATCGTTTATGGTT-3' reverse 
CLIP17 c F 5'-AGTCGGAGTTTCGAAGACGA-3' forward 
CLIP17/6/10 c R 5'-CCCTTCCGTCAATTCCTTTA-3' reverse 
CLIP6/17 a F 5'-GTTGGTTTTCGGAACTGAGG-3' forward 
CLIP6/17 b R 5'-CAAATGCTTTCGCTCTGGTC-3' reverse 
CLIP10 a F 5'-ACCCACAGAAGCGAGAAAGA-3' forward 
CLIP10 aR 5'-TGGAGCCTGTGGCTTAATTT-3' reverse 
CLIP10 b F 5'-AACCATACTCTCCCCGGAAC-3' forward 
CLIP10 b R 5'-ACCATAAACGAAGCCGACTG-3' reverse 
CLIP2/1/5 a F 5'-CACGCCCTCTTGAACTCTCT-3' forward 
CLIP2 a R 5'-TTCAACAAGTACCGTAAGGGAAA-3' reverse 
CLIP1/2/5 a F 5'-GAGAGTTCAAGAGGGCGTGA-3' forward 
CLIP1 a R 5'-ATCGACAATTTCCAGCCTTG-3' reverse 
CLIP1/2/5 a F 5'-GAGAGTTCAAGAGGGCGTGA-3' forward 
CLIP5 a R 5'-ACAGGGTGCGGGAAAGAT-3' reverse 
CLIP15 a F 5'-TCCTGTCAGCTGGAAAAACTG-3' forward 
CLIP15 a R 5'-GCCATGGTAAGGAGGTGAGA-3' reverse 
Table 8: CLIP target oligonucleotides 5.4. Statistical analysis  
Statistical differences were determined by t-test or analysis of variance (ANOVA) as appropriate. Data 
are expressed as means + SD. p values were considered significant at <0.05 (#). n≥3 for all 
experiments. 
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Results 
1. Promoter regulation of antioxidant genes 
To investigate PGC-1α transcriptional activity the focus was given to the posttranslational 
modification. In particular, the role played by the type III deacetylase protein SirT1 and its interaction 
with the transcription factor FoxO3a and the coactivator PGC-1α was analysed. The collaboration 
was studied on the promoter region of the detoxification genes where PGC-1α has a key role. 1.1. SirT1 over-expression induces the antioxidant genes 
PGC-1α and FoxO3a are two known key transcriptional regulators of antioxidant gene expression 
Introduction section 2.2. and 2.4.). In this chapter, to develop knowledge on PGC-1α  and the 
upstream transcriptional regulation, the focus is given to SirT1 mechanism of action. SirT1 was 
identified as a potential key player in transcription regulations due to its main characteristic as 
histone deacetylase (Introduction section 1.1.3.1.).  
Moreover, at the time this study was initiated SirT1 has been shown to control the activity of both 
PGC-1α and FoxO3a by deacetylation (Rodgers JT et al. 2005, van der Horst A et al. 2004, Kobayashi Y 
et al. 2005). Importantly, SirT1 activity on PGC-1α and FoxO3a has also been found to be functionally 
relevant in the control of endothelial activity during angiogenesis and liver, a process where ROS 
levels are known to be highly relevant (Introduction section 2.3.). In this light, the role played by 
SirT1 in the control of antioxidant gene expression was investigated and specifically if this regulation 
was dependent on PGC-1α and FoxO3a, since these two factors have previously shown direct 
implication in the coordinated regulation of antioxidant gene expression. 
Previous results, from our laboratory, showed that SirT1 over-expression induced the expression of 
several antioxidant genes (sod2-MnSOD, catalase, prx5 and tr2) in bovine aortic endothelial cells 
(BAEC), as well as the levels of PGC-1α and FoxO3a. This result suggested that SirT1 may be in fact a 
regulator of at least some antioxidant genes in endothelial cells. Importantly, SirT1 also up-regulated 
the mRNA and protein levels of both PGC-1α and FoxO3a. These results indicate that SirT1 activity on 
antioxidant genes could be at least partially dependent on PGC-1α and FoxO3a transcriptional 
regulation (Figure 2.1).  
The induction of the antioxidant genes by SirT1 is related to the levels of PGC-1α and Fox3a. The 
SirT1 induction of antioxidant gene expression occurs in a PGC-1α and FoxO3a dependent manner. 
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These results also support the idea that SirT1 is required to regulate PGC-1α and FoxO3a expression 
levels; SirT1 is likely to be relevant in the process maintaining the basal expression levels of a whole 
set of oxidative stress protection genes in endothelial cells.  
 
Figure 2.1:  SirT1 induction of PGC-1a, FoxO3a and antioxidant genes at mRNA and protein level.  
Analysis of oxidative stress protection genes in BAEC that were infected o/n with recombinant 
adenovirus as indicated and harvested 24 h post-infect ion. A) qRT-PCR mRNA expression analysis.   
B) Protein analysis by WB. Data are from ≥3 independent exper iments.  
Furthermore, as SirT1 is a deacetylase, not only of histones but also of proteins, the acetylation levels 
of the PGC-1α and FoxO3a were investigated.  
It is shown that SirT1 over-expression in BAEC reduced both PGC-1α and FoxO3a acetylation in 
oxidative stress conditions (Figure 2.2). Since acetylation had been previously shown to reduce both 
PGC-1α and Foxo3a activity and stability, deacetylation could contribute to the observed induction of 
antioxidant gene expression by SirT1 in a PGC-1α and FoxO3a dependent manner.  
Control of key transcriptional regulators and antioxidant genes by SirT1 
In order to further dissect the mechanisms that mediated SirT1 regulation of antioxidant gene 
expression, SirT1 was silenced in BAEC using a recombinant adenovirus that drives the expression of 
a SirT1 specific shRNA (shSirT1). Observation that Ad-shSirT1 decreased the mRNA and protein levels 
of MnSOD, catalase, Prx5, TR2, Prx3, Trx2, UCP-2, PGC-1α and FoxO3a, suggests that they are all 
targets of SirT1 (Figure 2.3). 
To determine if this regulation was cell type specific or could be observed in other cell types, we 
determined the expression levels of the antioxidant genes under study in SirT1+/+, and SirT1-/- MEFs. 
Analysis by qRT-PCR and Western Blot showed that the expression levels of the oxidative stress 
protection genes studied as well as PGC-1α and FoxO3a are lower in SirT1-/- MEFs than in SirT1+/+ 
MEFs, supporting the notion that SirT1 is a general regulator of antioxidant genes and is required to 
maintain the basal expression levels of the antioxidant system. 
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Figure 2.2:  S irT1 deacetylaton of PGC-1α  and FoxO3a in oxidative stress conditions. BAEC were co-
infected o/n with Ad-SirT1 and Ad-PGC-1α (A) or Ad-FoxO3a (B),  or the respective control adenoviruses.  
24h post- infect ion cel ls were deprived of serum o/n and then treated with 50 µM H2O2 or vehicle for  
4h. Whole cell  extracts were subjected to immunoprecipitation (IP)  with specific  PGC-1α,  FoxO3a or  
SirT1 antibodies or normal IgG, as a control,  and analysed by western blot as indicated. Data are from 
≥3 independent experiments. Data are means +SD (*) p ≤ 0.05 vs. control .  The blots presented 
correspond to a representative exper iment.  
 
Figure 2.3:  S i lencing of S irT1 down regulates PGC-1a, FoxO3a and antioxidant genes at mRNA and 
protein  level .  Analysis of  antioxidant genes in BAEC that were infected o/n with recombinant 
adenovirus as indicated and harvested 24 h post-infection. A) qRT-PCR mRNA expression analysis .  B) 
Protein analysis by WB. Data are from ≥3 independent experiments.  Data are means +SD (*) p ≤ 0.05 
vs.  control.  The b lots presented correspond to a representative experiment.  
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Figure 2.4:  Analysis of oxidative stress protection genes in serum deprived SirT1+ /+  and SirT1- /-  MEFs. A)  
qRT-PCR. B) Western Blot.  Data are from ≥3 independent experiments. Data are means +SD (*) p ≤ 0.05 
vs.  control.  The b lots presented correspond to a representative experiment.  
 
1.2. SirT1 regulation of PGC-1α/FoxO3a complex  
To investigate the mechanisms involved in SirT1 regulation of PGC-1α and SirT1 activity, it was 
investigated whether SirT1 regulated the formation of the PGC-1α/FoxO3a complex.  
First, the effect of SirT1 over-expression (Ad-SirT1) on the level of co-immunoprecipitated PGC-
1α/FoxO3a complex was tested.   
It was found that SirT1 increased the levels of FoxO3a associated with PGC-1α in these conditions 
(Fig. 2.5). Conversely, silencing of SirT1 (Ad-shSirT1) had the opposite effect (Fig. 2.6.).  
The results show that SirT1 decrease the levels of FoxO3a associated with PGC-1α in these 
conditions. Therefore SirT1 positively regulates the formation of a PGC-1α/FoxO3a complex. 
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Figure 2.5 :  SirT1 overexpression promotes the formation of  a PGC-1α/FoxO3a complex. BAEC were co-
infected o/n with Ad-PGC-1α  and the indicated adenoviruses. 12 h post-infect ion, cells  were deprived of 
serum o/n and then treated for 4 h with 50 µM H2O2. Whole cel l  extracts were subjected to 
immunoprecipitation (IP) with a specific PGC-1α antibody or normal IgG, as a control,  and analysed by 
Western Blot as indicated. Input indicates a  1/10 of whole cel l  extract not subjected to 
immunoprecipitation. The blots presented correspond to a representative experiment from ≥3 
independent experiments.  
 
Figure 2.6 :  SirT1 knockdown downregulates the formation of a PGC-1α/FoxO3a complex. A) BAEC were 
co- infected o/n with Ad-PGC-1α  and the indicated adenoviruses.  12 h post-infection, cells were 
deprived of serum o/n and then treated for 4 h with 50 µM H2O2. Whole cell  extracts were subjected to 
immunoprecipitation (IP) with a specific PGC-1α antibody or normal IgG, as a control,  and analysed by 
Western Blot as indicated. Input indicates a  1/10 of whole cel l  extract not subjected to 
immunoprecipitation. The blots presented correspond to a representative experiment from ≥3 
independent experiments.  
As previously shown (Figure 2.1-2.4), SirT1 is a general regulator of antioxidant genes in bovine aortic 
endothelial cells and in mouse embryonic fibroblasts. To further investigate the role of SirT1 in the 
regulation of the PGC-1α/FOXO3a complex formation, SIRT1+/+ and SIRT1-/- MEFs that over-expressed 
PGC-1α (Ad-PGC-1α) were used and the amount of FoxO3a that co-immunoprecipitate (co-IP) with 
PGC-1α was monitored. 
The result show that FoxO3a amount found in PGC-1α immunoprecipitation was lower in SirT1-/- 
MEFs than in SirT1+/+ MEFs. Previous observation and the mentioned results are supporting the 
evidence that SirT1 is a positive regulator of FoxO3a/PGC-1α complex formation (Fig. 2.7). 
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Figure 2.7 :  SirT1 deficient MEFs show reduced levels of  the PGC-1α/FoxO3a complex SIRT1+ / +  and 
SIRT1- /-  MEFs were infected o/n with Ad-PGC1α and 12 h post- infect ion cells  were deprived of serum 
o/n. Cel l  extracts were immunoprecipitated with an specif ic anti-PGC1α antibody (PGC-1α) or rabbit  
IgG as control ( IgG) and analysed by western blot. The blots presented correspond to a representative 
experiment from ≥3 independent experiments.  
Next it was investigated how Sirt1 could regulate the PGC-1α/FoxO3a complex formation. 
Two alternative mechanisms could explain SirT1 activity on the PGC-1α/FoxO3a complex, SirT1 could 
act either on PGC-1α and FoxO3a individually or on a pre-formed complex (Figure 2.8). As already 
introduced (Introduction and Figure 2.2), posttranslational modifications play an important role in 
the localisation, stability and specificity of interaction for both FoxO3a and PGC-1α.  
In order to determine whether the acetylation status of either PGC-1α or FoxO3a could be influenced 
by the formation of a PGC-1α/FoxO3a complex, FoxO3a acetylation levels in PGC-1α silenced BAEC 
and PGC-1α acetylation levels in FoxO3a silenced BAEC were tested.  
Suppression of PGC-1α expression resulted in a dramatic increase in FoxO3a acetylation (Figure 2.8). 
Similarly, shRNA-mediated silencing of FoxO3a induced an increase in acetylated PGC-1α (Figure 2.9).  
This result might suggest that SirT1 is likely to be active on the PGC-1α/FoxO3a complex, since in the 
absence of one of these factors, the other might not be deacetylated. 
 
 
 
Figure 2.8:  FoxO3a and PGC-1α  influence each 
other level of acetylat ion:  Silencing of PGC-1α .  
BAEC were infected o/n with Ad-shPGC-1α or the 
corresponding control adenoviruses, 12 h post-
infect ion, cel ls were deprived of serum o/n and 
harvested. Whole cell  extracts were subjected to 
immunoprecipitation (IP) with FoxO3a specific 
antibodies,  or normal IgG, as a control.  
Acetylation levels were analysed by western blot. 
Data are from ≥3 independent experiments.  Data 
are means +SD (*) p ≤ 0.05 vs.  control.  
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Figure 2.9:  FoxO3a and PGC-1α  influence each 
other level of acetylat ion:  Silencing of FoxO3a. 
BAEC were infected o/n with Ad-shFoxO3a or the 
corresponding control adenoviruses, 12 h post-
infect ion, cel ls were deprived of serum o/n and 
harvested. Whole cell  extracts were subjected to 
immunoprecipitation (IP)  with PGC-1α  specif ic 
antibodies,  or normal IgG, as a control.  
Acetylation levels were analysed by western blot. 
Data are from ≥3 independent experiments.  Data 
are means +SD (*) p ≤ 0.05 vs.  control.   
Generally speaking, modifying enzymes tend to work on a hit and go mechanism where they 
recognize the unmodified moiety of the target protein and the affinity drops following modification. 
Since the deacetylase activity of SirT1 is expected to work on two different proteins forming a 
complex while they are still in a complex. This results not only argues on the enhanced stability of a 
PGC-1α/Foxo3a complex when both are deacetylated, it further suggests that SirT1 may not leave 
the complex once the target protein is deacetylated but may actually stay associated with it and able 
to modify a different but nearby protein. This evidence would argue for two different interaction 
surfaces one for docking and one for modification within the SirT1 protein. Furthermore it may 
indicate that SirT1 can have different docking surfaces for PGC-1α and FoxO3a different from the 
acetyl binding domain. 1.3. SirT1 is recruited to the promoter regions of PGC-1α, FoxO3a and several antioxidant genes 
Taking into account the previous results, suggesting that SirT1 was part of a ternary complex with 
PGC-1α and FoxO3a together with evidence showing that PGC-1α and FoxO3a formed a complex 
that bound to regulatory elements of target antioxidant genes and data indicating that SirT1 was also 
important for this regulation, the question raised whether SirT1 could also be recruited to regulatory 
promoter regions in these genes together with PGC-1α. 
In order to elucidate the regulation mechanisms involving SirT1, SirT1 association with the promoter 
regions of the genes under survey, was questioned. To provide an answer, chromatin 
immunoprecipitation (ChIP) was the technique chosen. 
SirT1 recruitment to promoter regions where PGC-1α/FoxO3a complex have previously shown to 
associate was tested. An attempt to identify putative SirT1 binding sites in PGC-1α and FoxO3a 
promoters was made. Advantage was taken from the knowledge that SirT1 activity in cultured cells is dramatically modified by serum levels (Brunet A et al. 2004). Interestingly, one of the mildest conditions to 
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induce the detoxification system is serum starvation. Therefore 10% fetal bovine serum (FBS) and 
0.5% FBS conditions were used as a simple strategy to modulate SirT1 activity (Brunet A. et al. 2004).  
SirT1 did associate with the promoter regions of sod2 (MnSOD), catalase, prx3, prx5, ucp-2, pgc-1α, 
and foxO3a (trx2, tr2 were not analysed). Until now, Sirt1 was not mapped to a specific site in the 
promoter region of FoxO3a nor the antioxidant genes. Serum starvation generally increased SirT1 
recruitment with the remarkable exception of the prx5 gene, where it had the opposite effect (Figure 
2.10.). These data suggested that SirT1 is likely to be directly involved in the regulation of 
mitochondrial antioxidant genes, including pgc-1α and foxo3a, while forming a ternary complex with 
PGC-1α and FoxO3a recruited to the promoter regulatory sites (Olmos Y et al. 2013). 
 
Figure 2.10 :  S irT1 is recruited to promoter regions of ROS detoxif icat ion genes upon serum starvation.  
ChIP assays to identify SirT1 binding sites of promoter regions corresponding to the indicated ROS 
detoxif icat ion genes. Cross l inked chromatin Promoter occupancy was analysed by qPCR using speciﬁc 
primers.  ß-act in CDS was used to control  for non-specific enrichment.  Data are from ≥3 independent 
experiments. Data are means +SD (*)  p ≤ 0.05 vs. control.  1.4. Promoter environment: Acetylation levels 
SirT1 is a deacetlylase whose role in histone deacetylation is well characterized (Introduction 1.1.3.1). 
From the above results, SirT1 seemed to be recruited to specific target sites in the regulatory regions 
of the promoters of antioxidant genes (Figure 2.10.). 
This leads to the question of SirT1 recruitment to antioxidant genes and if upon recruitment to this 
specific sites, SirT1 would target nearby histone deacetylation. So far SirT1 histone deacetylase 
activity was presumed to work over large targeted chromatin domains rather than discrete specific 
binding sites. 
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Therefore, testing of whether SirT1 recruitment to antioxidant genes would be associated with a 
reduction in histone acetylation was carried out. H4 on lysine 16 (H4K16Ac) has been described as a 
position highly sensitive to SirT1 activity (Skurk C et al. 2004). To evaluate the deacetylation activity 
of SirT1, ChIP assays against the promoter regions of antioxidant genes were performed. Specific 
antibodies against the H4K16Ac epigenetic mark were used on SirT1 specific promoter binding 
regions.  
The result show that at the sites where SirT1 binding could be detected (catalase, prx3, prx5, ucp-2), 
changes in H4K16 acetylation levels in response to serum deprivation mirrored changes in SirT1 
recruitment (Figure 2.11.). In other words, more SirT1 binding correlated with reduced histone 
acetylation at the binding sites, and the opposite would also hold true. In general, increased SirT1 
binding correlated with decreased acetylation levels and vice versa. This observation suggested that 
upon recruitment of SirT1 to FoxO3a/PGC-1α binding sites, it deacetylated nearby H4K16 residues. 
 
Figure 2.11:  Acetylation level correlates with S irT1 localization at promoter s ites.  H4K16Ac ChIP assays 
of promoter regions corresponding to the indicated ROS detoxification genes. Cross l inked chromatin  
Promoter occupancy was analysed by qPCR using speciﬁc primers. β -actin CDS was used to control for 
non specific enrichment.  H4K16 acetylation levels at SirT1 sites. The position of the analysed fragments 
is indicated, using as reference (+1),  the posit ion of the ATG. Data are from ≥3 independent 
experiments. Data are means +SD (*)  p ≤ 0.05 vs. control.   1.5. Transcription activation: a sequential process  
The results from the former section 1.4., where somehow puzzling, since histone deacetylation is 
normally associated with gene silencing and reduced recruitment of RNAP II to promoter sites. The 
results identified SirT1 as a positive and specific regulator of antioxidant gene expression. In order to 
elucidate how SirT1 regulates antioxidant gene expression while deacetylating histones at the 
targeted binding sites, ChIP assays was used to monitor RNAP II recruitment to antioxidant genes. A 
scanning from the SirT1 binding sites to the initiation of the CDS sequences was performed. RNAP II is 
generally recruited close to the ATG, the transcription start site. As bona fide transcription start sites 
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where unknown, ATG sites were used as an approximate reference for RNAP II localization. To target 
RNAP II by ChIP, these sequences were investigated and specific oligonucleotides were designed. 
It was found that at positions proximal to the transcription start site (ATG primers for all genes 
except for ucp-2/-2500 since in this case the ATG is in exon 3) serum deprivation resulted in a 
dramatic decrease in RNAP II recruitment, suggesting that SirT1 dependent histone deacetylation 
negatively impacts on RNAP II recruitment at transcription start sites (Figure 2.12.). 
 
 
Figure 2.12:  RNA polymerase chromatin immunoprecipitation on promoter region of antioxidant 
defense system ChIP assays of  promoter regions corresponding to the indicated ROS detoxificat ion 
genes. RNA P II  recruitment. The posit ion of the analysed fragments is indicated, using as reference 
(+1),  the posit ion of the ATG. The position of the analysed fragments is indicated, using as reference 
(+1),  the posit ion of the ATG. Data are from ≥3 independent experiments. Data are means +SD (*) p ≤ 
0.05 vs. control.   
To monitor RNAP II recruitment to antioxidant genes, a scanning of the upstream sequences (from 
SirT1 binding to the ATG) of the genes under survey was made.  
It was found that the upstream sites where SirT1 binding had been identified showed two distinct 
patterns for RNAP II binding. On one hand at MnSOD, catalase and prx3, RNAP II binding was also 
reduced in starvation conditions, but only very moderately at the prx3 promoter (Figure 2.12.). 
Nevertheless, RNAP II recruitment was actually increased by serum deprivation at the prx5, ucp-2 
and pgc-1α promoters, suggesting that SirT1 recruitment could, at least in some cases, be associated 
to increased RNAP II recruitment at alternative start sites, despite of reduced acetylation on the site 
itself (Figure 2.12.).  
In order to elucidate how, regardless of a reduced RNAP II recruitment, SirT1 could enhance 
transcriptional levels of these target genes, two genes were selected with the two apparently 
disparate recruitment patters for further analysis, prx3 and ucp-2. 
SirT1 binding, RNAP II recruitment, and levels of elongating RNA Polymerase II (RNAP II; CTD serine-2 
phosphorylated: CTDS2P) versus initiation RNAP II (CTD serine-5 phosphorylated: CTDS5P) along each 
of the selected genes (prx3 and ucp-2) were monitored.  
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In positions proximal to the transcription start site, serum deprivation resulted in a reduction in 
RNAP II recruitment, but downstream of the sites where SirT1 binding had been identified, it resulted 
in an increase in RNAP II levels. Reduced recruitment at the start site and increased levels 
downstream could be indicative of increased transcription rates.  
The levels of elongating RNAP II by ChIP were performed using antibodies against the phosphorylated 
form of the C-terminal domain of RNAP II (CTD2P). Dramatic increases in “elongating RNAP II” in 
serum starvation conditions in both prx3 and ucp-2 genes were found, suggesting that reduced RNAP 
II recruitment at the start site was compensated by increased promoter clearance.  
These results might explain how SirT1 recruitment can be associated with a sustained or increased 
gene expression despite of a general reduction in RNAP II recruitment induced by serum deprivation 
(Figure 2.13.).  
 
 
 
 
Figure 2.13 :  Increased 
levels of e longating 
RNAP II  are associated 
with SirT1 recruitment.  
ChIP assays of promoter 
regions corresponding 
to the indicated ROS 
detoxif icat ion genes 
(Prx3 and UCP-2). Cross 
l inked chromatin 
Promoter occupancy 
was analysed by qPCR 
using speciﬁc primers.  
β -actin CDS was used to 
control for non-specific  
enrichment. The 
position of the analysed 
fragments is indicated, 
using as reference (+1),  
the position of the ATG.  
Prx3 and ucp-2 were 
analysed. Left panels  
analysis of  RNA P II  at  
the transcript ional start  
region and along the 
genes. Right panel,  
analysis of “elongating” 
RNA P II  levels  (RNA P II  
phosphorylated in the 
Ser2 posit ions of the 
CTD repeats of the RNA 
P II  largest subunit)  at  
the transcript ional start  
region and downstream 
of the ATG.  Data are 
from ≥3 independent 
experiments. Data are 
means +SD (*) p ≤ 0.05 
vs.  control.   
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In order to correlate histone deacetylation, SirT1 localisation on the target promoter region and gene 
transcription, SirT1 ChIP along the promoter and the coding sequence was performed. 
Importantly, the results showed that SirT1 binding could only be detected at promoter sites in the 
prx3 gene. In the ucp-2 sequence, binding to SirT1 was detected in the promoter region and, some 
extent, within the transcribed region but downstream of the ATG, suggesting that SirT1 at these 
selected promoters binds to specific sites mainly at the promoter region. The absence of SirT1, where 
elongating RNAP II is located, makes it unlikely to be associated with the elongating RNAP II complex. 
Therefore SirT1 is not directly involved in the epigenetic modification of the CDSs regions (Figure 
2.14.).   
 
 
 
 
 
 
 
 
Figure 2.14:  S irT1 is recruited to promoter  
regions (Prx3 and UCP-2).  ChIP assays of 
promoter regions corresponding to the 
indicated ROS detoxif icat ion genes. Cross 
l inked chromatin Promoter  occupancy was 
analysed by qPCR using speciﬁc pr imers.  β -
actin CDS was used to control for non-
specif ic enrichment. SirT1 recruitment 
along the genes, upstream and downstream 
of the ATG. Data are from ≥3 independent 
experiments. Data are means +SD (*) p ≤ 
0.05 vs. control.   
 
Observation that serum starvation of BAEC resulted in a significant induction in the mRNA of SirT1, 
MnSOD, UCP-2, and PGC-1α suggesting that some genes are positively induced under this conditions 
(Figure 2.15). Catalase, Peroxiredoxin 3 and 5 did show a great variability in the measurements, 
however a tendency towards increase is observed.  
These results might explain how SirT1 recruitment can be associated with a sustained or increased 
gene expression despite of the genome wide general reduction in RNAP II recruitment induced by 
serum deprivation (Figure 2.15.).  
Results 
61 | P a g e  
 
  
Figure 2.15 :  Antioxidant gene expression is sustained upon serum starvation.  mRNA and protein levels  
of SirT1 target genes in confluent BAEC cells in 10 % FBS or serum deprived (0.5% FBS) o/n were 
analysed by qRT-PCR and western blot  respectively.  Data are from ≥3 independent exper iments. Data 
are means +SD (*) p ≤ 0.05 vs.  control.  The b lots presented correspond to a representative experiment.   
The first aim of the work presented in this thesis was to determine if SirT1 collaborates with PGC-1α 
in regulating antioxidant genes and to find out through which mechanisms this regulation is 
mediated. The results demonstrate not only that SirT1 deacetylates PGC-1α and FoxO3a, but also 
that all three proteins together form an efficient ternary transcription elongation complex recruited 
to the regulating regions of the target antioxidant genes. After recruitment to the regulating regions, 
SirT1 deacetylates the nearby histones; this specific deacetylation does not lead to a gene silencing. 
However the exact mechanism of regulation is still not clear and remains to be elucidated. These 
results show for the first time that SirT1 can not only lead to a general silencing of chromatin, but can 
also induce specific gene expression when involved in a specific transcription complex. 
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2. Functional characterisation of PGC-1α RRM  
The transcriptional co-activator PGC-1α has been shown to be a key regulator of mitochondrial 
biogenesis, adaptive thermogenesis, glucose metabolism and oxidative stress in response to specific 
signals (Introduction section 2.2.). The PGC-1α carboxyl terminal domain has specific domains with 
roles in transducing cellular metabolic signals. To elucidate the function of the RNA recognition motif 
(RRM) and the Arginine/Serine (RS) domain, several DNA constructs were generated by molecular 
biology engineering. Some constructs generated lack both the RRM and RS domains (∆RRM/∆RS 
PGC-1α), other constructs lack either the RRM (∆RRM PGC-1α) or RS (∆RS PGC-1α) domain (Figure 
2.16.). These constructs were used to clarify the role of the domains in PGC-1α activity. In this 
section ∆RRM PGC-1α was studied. 
 
Figure 2.16:  PGC-1α  C-terminal constructs: lacking the C-terminal region, lacking both the RRM and RS 
domains (∆RRM/∆RS PGC-1α) ,  either the RRM (∆RRM PGC-1α)  or RS (∆RS PGC-1α)  domain.   
Previous studies from the group (Sanchez-Ramos C et al. 2013) have shown that deletion of the RRM 
of PGC-1α reduces its capacity to trans-activate several genes involved in mitochondrial biogenesis. 
In order to investigate the mechanisms involved and the target specificity the activity of mutants of 
PGC-1α carboxyl that harbour a specific deletion of the RRM was tested and its capacity to regulate 
antioxidant gene expression was analysed. It was found that a mutant lacking the RRM was less 
efficient than the wild type protein in the induction of all antioxidant genes tested (sod2-MnSOD, 
catalase, prx3, prx5, trx2, ucp-2) with the possible exception of tr2 in MEFs (Figure 2.17.).  
Figure 2.17:  PGC-1α  adenovirus can restore 
the antioxidant gene induction but not Ad-
PGC-1α-∆SR/∆RRM. MEFs were infected with 
the indicated adenoviruses (Ad, Ad-PGC-1α  
Ad-PGC-1α-∆SR /∆RRM). mRNA expression is 
shown as the fold induction above the level in  
cells infected with control adenovirus (Ad).  
Control samples were assigned the value of 1. 
Mn superoxide dismutase (MnSOD), uncoupl ing 
protein  2 (UCP-2),  peroxiredoxins 3 and 5 
(Prx3 and Prx5),  th ioredoxin 2 (Trx2),  
thioredoxin reductase 2 (TrxR2) and catalase 
(Cat).  Data are means +SD. (*) P ≤0.05.  
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Translocated in liposarcoma (TLS) is a transcriptional cofactor of PGC-1α that interacts with its CTD. 
TLS regulates PGC-1α activity on antioxidant genes (Sanchez-Ramos C et al. 2013). When the 
coactivation activity of TLS on a PGC-1α mutant lacking the RRM was tested, it was found that even 
though TLS could still interact with PGC-1α-∆RRM, TLS could not coactivate the PGC-1α-∆RRM 
mutant to induce catalase, prx5, trx2 and ucp-2. However, it was still able to coactivate sod2, prx3 
and tr2 gene (Figure 2.18.). 
 
Figure 2.18:  TLS act ivation of PGC-1α  and PGC-1α-∆∆ ,  consequences on the induction of the 
antioxidant genes .  MEFs were infected with the indicated adenoviruses (Ad, Ad-TLS, Ad-PGC-1α  Ad-
PGC-1α-∆∆) .  mRNA expression is  shown as the fold induction above the level in cel ls  infected with 
control adenovirus (Ad). Control  samples were assigned the value of  1.  Mn superoxide dismutase 
(MnSOD), uncoupl ing protein 2 (UCP-2),  peroxiredoxins 3 and 5 (Prx3 and Prx5),  thioredoxin 2 (Trx2) ,  
thioredoxin reductase 2 (TrxR2) and catalase (Cat).  Data are means +SD. (*) p ≤0.05.  
In order to investigate the coactivation mechanisms involved, the capacity of the coactivator TLS to 
coactivate PGC-1α wt or a mutant lacking the RRM on the proximal UCP2 promoter using a luciferase 
reporter assay was tested.  
It was found that the WT but not the ∆RRM was able to coactivate TLS on the proximal UCP-2 
promoter (Figure 2.19.). These results suggest that the RRM is necessary for the regulation of some 
but not all PGC-1α target genes and it may be required for functional interaction with some 
coactivators in a promoter specific manner. Importantly, promoter sequences are sufficient for RRM 
dependent regulation of target gene expression. 
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Figure 2.19 : TLS can coactivate PGC-1α WT but not PGC-1α-∆RRM at the UCP-2 promoter. 30% 
confluent FAO cells were transfected with 0.25 µg of pUCP2-luc, 0.25µg of S-HA-PGC-1α,  or S-
HA-PGC-1α-∆RRM, 1 µg pSG5-FL-TLS or the corresponding empty vectors.  Luciferase activity 
was determined 24 h post-transfection.  2.1. Analysis of PGC-1α activity in hepatocytes 
To further characterise the gene specificity of the RRM motif whole genome analysis of PGC-1α 
activity was carried out. Primary hepatocytes were selected as a relevant cell type, since the liver is 
the central metabolic organ of the organism and PGC-1α is essentially a metabolic regulator playing a 
key role in liver function. Primary hepatocytes isolated from PGC-1α+/+ and PGC-1α-/- mice were 
chosen as a cellular model for this study.  
First as a control analysis, total RNA was isolated from primary hepatocytes from wild-type (WT) and 
KO PGC-1α animals and analysed by qRT-PCR to determine the expression levels of several 
antioxidant genes. In the absence of PGC-1α in KO hepatocytes the levels of prx3, prx5, ucp-2 and 
catalase were significantly lower than in the WT hepatocytes (Fig.2.20.).   
  
 
Figure 2.20:  PGC-1α  
regulation of oxidative 
stress protection genes. 
qRT-PCR analysis  
oxidative stress protection 
genes in PGC-1α+/+ and 
PGC-1α-/- hepatocytes.  
18S RNA was used as a 
loading control. Control 
samples were assigned the 
value of 1. Data are 
means +SD. (*) P ≤0.05. 
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2.2. Whole genome expression analysis of PGC-1α+/+ and PGC-1α-/- primary hepatocytes  
To get further insight into the regulatory activity of PGC-1α in hepatocytes, it was considered to be 
informative to carry out a whole genome expression analysis of PGC-1α using a microarray based 
palteform. Microarrays (i.e Affymetrix Exon Arrays) and RNA-Seq (i.e. Illumina sequencing system) 
are currently the two most common experimental platforms for the whole genome expression 
analysis. The selected platform, Affymetrix GeneChip microarrays makes use of 60nt long probes 
corresponding to transcript sequences.  
The probes are synthesized in situ on the slide using a photolithographic method. Labeled cDNA 
prepared from mRNA isolated from PGC-1α+/+ and PGC-1α-/- primary hepatocytes was hybridized on 
the slides. Two independent array analysis were carried out, each used samples from 3 different WT 
and 3 different KO mice (total 6 WT and 6 KO mice), and for each of the samples three technical 
replicates were processed. Following slide scanning, a relative quantification analysis of transcript 
levels was performed as implemented (Dalma-Weiszhausz DD et al. 2002). Data outcomes after 
background correction and inter-chip, extra-chip normalization, showed that the up-regulated and 
down-regulated genes were consistently replicated in the two experiments. Considering that the 
primary cells are used after extraction from living animals, and that the preparation requires 
technical skill to perform the liver transfusion, the results obtained show a very low inter-assay 
variability. The array data from the two experiments shows reproducibility and consistency when 
analyzing the inter-assay and the intra-assay results.  
In this experiment, a gene is considered to be up-regulated by PGC-1α when the log2 ratio signal 
(WT/KO) is greater than 2. Similarly, a gene is considered to be down-regulated when the log2 ratio 
signal (WT/KO) is less than -2. 
Of the 421 genes identified as being positively regulated by PGC-1α in the first experiment, 288 of 
them were also found to show significantly higher levels in the WT than in the KO hepatocytes in the 
second experiment (Figure 2.21.). Similarly, of the 238 genes identified as negatively regulated by 
PGC-1α in the first experiment, 145 of them were also found to have lower expression level in the 
second experiment. The remaining 133 differentially expressed genes identified in the first 
experiment, in the second experiment these genes either did not reach the threshold of log value of 
2 (eg.: Olfr1450), did not share a common identifying tag, or were not present in the second set of 
arrays (Figure 2.21.). 
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Figure 2.21 :  Genome wide analysis  of PGC-1α  WT and KO hepatocytes. Whole genome expression 
arrays were used to evaluate the gene expression changes between PGC-1α+ /+  and PGC-1α - / -  
hepatocytes. The diagram i l lustrates the total  number of  genes d ifferentially  down or up regulated by 
PGC-1α  in hepatocytes,  comparing the first and the second exper iment.  
The following tables summarize twenty representative genes up-regulated and twenty down-
regulated within the two assays (Tables 9 and 10).  
  
 
 
 
 
Table 9 : List of the 20 top 
genes down regulated by 
PGC-1α  in hepatocytes.  
The fold change in PGC-
1α+/+ and PGC-1α-/- 
hepatocytes, and the 
corrected p values are 
indicated.  
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Table 10:  List of the 20 top genes up regulated by PGC-1α  in hepatocytes.  The fold change in 
PGC-1α+/+ and PGC-1α-/- hepatocytes,  and the corrected p values are indicated.  
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Novel putative PGC-1α regulated gene families 
Gene cluster analysis identified new gene families of PGC-1α regulated genes, in particular, the 
cytochrome P450, family2. This gene family includes a group of xenobiotic metabolizing enzymes 
regulated in response to fasting, known to be transcriptionally regulated by the nuclear receptors 
constituve active/androstane receptor (CAR) and pregnane X receptor (PXR). PGC-1α has been 
previously shown to coactivate PXR and CAR and to be directly involved in the regulation of Cyp2A5 
(Konno Y et al. 2008). Now it is observed that PGC-1α can also positively regulate two other family 
members, Cyp2b13/Cyp2b9, whose protein products work in a coordinated manner and are known 
to be responsive to a common set of regulatory signals. Both have been shown to be induced by 
fasting, in response to glucagon and cAMP, by CREB, a transcription factor that induces PGC-1α 
expression and, is also coactivated by PGC-1α (Hawkins GA et al. 2002). These proteins are involved 
in oxidation-reduction reactions that produce as a by-product, H2O2, so their activity increases 
cellular oxidative stress unless there is a coordinated induction of antioxidant proteins. By-product, 
H2O2, xenobiotic activity has also been shown to play a relevant role in drug resistance in cancer. 
Importantly these genes have also been shown to be co-transcriptionally regulated with solute 
carrier transporters that also play a role in drug resistance by decreasing the cellular concentration of 
the chemotherapeutic drug, in the liver and in other tissues (Horvath HC et al. 2010). Consistently, 
several solute carrier proteins where found to be regulated by PGC-1α in hepatocytes.  
One interesting member of the solute carrier proteins that was found to be positively regulated by 
PGC-1α is Solute carrier family 30, member 10, Slc30a10 (NM_001033286). Slc30a10 is highly 
expressed in the liver and is inducible by manganese (Mn). Its protein product appears to be critical 
in maintaining manganese levels, and has higher specificity for Mn than zinc (Zn). Mn is a key co-
factor of several enzymes, including MnSOD. Loss of function mutations appear to result in a 
pleomorphic phenotype, including dystonia and adult-onset Parkinsonism in humans, both 
alterations may be the result of deficient mitochondrial function. Two different RNA probes for this 
gene were present in the Affymetrix GeneChip microarray. Interestingly, only one seems to be 
positively regulated by PGC-1α (A_52_P883557) while the other probe was not (A_51_P173445). 
Both sequences are present in the 3’UTR. The differentially regulated probe (A_52_P883557) is at the 
far end of the sequence, whereas the probe (A_51_P173445) is found close to the fourth exon. This 
observation may suggest that mRNAs with alterative 3’UTRs RNAs may be differentially regulated by 
PGC-1α. 
A part from the families described above, the Itgax gene (NM_021334) is also significantly higher in 
WT than in PGC-1α KO hepatocytes. This gene encodes the integrin alpha X chain protein. This 
protein is involved in the interaction of circulating neutrophils and monocytes with the activated 
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vascular endothelium to promote their extravasation. This protein combines with the beta 2 chain 
(ITGB2) to form a leukocyte-specific integrin referred to as inactivated-C3b (iC3b) receptor 4 (CR4). 
The alpha X beta 2 complex seems to overlap the properties of the alpha M beta 2 integrin in the 
adherence of neutrophils and monocytes to stimulate endothelium cells, and in the phagocytosis of 
complement coated particles. Two transcript variants encoding different isoforms have been found 
for this gene (Ensembl). Its role in hepatocytes is currently uncharacterized. 2.3. The RNA recognition motif (RRM) of PGC-1α regulates the transcription of antioxidant genes  
To elucidate the genome wide functional contribution of the RNA recognition motif (RRM) to the 
regulation of liver target genes of PGC-1α, adenoviral vectors coding WT PGC-1α or a construct 
where the RRM was deleted (PGC-1α-∆RRM) was used. Primary hepatocytes from PGC-1α WT and 
KO mice were transfected with Ad-PGC-1α, Ad-PGC-1α-∆RRM or a control adenovirus (Ad-S). 48h 
after infection, mRNA was isolated and analysed. As a control, qRT-PCR analysis of antioxidant genes 
was used to test whether Ad-PGC-1α recovered target gene expression in PGC-1α KO hepatocytes. 
The results indicate that when transfecting the KO PGC-1α hepatocytes with full length PGC-1α gene, 
full length PGC-1α is expressed and the functionality of PGC-1α in the KO hepatocytes, on the 
antioxidant genes is restored.  Consistently Ad-PGC-1α infection resulted in a general induction of 
antioxidant genes (Figure 2.22.). It is possible to suggest that the functionality of PGC-1α in other 
pathways is also restored. 
 
Figure 2.22:  PGC-1α  
restores oxidative stress 
expression in PGC-1α - / -  
hepatocytes. qRT-PCR 
analysis  of  the induction of 
oxidative stress protection 
genes in PGC-1α - / -  
hepatocytes that were 
infected with PGC-1α  or 
the corresponding control.  
mRNA expression is shown 
as the fold induction above 
the level  in cel ls  infected 
with control adenovirus. 
Control samples were 
assigned the value of 1. 
18S was used as a loading 
control.  Data are means 
+SD.  *P< 0.05.  
When infecting the KO PGC-1α cells with the adenovirus driven wild type PGC-1α or PGC-1α mutant 
lacking the RRM motif (∆RRM PGC-1α), expressing the PGC-1α protein without the RRM domain, two 
distinct patterns of gene regulation were observed.  
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For some antioxidant genes, mRNA levels were restored to the same level after infection with the full 
length PGC-1α protein or with the ∆RRM deletion mutant (sod-2 (MnSOD) and prx3). This indicates 
that transcription regulation of these specific genes is independent from the RRM. 
For other antioxidant genes, mRNA levels were significantly decreased, less induced by PGC-1α-
∆RRM than by the WT protein (prx5, catalase and ucp-2).  This gene profile suggests that the 
transcriptional regulation of these genes requires at least partially the RRM of PGC-1α. In particular, 
UCP-2 levels were not significantly induced by the ∆RRM mutant, suggesting that tis gene is strongly 
dependent on the RRM.  
This experiment therefore supports the relevance of the RRM domain in PGC-1α mediated regulation 
of transcription for specific genes (Figure 2.23.). These results support a gene and context specific 
dependency on RRM related function. 
 
Figure 2.23:  PGC-1α  and 
PGC-1α-∆RRM in the 
regulation of oxidative 
stress protect ion genes in 
hepatocytes. qRT-PCR 
analysis of  the induction of 
oxidative stress protect ion 
genes in PGC-1α - / -  
hepatocytes that were 
infected with PGC-1α  or 
PGC-1α-∆RRM. mRNA 
expression is shown as the 
fold  induction above the 
level in cells infected with 
control adenovirus. Control  
samples were assigned the 
value of 1. The CDS of β -
actin was used as a negative 
enrichment control.  Data are 
means +SD. *P< 0.05.  2.4. Expression of ∆RRM PGC-1α in PGC-1α KO hepatocytes effect on the cell expression profile  
In order to gain further insight into the functional relevance of PGC-1α RRM, mRNA from PGC-1α-/- 
primary hepatocytes transfected with adenovirus with either full-length PGC-1α or PGC-1α-∆RRM 
was hybridized on GeneChip arrays. Three independent experiments were analysed using three 
replicates. Raw data was analysed following background correction and inter-chip, extra-chip 
normalization as indicated above (Materials and Methods).  
The top twenty differentially regulated genes showing lower levels of expression in the PGC-1α-
∆RRM samples than in the WT PGC-1α samples are shown in the table below (Table 11). 
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Table 11: List of the 20 
top genes showing 
significantly reduced 
expression in PGC-1α- / -  
hepatocytes infected with 
PGC-1α-∆RRM than in 
PGC-1α - / -  hepatocytes.  
The fold change and the 
corrected p values are 
indicated.
Interestingly, it was also found that for some previously identified PGC-1α target genes, induction by 
PGC-1α-∆RRM was actually higher than that observed with WT protein. The 20 top examples are 
listed in the table below (Table 12). 
 
 
 
 
 
 
 
 
Table 12: List of the 20 
top genes showing 
significantly higher 
expression in PGC-1α- / -  
hepatocytes infected with 
PGC-1α-∆RRM than in 
PGC-1α - / -  hepatocytes.  
The fold change and the 
corrected p values are 
indicated.
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2.5. PGC-1α-∆RRM qRT-PCR functional validation 
qRT-PCR analysis was used to validate the micro array analysis. Three genes that were significantly 
more induced by PGC-1α-∆RRM than by PGC-1α and three that were significantly less induced by 
PGC-1α-∆RRM than by PGC-1α were selected for further investigation.  
These genes are, Cyp24a1, Cxcr7, Camk2b from the more induced and, Inpp5j, Cxcl1, Slc17a3 from 
the less induced (Figure 2.24. and 2.25.).  
An example provided by cytochrome P450, family 24 subfamily a polypeptide 1 (Cyp24a1) is 
encoding a gene member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 
proteins are monooxygenases which catalyse many reactions involved in drug catabolism and the 
synthesis of cholesterol, vitamin D3, steroids and other lipids. As noted above, PGC-1α has been 
shown to regulate several members of the P450 superfamily. It was found that PGC-1α-∆RRM 
induced the expression of the 3’UTR more than the WT protein (PGC-1α) (Fig. 2.24.).  
To validate the results, qRT-PCR is applied to the hepatocyte isolated RNA. qRT-PCR data was 
generally found to be consistent with the expression changes previously identified in the arrays, 
further supporting the gene specific activity of the PGC-1α RRM. The results are shown in Figure 
2.24. However, within the six selected genes, some did not show the previously identified changes 
(Camk2b and Inpp5j). 
In general, the results confirmed the observation in the array described in the upper section (2.4.). 
PGC-1α has an RNA recognition motif that has been shown to be functionally relevant in mediating 
PGC-1α transcriptional regulatory activities for specific genes. It can be concluded that the RRM is 
regulating the activity of the genes studied in this section (Figure 2.24. and 2.25.). 
 
Figure 2.24:  PGC-1α  and PGC-
1α-∆RRM differentially 
regulate gene expression in 
hepatocytes: more induced in 
PGC-1α .  qRT-PCR analysis  of  
the induction of selected 
genes (Cyp24a1, Cxcr7, 
Camk2b)  in PGC-1α - / -  
hepatocytes that were 
infected with PGC-1α  or PGC-
1α-∆RRM. mRNA expression is  
shown as the fold induction 
above the level in cells  
transfected with control  
adenovirus. Control  samples 
were assigned the value of  1. 
The CDS of ß-act in was used 
as a negative enrichment 
control Data are means +SD.  
*P< 0.05.  
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Figure 2.25:  PGC-1α  and 
PGC-1α-∆RRM differential ly 
regulate gene expression in 
hepatocytes: less induced in 
PGC-1α .  qRT-PCR analysis  of 
the induction of selected 
genes (Inpp5j,  Cxcl1,  
Slc17a3)  in PGC-1α - / -  
hepatocytes that were 
infected with PGC-1α  or 
PGC-1α-∆RRM. mRNA 
expression is shown as the 
fold  induction above the 
level in cells transfected 
with control adenovirus. 
Control samples were 
assigned the value of 1.  The 
CDS of ß-actin was used as a 
negative enrichment control.  
Data are means +SD. *P< 
0.05.  
Alternative expression pattern: PGC-1α / ∆RRM PGC-1α 
Gene expression microarrays include specific tags for several sequences within a single gene, 
allowing the identification of splicing variants. This feature was used to further investigate if PGC-1α-
∆RRM could play a role in differential regulation of splicing variants. Some tag specific differences 
were noticed between the PGC-1α and PGC-1α-∆RRM. This variation prompted a careful 
examination of selected target genes, in particular Camk2b and Slc17a3. These two genes seemed to 
present possible differential expression patterns within the gene dependent on the presence of the 
RRM. It was noted that within a gene, some sequences were significantly and differentially expressed 
in a RRM dependent manner (Table 13).  
The results from the former chapter showed a ternary complex formation (SirT1-PGC-1α-FoxO3a) 
involved in gene regulation. Interestingly, the database renders accessible results from array 
experiments where wild type hepatocytes were compared to siSirT1 hepatocytes. The comparison is 
included table 4 for the genes previously selected. Strikingly, some genes showed the same 
tendency. 
qRT-PCR analysis was also performed on Slc17a3 (NM_134069) (Figure 2.26.).  The slc17a3 gene has 
4 splicing variants. The expression levels of the region between exons 9 and 11 is higher in PGC-1α 
KO cells transfected with PGC-1α-∆RRM than with WT PGC-1α, but the expression levels of the 3’ 
UTR are not affected by the presence or the absence of the RRM, again suggesting a role of the RRM 
in 3’UTR selection. 
 
 
Results 
74 | P a g e  
 
 
Table 13 :  Gene-tag specific changes for the contrast  PGC-1α-∆RRM/PGC-1α WT as identif ied in the 
microarray analysis.  
 
The Calcium/Calmodulin dependent protein kinase II beta (Camk2b) gene has several splicing 
variants as well as alternative 5’ and 3’ UTRs. The gene codes for a calcium sensitive kinase that has 
been proposed to regulate PGC-1α expression through the formation of a complex with PGC-1α itself 
that binds to the promoter region of the pgc-1a gene (Czubryt et al., 2003, Handschin et al., 2003).  
Three sets of qRT-PCR oligonucleotides were designed targeting two of the 3’UTR and one the region 
between exons 19-21 of Camk2b. The qRT-PCR analysis shows that the two 3’UTR sequences were 
up-regulated more strongly by PGC-1α-∆RRM than by WT PGC-1α while no variation was observed in 
the CDS region. This result shows a specific role of RRM in the identification of transcriptional 
termination sites that has to be confirmed by further functional assays (Figure 2.26.). 
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Figure 2.26:  PGC-1α and PGC-1α-∆RRM differential ly regulate 3’UTR selection. qRT-PCR analysis of 
slc17a3, Impp5 and Camk2b gene expression in  PGC-1α - / -  hepatocytes that were infected with PGC-1α  
or PGC-1α-∆RRM. mRNA expression is shown as the fold induction above the level in cel ls infected with 
control adenovirus. Control  samples were assigned the value of 1. Data are means +SD.  *P< 0.05.  
All together, the results support the notion of the RRM playing a functional role in PGC-1α target 
gene regulation. Furthermore, they show that RRM requirement is gene specific, playing a regulatory 
role for specific target genes. Finally, they suggest that PGC-1α activity may relate to the stabilisation 
of the transcript either by facilitating elongation/termination or by directly regulating RNA stability 
through the binding of UTR regions. PGC-1α has a RNA recognition motif (RRM) whose deletion 
abolishes some of the transactivation capacity of PGC-1α. 
The second aim of this work was to study the functionality of the RRM motif in the specific context of 
regulating antioxidant genes. The results showed that some genes are more sensitive to the absence 
of RRM than others. To have a global overview of the genomic functionality of the RRM, a complete 
genome microarray expression analysis comparing wild-type PGC-1α protein to the PGC-1α protein 
lacking the RRM was performed. The observation that the deletion of the PGC-1α RRM differentially 
affects genes regulated by PGC-1α suggests that the RRM could be involved in selection of 3’UTR and 
as a consequence modify RNA transcripts. 
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3. Identification of PGC-1α ligand RNAs  
In order to get insight into the mechanisms involved in RNA recognition motif (RRM) dependent 
regulation of gene expression, it was decided to investigate whether or not this domain showed RNA 
binding activity and if so to identify the ligand RNAs. 3.1. PGC-1α RNA binding activity  
To investigate the basis of the RRM function it was first tested whether PGC-1α  can actually bind 
RNA in cells. Therefore, a combination of UV crosslinking with specific antibody immunoprecipitation 
was performed as previously described (Greenberg JR 1979, Wagenmakers AJ et al. 1980, Choi YD 
and Dreyfuss G 1984). 
 
Figure 2.28: CrossLinked ImmunoPrecipitation (CLIP) Process 
(adapted from Yeo GW et al. 2009).  
As PGC-1α is composed of several domains and RRM is involved in regulation of mRNA, the assay was 
performed with the Carboxyl terminal domain (CTD) construct. The CTD is composed of the 
Arginine/Serine (RS) domain and the RRM until the C-terminal region of the protein.  
PGC-1α or its C-terminal mutants was transiently transfected in HEK 293T cells. 24 h post 
transfection cells were UV irradiated in order to crosslink proteins to neighboring nucleic acids. 
Whole cell extracts (WCE) were prepared and PGC-1α was immunoprecipitated (IP). The 
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immunprecipitated crosslinked oligonucleotides were labelled with 32P, using T4 polynucleotide 
kinase.  
32P labelled PGC-1α  was separated by SDS-PAGE gel separation (Figure 2.29.) and subsequently 
detected. The result showed that PGC-1α can be cross-linked to nucleic acid in cells.  
PGC-1α-∆RS mutant that retained the RRM was specifically labelled, suggesting that the RRM of PGC-
1α was actually used to bind nucleic acid.  
All mutants tested that lacked the RRM, including PGC-1α-∆CTD, the PGC-1α-∆RRM/∆SR mutant and 
PGC-1α-∆RRM gave only a background signal. A hypothesis to explain the background binding is a 
hetero-dimerisation of PGC-1α with a mutant form lacking the RRM. 
To identify the nature of the nucleic acid bound to PGC-1α, the labelled band was excised from the 
gel, protein was removed by protease K treatment, the remaining nucleic acid was incubated with 
either RNase A or DNase I enzymes. The material was analysed in a urea-denaturing gel. The result 
shown on Figure 2.29. illustrate the finding that the isolated nucleic acid was sensitive to RNase A 
treatment and resistant to DNase I.  The result is supporting the idea that PGC-1α was binding an 
RNA molecule.  
 
 
 
 
Figure 2.29:  PGC-1α  
associates with RNA in cel ls.  
70% confluent 293T cells (10 
cm Ø plates) were 
transfected with 12.5 µg of 
3.1-Flag-PGC-1α ,  and C-
terminal al leles,  24h 
posttransfection, cel ls were 
UV treated to crosslink 
nucleic acids to proteins. 
PGC-1α  was IP from WCE, 
and polynucleotides in the 
immunoprecipitates were 
end-labeled with 3 2P. (A-C) 
The PGC-1α labeled 
polynucleotide complex was 
resolved on a 7.5% PAGE-SDS 
gel.  As indicated extracts 
were treated with RNase A1 
or DNase I.  (B)The labeled 
materia l was excised from 
the gel,  digested with 
proteinase K,  recovered by 
ethanol precipitat ion, 
divided into three aliquots 
that were subjected to 
repeat digest ion with RNAse  
A1 or DNAse I  and resolved 
on a 20%-7 M urea gel.   
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An alternative approach was used to confirm the nature and specificity of the identified material. WT 
PGC-1α or PGC-1α-∆CTD mutant were UV crosslinked to the bound nucleic acid and 
immunoprecipitated. The immunoprecipitated material was incubated with RNAseA or DNAse I, 
labelled and analysed by SDS-PAGE separation and radiodetected. The only material associated with 
WT PGC-1α  was sensitive to RNAse treatment, while the signal associated with PGC-1α-∆CTD 
mutant was insensitive to both RNAse and DNAse I treatment. The result suggests that the 
background signal was not derived from a bound nucleic acid. 
In order to determine the nature of the RNAs that PGC-1α binds in vivo, it was first investigated 
whether PGC-1α would remain stably associated with RNA during standard immunoprecipitation 
conditions. The experimental design was as follows. PGC-1α or the mutants PGC-1-∆RRM, -∆SR,  
-∆CTD, -∆SR∆RRM were transiently transfected into HEK 293T cells and immunoprecipitated with a 
specific PGC-1α antibody. Isolated RNA from the immunoprecipitated material was analysed under 
native acrylamide gels stained with EtBr.  
RNAs were detected in the immunoprecipitates of PGC-1α and PGC-1α-∆SR but not in the 
immunoprecipitates of those PGC-1α alleles that lack the RRM (Figure 2.30.). Therefore, it was 
possible to purify the RNAs bound to PGC-1α containing the RRM. It was observed that while the 
PGC-1α-∆SR mutant was still able to associate with RNA, the ∆RRM deletion mutant was not (Figure 
2.30.). Thus it is possible to conclude that stable RNA binding was mediated by the RRM. 
 
Figure 2.30:  RNA associates with PGC-1α harboring the RRM. 70% confluent 293T cel ls were 
transfected with 3.1-Flag-PGC-1α  WT, the indicated C-terminal mutants,  or the corresponding empty 
vector. 24 h post-transfection, cel ls were harvested and PGC-1α  was IP from DNase I  treated WCE. RNA 
was extracted with Trizol from the immunoprecipitates, and analysed on a native acrylamide gel  
stained with EtBr.  
Aiming to identify the nature of those RNAs, the RNA present in the immunoprecipitates was 
retrotranscribed and the resulting cDNA was randomly amplified. The quality of the amplification 
reaction was determined by analysing the amplified DNA in an agarose gel stained with EtBr (Figure 
2.31. A.). To control the reaction, the immunoprecipitated protein was monitored by western 
blotting (Figure 2.31. B.). The result is showing equal amount of protein PGC-1α and PGC-1α-∆RRM 
immunoprecipitated.  
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To further evaluate the reaction, in parallel to the PGC-1α material immunoprecipitated by the 
specific antibody in the WCE, cells were transfected only with the vehicle plasmid, with PGC-1α-
∆RRM and analysed. The amount of amplified material in the control reactions was always much 
smaller than in the PGC-1α lane. A smear of nucleic acid was only observed in the amplification from 
WCE containing the wild type PGC-1α, suggesting the presence of a population of different RNAs in 
the starting material. In summary, it was possible to amplify several type of RNAs bound to PGC-1α 
containing the RRM suggesting that not only one type, or size of RNA is bound to the RRM of PGC-1α 
in vivo. 
 
 
 
Figure 2.31:  RNA binding to 
PGC-1α  in vivo. 70% 
conf luent 293T were 
transfected with 3.1-Flag-
PGC-1α  WT, 3.1-Flag-PGC-
1α-∆CTD, or the 
corresponding empty vector. 
Panel A: 24 h 
posttransfection, cel ls were 
harvested and PGC-1α was 
IP from DNase I  treated 
WCE. RNA was extracted 
with Trizol from the 
immunoprecipitates, 
subjected to RT and random 
PCR amplif ication. RT was 
performed using primer 
Round A as template (5’-
GTTTCCCAGTCACGATCNNNN
NNNNNN-3’),  followed by 20 
cycles of PCR amplif icat ion 
with primer Round B (5´-
GTTTCCCAGTCACGATC-3´).  
Panel B shows the control IP-
western.  
To further investigate whether RRM of PGC-1α interaction with RNA is active and functional, an in 
vitro Glutathion S-Transferase (GST) pull down assay was designed. The assay incorporated a double 
stranded DNA (dsDNA) as negative control and two single stranded RNAs (ssRNA). The nucleic acid 
interaction with GST- PGC-1α-CTD was assayed (Figure 2.32.). The results of this assay showed that 
dsDNA did not bind to GST-CTD construct.  This observation confirms the former findings of specific 
interaction of PGC-1α with RNA (Figure 2.29.) 
The two RNA species tested were the E2 snoRNA situated in intron 4 (RNA1) and 1.7 kb of the pre-
mRNA LR-1 fragment (RNA2) (Nag MK et al. 1993).  The 1.7 kb of the pre-mRNA LR-1 fragment was 
selected because it contained the E2 coding intron together with putative regulatory mRNA 
processing sequences. The association between immobilized GST fusion protein for PGC-1α-CTD and 
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the two in vitro transcribed 32P-labeled RNAs, one with a strong hair pin structure, a spliced form (E2: 
RNA1) and a pre-RNA fragment with an extended structure from the gene LR-1, an immature form 
(RNA2) was assayed. As expected, PGC-1α-CTD could bind the two 32P-labeled RNAs (Figure 2.32.).  
In order to evaluate the strength and specificity of the binding of the RNAs to the CTD domain, the 
assay design incorporate competition with non-specific cold RNAs (tRNA) at increasing concentration. 
The results show that increasing concentrations of non-specific cold RNAs competed more efficiently 
PGC-1α-CTD binding to RNA1 (Fig. 2.32., right pane: lanes 1-4) than to the 3’ 1.7 kb LR-1 pre-mRNA 
fragment (RNA2; Figure 2.32.) as the labelled RNA1 was displaced more efficiently. In summary, since 
the two RNAs have different affinities, the binding of LR-1 pre-RNA (RNA2) is more efficient than the 
E2 snoRNA (RNA1).  
In addition to the selective binding to RNA versus DNA, the last observation suggests that the RRM 
has some target specificity that could be sequence or structure dependent.   
 
Figure 2.32 :  PGC-1α-CTD can interact preferential ly with ssRNA in vitro. (A) Purif ied GST-CTD 
immobil ized on glutathione beads were incubated with the indicated polynucleotide. LR-1 CDS: RNA1 or  
3’ LR-1 pre-RNA (1.7 kb)  E2: RNA2,  or  DNA. (B) The preparation (GST/polynucleotide) was incubated in  
the presence of 0,  0.1 or 10 µg of tRNA, used as non-specif ic competitor. 32P labeled polynucleotides 
were extracted and detected by autoradiography fol lowing separation on 1% agarose gels and 
autoradiography.
LR-1 pre-RNA still has to be processed during it life cycle, which is not the case for E2 RNA. This 
enhanced affinity could suggest a preferential binding to immature RNA to the CTD domain of PGC-
1α. The data also supports the idea of a direct interaction between PGC-1α and a pre-mRNA. From 
the results obtained, a specific sequence is supposed to be bound by PGC-1α protein therefore at 
least one binding site should be present in LR-1, 1.7 kb fragment. The results would therefore be 
consistent with the possibility of PGC-1α binding specific RNAs in vivo. 
Both RNA species (RNA1 and RNA2) are displaced by increasing amount of tRNA. This observation 
shows a dynamic process of binding, suggesting an adaptation if environmental conditions changes. 
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The result supports the hypothesis of regulatory choice in which PGC-1α-CTD domain could be 
involved in vivo.  
This result is consistent with studies from other RNA binding proteins. As a rule, RNA binding tends to 
be less sequence specific than DNA binding and relies to large extends on the recognition of 
particular secondary structures and/or hybridization to other nucleic acid.  
The data also shows a preference of binding to RNA versus DNA, and moreover to immature, 
unprocessed RNA.  3.2. Identification of RNA species bound by PGC-1α 
  3.2.1. RNA Preparation 
Since the discovery of the first small silencing RNA (siRNA) in 1993, a wide variety of new RNA types 
have been identified (Ghildiyal M and Zamore PD 2009). Technical improvements have allowed the 
identification of siRNA and their functional characterisation. This was an insight into many RNA 
activities, eg. RNA nature, genomic localisation,... Furthermore, starting with the identification of 
Argonaute and miRNA processing machinery (Zisoulis DG et al. 2010) major efforts have focused on 
the development of techniques that facilitate the identification of specific protein-bound RNA 
molecules.  A combination of UV crosslinking with specific antibody immunoprecipitation (CLIP), 
followed by amplification and high throughput sequencing (HTS-CLIP) has become a standard 
method to identify novel RNA proteins ligands Figure 2.33. (Licatalosi et al 2008, Yeo et al 2009, 
Sanford et al 2009, Granneman et al 2009, Guil and Caceres 2007, Chi et al 2009). 
 
Figure 2.33:  High Throughput Sequencing Cross- linked immunoprecip itat ion:  HTS-CLIP  
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In order to identify the PGC-1α ligand RNAs, CLIP assay was carried out in a functionally relevant cell 
type. The cell type used was rat hepatoma cells (FAO), because they preserve the hepatocyte 
structure and most of their functions. To that end, the cells were infected with Adenovirus coding for 
HA-PGC-1α. Following UV crosslinking and immunoprecipitation, the ligand RNA was radiolabeled 
and revealed by western blot and autoradiography (Figure 2. 34.). First, the identification of RNA-
PGC-1α complex was confirmed in FAO.  
 
 
Figure 2.34 : Crosslink and 
immunoprecipitation steps 
of CLIP. FAO cells were 
infected with Ad-HA-PGC-
1α.  24h postinfection, 
cells were UV treated to 
crossl ink nucleic  acids to 
proteins. PGC-1α was IP 
from DNase I treated 
WCE, and polynucleotides 
in the immunoprecipitates 
were end-labeled with 3 2P. 
The PGC-1α labeled 
polynucleotide complex 
was resolved on a 7.5% 
SDS-PAGE gel and 
revealed by western blot 
and autoradiography.  
To isolate the bound RNA following UV crosslinking of the protein of interest and 
immunoprecipitation of the protein-RNA complex, the protein was digested with proteases and the 
remaining RNA was purified. The RNA sample was 3’ ligated to a 19 mer linker and 5′ labelled with 
32P-γATP, using the oligomers indicated in Figure 2.35.  
 
 
Figure 2.35:  3’ l igation PGC-1α l igand 
RNA fol lowing. Left panel: FAO cells  
were infected with Ad-HA-PGC-1α ,  
cells were UV treated to crossl ink 
nucleic acids to proteins.  PGC-1α  was 
IP and polynucleotides in the 
immunoprecipitates were end-labelled 
with 32P. The PGC-1α  labelled 
polynucleotide complex was protease 
digested. The isolated RNA was 3’ 
labelled. R ight panel:  Two controls (19 
mer and 24 mer) were subjected to 3’  
and 5’ l igation. The RNA species were 
resolved on native PAGE and revealed 
by phosphoimager.  
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To boost the ligation efficiency a modified version of the T4 RNA ligase (T4 RNA ligase 2 truncated) 
first developed in Dr. Tuschl’s laboratory was used (Rajasethupathy P et al. 2009). Labelled RNA was 
analysed by PAGE. Several experiment carried out could consistently identify a 3’ end labelled RNA of 
around 60 nucleotides, suggesting that PGC-1α could bind RNAs about 40 nt long (Fig. 2.35).  
The labelled RNA was excised from the gel and RNA was recovered by electro-elution and 
precipitation. Following Dr. Tuschl’s protocol it was initially aimed to construct RNA libraries where 
the extracted RNA would be ligated with specific oligonucleotides at both 3’ and 5’ ends that 
introduced sequencing bar codes and then to analyse them by mass sequencing. However, the 
amount of gel-recovered material was too low to further proceed and the library preparation 
strategy had to be changed.  
3.2.2. RNA amplification and library preparation 
As indicated above, the initial studies used FAO cells. At this point primary hepatocytes were used to 
further elucidate PGC-1α mechanism of action. The primary hepatocytes were used because they are 
not transformed and respond more efficiently than immortalized cell lines to metabolic regulators 
like PGC-1α. Furthermore, not only WT hepatocytes but also PGC-1α KO hepatocytes were used, 
facilitating the background correction and the analysis of PGC-1α ∆RRM mutants that would be 
expressed using adenoviral infection. Hence, wild type and PGC-1α KO hepatocytes were infected 
with adenoviral vectors that coded for HA-tagged PGC-1α or HA-tagged ∆RRM-PGC-1α. 
 
Figure 2.36:  Summary of the different c luster  amplif ication steps.  Immobil isation is fol lowed by 
bridging, amplif ication and a reading step.   
As in section 3.2.1., the CLIP workflow was used as previously indicated (Figure 2.33.) but instead a 
commercially available kit was used and an additional amplification step was introduced before the 
reverse transcription. In short, following stabilisation of in vivo protein-RNA interactions by UV 
irradiation, and antibody-mediated enrichment of specific RNA-protein complexes (anti-HA 
monoclonal antibody 12CA5), gel electrophoresis was used to isolate protein-RNA adducts 3′ RNA 
linker ligation and 5′ labelling using 32P-γATP. Recovered RNA was ligated to 3’ and 5’ adapters 
sequentially introduced before amplification by RT-PCR (TruSeq small RNA: RS-930-1012).  RT-PCR 
was performed to produce a stable DNA Adapter library. The final step was a PCR amplification 
introducing the index sequence. These index sequences bind the flow cell and allow amplification 
during the preliminary step of the RNA sequencing (Figure 2.36). RNA libraries were analyzed by 
mass sequencing using an Illumina platform. 
Results 
84 | P a g e  
 
In order to control for specificity, several libraries were constructed. Primary hepatocytes were 
infected with the HA-shuttle (empty) adenovirus or the HA-∆RRM-PGC-1α adenovirus. As already 
explained (Section 3.1.), the deletion of the RRM makes the protein unable to bind RNA, and hence it 
was used as an additional control for nonspecific binding. Non-denaturing polyacrylamide gel analysis 
of the final amplification products are shown in Figure 2.37. The amplified bands (cDNA) were 
isolated and analysed by mass sequencing.  
It was anticipated that if the amplified material from the RT-PCR reaction derived from a PGC-1α 
specific RNA ligand, it should not be present in the shuttle nor in the ∆RRM-PGC-1α samples because 
this structure do not contain RRM able to bind RNA. The only band present would be background 
random amplification signals of the adapters. Furthermore, the band derived from a PGC-1α specific 
RNA ligand was expected to have a size of approximatively 140-150 bp, or its concatemers, since in 
the previous assay a 60 nt labelled band was consistently identified before (Figure 2.35.). However, 
the major amplified DNA band in HA-shuttle or HA-∆RRM-PGC-1α had a size of about 125 bp and was 
present in the control reactions. A major drawback in preparing nucleic acid fragment libraries by 
ligation of adapters to the ends of template nucleic acid fragments is the formation of adapter-
dimers. Adapter-dimers are formed by the ligation of two adapters directly to each other such that 
they do not contain a nucleic acid template fragment as an insert. A minor band with the expected 
size of adapter dimers (size 120-125 nt) and a major band with the size of a predictable concatamer 
(size from 130-135 nt) were present in the control reaction. Nevertheless, no other contaminants 
could be detected; suggesting that the reaction was well controlled (Figure 2.37.). 
 
 
Figure 2.37 :  L ibrary  control.  RT-PCR 
amplif icat ion products from WT-shuttle and 
WT-∆RRM-PGC-1α were resolved on an 
agarose gel.  The preparation was applied in 
duplicate.  (*)  indicate the non-specific  
amplif icat ion products.  
Additional internal controls for the RT and PCR reactions were included using the 19-mer and 24-mer 
oligonucleotides as templates. In Figure 2.38, the 19-mer and 24-mer band ligated to the 3’ and 5’ 
oligonucleotides are clearly identified.  
As already mentioned, if a specific product had been ligated between the specific 3’-5’ oligos and 
indexes, it should appear as a band of around 140-150 nt or its concatemers, since in the previous 
assay a 60 nt labelled band was consistently identified before (2.35.). In the preparation derived from 
WT and KO PGC-1α hepatocytes infected with HA-PGC-1α adenoviruses a product band of the 
expected size was identified (140-150 nt).  
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When low amounts of starting material were used (as was the case for the 19 mer- WT PGC-1α 
reaction), the proportion of adapters dimers was higher (amplified band size 120-125 nt). This band 
could be discriminated from the “specific” cDNA product. Another background band, attributed to 
the formation of adapter concatamers (size from 130-135 nt), could be observed directly below the 
specific PGC-1α RNA ligand band as in 19 mer amplification. The 130-135 nt band was more clearly 
visible in the samples derived from KO PGC-1α hepatocytes and was less evident in the 24 mer 
control reaction than in the KO HA-PGC-1α reaction. This effect could be related to the relatively 
lower amount of starting material present in the KO HA-PGC-1α and 19 mer preparations.  
 
Figure 2.38:  RT-PCR amplif ication products. Hepatocytes were transfected, crossl inked. The specifically  
bound RNA was isolated and RT-PCR protocol  was performed allowing insertion of specific code bare. 
The products were resolved on an agarose gel.  19 mer, 24 mer, WT-PGC-1α and KO-PGC-1α  
preparations are presented in duplicate. (*) indicate the non-specif ic amplif ication products.  
The specific cDNA product was difficult to separate during the isolation process from the adapter 
concatamer bands and was later taken into account for the analysis of the reads. 
Bands corresponding to approximately 150-155 nt are described as pre-miRNA or piRNA in the 
commercially available kit. No such bands were present in our preparations allowing concluding that 
the RNA identified is neither a pre-miRNA nor piRNA.  
Preparations derived from WT hepatocytes infected with HA-PGC-1α adenovirus showed additional 
bands of >200 nt, that could derive from a 2x concatemer of the ligand RNA or from amplified tRNA 
molecules. The two sets of bands (140-150 bp and >200 nt) were excised from the gel, eluted and 
precipitated.  
The integrity of the material following gel extraction was evaluated using a bioanalyzer; the High 
Sensitivity DNA Chip from Agilent Technologies 2100 Bioanalyser. This instrument validates the size 
of the bands extracted from the gels and showed a single size material (only one band was 
identified). Based on these results it was decided to use these samples for mass sequencing analysis. 
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3.3. Target Identification 
3.3.1. Data analysis 
Sequencing on Solexa was performed at the genomic unit at “Centro Nacional de Investigacion 
Cardiovascular (CNIC)”, as described in Material and Method and following the guidelines from 
Illumina. 
In order to obtain complete sequence coverage from the 212 nt preparation a pair-end sequencing 
run was performed allowing to read approximately half of the sequence in both directions. The small 
size preparations were sequenced using a single-end sequencing set-up. Since control samples had 
different barcodes, it was possible to mix them in a single flow cell. Control samples 
The presence of the adaptor-concatamers was a major drawback in the analysis. These molecules are 
undesirable, because adapter-concatamers are generally smaller than the fragments contained in the 
libraries and therefore they amplify and accumulate at a faster rate. This reduces the efficiency of the 
amplification reaction by limiting amplification of the library fragments because of depletion of 
components in the amplification reaction, such as for example dNTP's and primers. Another, more 
serious concern is that, when such amplified fragments are sequenced they do not give useful 
sequence information since they contain no insert. Thus, the preparation of libraries with a low level 
of adaptor-concatamers is highly advantageous in the sequencing of polynucleotides. Although the 
Bioanalyser did not show these bands, after cleaning the control data sets, a large proportion of 
reads bearing the adaptor code were found. 
For each of the datasets mentioned above, the Illumina-Solexa small RNA sequencing data was 
filtered by eliminating low quality reads, adaptor sequences and adaptor contaminants in order to 
generate clean reads using Cutadapt 1.0. The control samples (constructs: HA-Shuttle, or HA-∆RRM 
PGC-1α) showed very low amounts of counts after cleaning (around 0.2 million reads).  Specific RNA identification 
A total of around 35 million reads for the pair-end sequencing run and 12 million reads for the single-
end sequencing were obtained after cutadapt treatment for the specific preparation suggesting a 
specific amplification of ligand RNA. None of the identified sequences showed similarities with the 
control samples, demonstrating specificity in amplification.  
Around 33% of these reads from WT or KO cells infected with HA-PGC-1α adenovirus were very short 
fragments of 12 to 24 nt. Surprisingly, the results of the pair-end sequencing run did not give longer 
nucleotide length. In fact, less than 1% showed a length of over 75 nt. It was hypothesised that these 
sequences were the result of the concatamerisation of the barcode-target-barcode, and not the 
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described tRNA sequences. This may also explain the observed DNA ladder now attributable to 
several concatemerisation levels. 
Another relevant observation was the presence in the main data (33% sequences) of the 8 bp target 
sequence of the restriction enzyme PmeI (GTTT^AAAC). This sequence is present in the adenoviral 
vector and apparently was enriched and amplified specifically in the HA-PGC-1α samples, and not in 
the other samples, possibly suggesting some grade of sequence specificity. These sequences were 
part of the 12 to 24 nt long pool. 
3.3.2. Identification of target sequences 
The sequences identified in the samples from WT and KO hepatocytes infected with Ad-HA-PGC-1α 
were mainly 12 to 24 nt long. In order to identify clusters from the 12 to 24 nt long sequences, the 
ClustalW software was used. These sequences or reads, were mainly variants of a consensus 
sequence with one or more mismatches, short insertions or deletions. The identified sequences were 
aligned to the mouse reference genome (NCBI v37, mm9) using Integrative Genomics Viewer (IGV). 
The clean reads that could be perfectly aligned were considered as mapped reads, and the 
remainders were considered as unmapped reads. Most sequences mapped to noncoding intergenic 
regions that might be tentatively considered promoter/regulatory regions. 
The chromosomal localization of the BLAST sequence was zoomed-in on the aligned reads on the 
mouse genome. To test the specificity of the read the graphic includes the HA-shuttle and HA-PGC-1α 
results. As a representative example, the chromosomal context of the hits found in chromosomes 17 
and 5 are shown in Figures 2.39 and 2.40. 
 
 
Figure 2.39 : Integrative Genomics Viewer on Chromosome 17 regions. RNA sequencing signal 
on chromosome 17 with the corresponding genome localization.  
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Figure 2.40: Integrative Genomics Viewer on Chromosome 5 regions. RNA sequencing signal on 
chromosome 5 with the corresponding genome localization.  Validation of targets: RNA immunoprecipitation 
In order to validate the results, and confirm the identified sequences as true targets of the PGC-1α 
RRM, RNA immunoprecipitation analysis was carried out. 
FAO cells were infected with the following adenoviral vectors: HA-shuttle, HA-PGC-1α and HA-∆RRM 
PGC-1α. WCE were used for specific anti-HA immunopericipitation of the targeted proteins. Agarose 
beads were linked to the specific antibody (HA). The complexed beads were incubated with total RNA 
from FAO cells, and washed. The bound RNA fraction was then extracted from the complex bound 
beads following a standard RNA purification protocol. Non-specific binding was avoided by restrictive 
binding conditions. The recovered RNA was analyzed by qRT-PCR using oligonucelotides designed to 
the putative target sequences identified in the HIT-CLIP assay. Selected chromosome sequences are 
located in chromosomes 1-2-5-6-10-15 and 17.  
Specific binding should result in the specific amplification of the tested region. Of all the 
chromosomal regions tested, only one set of primers targeting chromosome 17 showed significant 
specific amplification on the immunoprecipitated fraction. This region is part of a predicted gene 
Gm21946, also identified as Esp38: Exocrine gland secreted peptide 38 present in the extracellular 
space and bearing pheromone activity. This approach is limited by the short sequence and the 
difficulties to design specific oligonucleotides. A possible alternative approach is proposed in the 
discussion. 
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GeneChip targets 
In order to gather further functional insight on the function of the PGC-1α RRM a group of genes was 
selected that showed marked significant gene expression differences for the contrast PGC-1α/PGC-
1α-∆RRM (section 2.5.) and scanned them for putative CLIP hits. The genes Camk2b, Cyp2b13, Cxcr7, 
Cxcl1, Slc17a3, Cy2b10 included putative specific RNA ligated sequences were found as derived from 
an IGV analysis of the CLIP results. This preliminary data further support the notion of the specific 
binding of PGC-1α to ligand RNA sequences. 
In summary, these results support the idea that PGC-1α binds RNA in a sequence specific manner. 
Further validation of targets and mechanisms are however still necessary to understand the 
functional relevance of the ligated RNAs. 
 
Figure 2.41: Integrative Genomics Viewer on GeneChip targets. RNA sequencing signal on 
Camk2b with the corresponding genome localisation. 
 
 
Figure 2.42 : Integrative Genomics Viewer on GeneChip targets. RNA sequencing signal on 
Cxcl1 with the corresponding genome localisation.  
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Figure 2.43 : Integrative Genomics Viewer on GeneChip targets. RNA sequencing signal on 
Cxcr7 with the corresponding genome localisation.  
 
 
Figure 2.44 : Integrative Genomics Viewer on GeneChip targets. RNA sequencing signal on 
Cy2b10 with the corresponding genome localisation.  
 
The final aim of this study was to confirm and identify RNA species binding to PGC-1α RRM. The 
technique applied to confirm and identify these RNA species was high throughput cross-linked 
immuno-precipitation (HIT-CLIP). The use of HIT-CLIP confirmed binding of RNA to PGC-1α. The 
presence of RRM suggests preferential transcription of some protein isoforms. The combination of 
the obtained results from array and RNA sequencing support this hypothesis. 
In summary, this study not only gives detailed information about ROS detoxification gene regulation 
by PGC-1α but also allowed the identification of new mechanisms of action for SirT1 and PGC-1α. 
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Discussion 
All cellular processes such as cell development, differentiation, growth and metabolism are tightly 
regulated at different levels. Importantly, transcriptional regulation is the first limiting step in the 
control of any cellular process. Transcription is a highly dynamic process involving several steps, each 
one subject to regulation. Through alternative exon use, transcriptional regulator can also impact 
protein diversity without increasing gene number. Furthermore, not only is mRNA continuously being 
processed, it is also continuously being degraded. As a consequence mRNA can be regarded as a 
short-term memory for biological information. The complexity and tight regulation of the 
transcriptional process makes necessary the participation of a vast array of proteins with many 
different functions (Orphanides G and Reinberg D 2002). RNA polymerase II (RNAP II) transcribes all 
mRNA genes and a wide array of long and short non-coding RNAs, making it an essential component 
in gene expression control. Regulatory factors are often combined, in complex ways, into multiple 
layers of regulation and frequently can be either transcriptional activators or repressors, depending 
on the context.  
Both the temporal and quantitative pattern of gene expression are subject to stringent control, 
which is essential for all cell processes (such as metabolism, proliferation, differentiation and the 
response to environmental signals). One example of a specific context is the mitochondrial content 
and respiration efficiency.  The great variability from cell type to cell type from mitochondrial content 
and respiration efficiency reflect the physiological status of the cell (Moyes CD and Hood DA 2003). In 
this complex process, Peroxisome proliferator-activated receptor gamma (PPARγ)-coactivator 1 alpha 
(PGC-1α) has been described as a key player. PGC-1α coordinates expression of mitochondrial and 
nuclear encoded proteins activated in response to increased demand of mitochondrial output. In 
addition to the regulation of genes encoding mitochondrial biogenesis and mitochondrial respiratory 
activity, PGC-1α regulates other general or tissue specific genes involved in metabolic control. This 
includes gluconeogenesis in the mammalian liver, adaptive thermogenesis in brown adipose tissues, 
preferential fatty acid utilization and oxidation in the heart. Furthermore, PGC-1α regulates the 
expression of antioxidant genes, preventing excessive reactive oxygen species (ROS) accumulation in 
conditions of increased electron transport chain (ETC) activity. PGC-1α works as a transcriptional 
coactivator that must integrate several metabolic signals and interact with many transcription factors 
and co-factors to provide both gene specific and tissue specific transcriptional regulation. The 
mechanisms involved in PGC-1α transcriptional control are the focus of the presented study. The 
results obtained can be discussed under three main sections: 
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A ternary complex formed by SirT1, FoxO3a and PGC-1α is recruited to 
the promoter of antioxidant genes to control gene expression  
The identification of the key transcriptional factors involved in the regulation of oxidative stress 
defence mechanisms is of great importance in the context of the vascular endothelium, where high 
ROS levels play a determinant role in endothelial dysfunction and therefore in the appearance and 
progression of atherosclerosis as well as in the control of the angiogenesis processes. This study 
shows that SirT1 positively regulates the expression of a group of oxidative stress protection genes in 
vascular endothelial cells and provide evidence that at least for some of this group of genes this 
effect is likely to be mediated by the SirT1 regulation of the PGC-1α/FoxO3a transcriptional complex. 
Previous work had shown that PGC-1α is recruited to the promoter regions of the regulated 
antioxidant genes in endothelial cells (Valle I et al. 2005). Furthermore, later studies had identified 
the Forkhead class O protein 3a (FoxO3a), as the DNA binding transcriptional factor that drives the 
recruitment of PGC-1α to the promoter of antioxidant genes (Olmos Y et al. 2009).  Aiming to identify 
additional cofactors, it was noted that both PGC-1α and FoxO3a have been shown to be targeted by 
the deacetylase SirT1, and that both proteins were acetylated in response to oxidative stress (van der 
Horst A et al. 2004, Kobayashi Y et al. 2005, Rodgers JT et al. 2008). Importantly, SirT1 is induced by 
NAD+, acting as a sensor of the cellular redox and nutritional status. Therefore, the hypothesis in this 
work is that SirT1 could be a relevant regulatory player of antioxidant gene expression, activating 
PGC-1α and FoxO3a in response to oxidative stress and reduced availability of reducing equivalents. 
Later analysis demonstrated that overexpression of SirT1 induced the expression of antioxidant 
genes in a PGC-1α and FoxO3a dependent manner, further supporting the hypothesis of SirT1 
regulatory role in the antioxidant gene expression. The tested of the effect of SirT1 depletion on 
antioxidant gene expression confirmed the involvement of SirT1 in antioxidant gene expression. 
To further support the hypothesis, it was investigated how SirT1 deacetylation of both FoxO3a and 
PGC-1α could play a role in SirT1 induction of antioxidant genes. The tested effect of SirT1 on 
formation of the FoxO3a/PGC-1α complex was found to be an increased formation of the PGC-
1α/FoxO3a complex in the presence of SirT1. It was proposed that SirT1 could work through two 
alternate mechanisms. SirT1 could deacetylate FoxO3a and PGC-1α independently and the 
deacetylated proteins could have an enhanced affinity for each other. Alternatively, SirT1 could be 
part of a ternary complex recruited to the target promoters. To challenge this hypothesis, it was 
tested whether FoxO3a and PGC-1α could modulate each other’s level of acetylation. The finding is 
that PGC-1α decreases FoxO3a acetylation and FoxO3a reduces PGC-1α acetylation when present. As 
none of the two proteins bare deacetylation activity, the data is supporting the notion that SirT1 is 
part of a ternary complex together with PGC-1α and FoxO3a. 
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Since previously demonstrated in that FoxO3a and PGC-1α form a complex that is recruited to 
antioxidant gene promoters (Olmos Y et al. 2009), hypothesis of SirT1 as partner of the recruited 
regulatory complex have been made. To test this idea, ChIP analysis was used. The outcome was that 
SirT1 associates with the regulatory regions of a panel of antioxidant genes consolidating the 
approach. Important information about SirT1 binding was its association with reduced H4K16Ac, a 
hallmark of SirT1 activity. It is generally considered that reduced acetylation is associated with gene 
silencing. However, a number of studies carried out mainly in yeast, have shown that histone 
deacetylation and in particular H4K16 deacetylation can play a positive role in gene expression 
regulation (Skurk C et al. 2004). SirT1 mechanisms of action on chromatin described so far, involve 
the deacetylation of histones within the coding regions of active genes to ensure proper transcription 
initiation, by repressing aberrant initiation within the coding region (Kim MJ et al. 2009). This type of 
promoter specific effects are still poorly characterised (Sharma VM et al. 2007). The results show that 
SirT1 deacetylation of H4K16 is accompanied by a general reduction in RNAP II levels in the promoter 
proximal regions but this does not result in decreased gene expression. Importantly, finding that 
SirT1 recruitment was associated with increased levels of elongating RNAPII is suggesting that SirT1 
activity might be contributing to repressing aberrant initiation and/or increased recruitment of 
elongation factors.  
Although the mechanisms involved in the transcriptional activation by histone deacetylases are still 
unclear, there is some evidence that the lysine specificity of the deacetylase may be a critical 
determinant. In particular, H4K16 appears to be an important target for deacetylases playing an 
activating role (Wang A et al. 2002). It appears that unacetylated H4K16, in the context of acetylation 
at other epigenetic sites is important for transcription, but unacetylated H4K16 in the context of 
other unacetylated residues is important for heterochromatin formation. The complexity of 
epigenetic code and collaborative signals is highlighted. So far, the only characterised example in 
mammals in which H4K16Ac is linked to gene silencing is rDNA cluster regulation (Zhou Y and 
Grummt I 2005). A recent study has shed some light on the mechanism through which acetylated 
H4K16Ac plays a dual role in gene silencing: it recruits Sir2-4 and repels Sir3. (Oppikofer M. et al. 
2011). Therefore, acetylation would serve to recruit SirT1 to the target gene and this recruitment 
may result in enhanced or decreased transcription depending on whether or not additional 
silencing/activating factors are subsequently recruited. Experimental evidence for this type of 
regulation in mammals is however missing. To gain a global view of the events, further experiments 
have been designed combining ChIP of different protein involved in gene transcription initiation. 
The results suggest that SirT1 is likely to act, at least in part, by directly binding to promoter target 
genes, probably recruited through its interaction with transcription factors. Although SirT1 acts 
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predominantly as a co-repressor, there is evidence that SirT1 can also serve as a co-activator. For 
example, SirT1 recycles Tat to its unacetylated form and acts as a transcriptional co-activator during 
Tat transactivation (Pagans S. et al. 2005). 
Monsalve and co-workers (Monsalve M et al. 2000) demonstrated PGC-1α N-terminal domain 
interacts with pre-initiation complex (PIC) RNAP II CTD serine-5 phosphorylated while PGC-1α C-
terminal domain interacts with elongating RNAP II CTD serine-2 phosphorylated. An interesting 
possibility is that SirT1 may regulate the interaction of PGC-1α with the elongation complex. 
Moreover, FoxO3a also interacts with PGC-1α through its C-terminal domain and could also 
contribute to the transition between the initiation and elongation complexes. 
FoxO3a has been shown to work as a priming factor, able to interact with target promoter sites even 
when chromatin is in a relative compact state, or hypo-acetylated (Matsuzaki H et al. 2005) 
suggesting that FoxO3a DNA binding activity to antioxidant genes may not be negatively affected by 
SirT1 deacetylation of nearby histones.  
It should also be noted that the results are the first to demonstrate that SirT1 can have a 
transcriptional activation activity upon recruitment to chromatin sites. It is also the first piece of 
work to demonstrate a site-specific regulatory activity on a panel of antioxidant genes rather than a 
general silencing effect on all the transcription system. Furthermore, the results are the first to 
elucidate a mechanism in mammals through with deacetylation does not result in transcriptional 
silencing. 
However, the mechanistic details of how SirT1 induces the transition from the initiation to the 
elongation complex remain to be elucidated. The transcription initiation process is complex and well 
regulated.  The earliest stages of transcription are marked by instability of the transcription complex 
and a pronounced tendency to release short pieces of RNA (2-5mers) in a transcriptional phase, 
which is termed “abortive initiation”. Stabilization of early elongation complexes is observed when 
the DNA-RNA hybrid reaches 8 bases in length (Kireeva ML et al. 2000). RNA synthesis can be 
interrupted by pausing and/or arrest, which occurs with a backward movement of the RNAPII, 
termed “backtracking” (Figure 1.4). Of importance, it has been noted that unidirectional transcription 
is no longer the only way to proceed for RNAP II (Seila AC et al. 2008) at many, if not all, transcription 
sites. During the unstable phase, RNAP II can start transcription in both directions, in a process called 
divergent transcription (Seila AC et al. 2008). Transcription proceeds until the machinery encounters 
additional signals that enforce the selection of one direction..  
The initiation process culminates with the recruitment of the positive transcription elongation factor 
b (P-TEFb). Once recruited, P-TEFb phosphorylates RNAP II at its serine 2 residue, releasing it from its 
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paused status (Lis JT et al. 2000, Ni Z et al. 2008). After RNAPII is released from its paused state, 
RNAP II proceeds into productive transcription elongation and completes transcription of genes 
(Figure 1.4). The events leading up to polymerase pause release often includes the covalent 
modifications of nucleosome barriers near the pausing event (Kireeva ML et al. 2005, Bondarenko VA 
et al. 2006, Li CF et al. 2006). 
The results presented in this work in chapter 2, suggest that SirT1 recruitment with concomitant 
histone deacetylation and reduced RNAP II serine-5 recruitment does not necessarily cause a 
reduction in mRNA levels but instead it is associated with an increase in gene expression. The fact 
that SirT1 is present upstream of the core promoter could also be consistent with the hypothesis of 
SirT1 forming a barrier in one direction.  This barrier could be one of the signals driving transcription 
machinery from divergent to unidirectional transcription. SirT1 could also foster access downstream 
to sequence specific binding transcription factors. An example of mechanism could be by promoting 
upstream closing of the chromatin thereby hindering access to the underlying sequences.   
Recruitment of P-TEFb during pausing to facilitate polymerase pause release can be elicited through 
several alternative mechanisms, the two most common being its recruitment by factors that bind 
chromatin by transcription factors (Peterlin BM and Price DH 2006). An illustrative example of P-TEFb 
recruitment is provided in the study performed by Zippo A et al. 2009. This study discovered that the 
bromodomain containing 4 (BRD4) protein could bind to the acetylated H4K16 and H3K9 and recruit 
P-TEFb to facilitate polymerase pause release. Other studies have found that P-TEFb could be 
recruited to regions of active transcription by transcription factors like c-Myc (Eberhardy SR and 
Farnham PJ 2002). This emerging data from this study support the findings presented by Eberhardy 
SR and Farnham PJ of an alternative complex, interactive, regulation of transcription. The results add 
supporting data to the diversity developed by the transcription machinery and build argument to a 
generally used pausing process. 
Taken together, the findings highlight the complexity of the pausing event as well as important roles 
for chromatin in regulating eukaryotic transcription the formation of barrier elements for the 
transcriptional machinery and specific complex formation (SirT1/PGC-1α/FoxO3a) with 
posttranslational modification as regulator of affinity. 
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Functional characterisation of PGC-1α RRM 
After having been focusing on the transcription initiation, detoxification genes promoter regulation, 
PGC-1α complex formation and regulation, the second part of the work is focusing on PGC-1α  
specific domain features.  
Drug targeted proteins are generally enzymes, whose activity is regulated by drugs, most of which 
get incorporated into the ligand binding pocket and consequently modify the enzymes proof of 
activity. PGC-1α is not an enzyme, but it possesses a putative targetable domain, the RRM. The use of 
this domain to modulate PGC-1α requires a characterisation of its functional role, and the 
demonstration that RNA binding actually modifies its activity. These two key issues are addressed in 
the present study.  
The previous results from our laboratory (Monsalve M et al. 2000) had shown that deletion of the 
RRM decreased the capacity of PGC-1α to induce mitochondrial biogenesis. In this study the ability of 
∆RRM mutants to induce antioxidant gene expression was tested. The finding was that the ∆RRM 
mutant had a reduced capacity to induce several, but not all, antioxidant genes, identifying that RRM 
is playing a role in antioxidant gene expression and suggesting that the dependency on the RRM is 
gene specific. Importantly, PGC-1α co-activator TLS, previously has been shown to co-regulate PGC-
1α activity on antioxidant genes, but not in mitochondrial biogenesis genes. The experiments 
performed in the study, used PGC-α-∆RRM and TLS this combination could boost PGC-α-∆RRM 
activity at some genes but not others (Figures 2.18. and 2.19.). For the present study, one of the 
antioxidant genes was selected (ucp-2) for further evaluation and using  reporter gene assays 
demonstrate that the proximal promoter region (200 bp) was enough to confer RRM specificity to 
the TLS-PGC-1α regulation of UCP-2 . This result suggested that RRM dependent activity does not 
have sequence requirements beyond that region, at least for the ucp-2 gene even though the 
additional regulatory elements cannot be ruled out.  
Taking into account the results that the RRM activity seemed to be gene specific, the next step was 
to carry out a genome wide transcriptional analysis to identify other specific genes regulated by PGC-
1α RRM. The cellular model of choice was primary hepatocytes. These cells were selected because 
the liver is the central organ in metabolic control in the organism and functional relevance of PGC-1α 
in the liver is well established. Furthermore, primary hepatocytes from both WT and PGC-1α KO mice 
were isolated, facilitating the functional analysis of the ∆RRM mutant on a PGC-1α null background. 
First, validation of the model was performed to ensure that adenoviral driven expression of PGC-1α 
WT in KO hepatocytes resulted in the expected up-regulation of known PGC-1α target genes. Next, 
whole genome gene expression microarrays was used to compare gene expression in WT vs KO PGC-
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1α hepatocytes. In addition to previously reported PGC-1α regulated genes, additional gene families 
were found that could be targeted by PGC-1α, in particular 7 members of the Cyp2 P450 family and 
solute carriers. These two families of genes are involved in detoxification of natural compounds and 
xenobiotics, their activity is crucial to prevent drug induced liver toxicity but they also limit the 
bioavailability of therapeutic drugs, including those used in tumor chemotherapy (Konno Y et al. 
2009, Horvath HC et al. 2010). 
The cyp2 gene cluster on chromosome 19q13.2 includes several genes and pseudogenes from the 
cyp2A, cypB, and cyp2F subfamilies. Cyp2b13/Cyp2b9 work synergistically and are known to be 
regulated in a coordinate fashion.  
slc30a10 is a solute carrier family member, identified as a PGC-1α regulated gene. Interestingly, two 
exon probes were differentially expressed; possibly suggesting that PGC-1α could be involved in an 
alternative splicing event. The available genomic information found in databases is also consistent 
with the existence of alternatively spliced transcript variants. Slc30a10 is highly expressed in liver, its 
protein product appears to be critical in maintaining intracellular manganese (Mn) levels. Mn is a 
cofactor of several important enzymes, including the mitochondrial superoxide dismutase, MnSOD. 
Loss of function mutations results in a pleomorphic phenotype, including dystonia and adult-onset 
Parkinsonism; conditions otherwise related to poor mitochondrial function.  
In order to elucidate the functional role of PGC-1α RRM at a genome wide level, whole genome gene 
expression microarrays was used to compare gene expression in PGC-1α-/- primary hepatocytes 
infected with adenovirus driving the expression of WT PGC-1α or PGC-1α-∆RRM Deletion of the RRM 
was found to largely phenocopies the full KO, with a general reduction in the activation of PGC-1α 
target genes. Still, significant gene specific differences were noted among the two groups (PGC-1α 
KO and PGC-1α-∆RRM). The twenty top genes up-regulated and down-regulated as annotated by the contrast ∆RRM/WT within the assay are listed in Table 1.3. Technical validation of the array 
results by q-RT-PCR supported the identification of RRM dependent PGC-1α targets.  Three genes identified in the WT/KO microarray analysis as novel PGC-1α regulated genes were also clearly identified as dependent on the activity of the RRM in the second microarray analysis 
for the contrast ∆RRM/WT, namely: Cytochrome P450 family 24 subfamily a polypeptide 1 
(Cyp24a1), C-X-C chemokine receptor type 7 (Cxcr7) and calcium/calmodulin-dependant protein 
kinase II beta (Camk2b). Interestingly, of all the P450 genes regulated by PGC-1α, Cyp24a1 is the only 
member whose regulation required the RRM. This observation suggests different regulation of the 
family members and different ways PGC-1α can regulate genes (RRM or other domains and cofactor 
binding). Cyp24a1 is localised in the inner mitochondrial membrane and is involved in vitamin D3 
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degradation, downstream of Cyp2r1 and Cyp27b1. A particular characteristic of this protein is that is 
generally present at low levels in the cells but undergoes rapid induction in response to elevated 
concentrations of vitamin D3. High levels of Cyp24a1 in colorectal cancer have been described as 
associated with more aggressive tumors (Horvath HC et al. 2010). However, the transcriptional 
regulators involved in the control of its expression were so far unknown.  
The Calcium/Calmodulin dependent protein kinase II beta (Camk2b) gene has a variety of splicing 
forms and codes for a number of alternatively processed transcripts. In the presence of Ca2+, 
CAMK2b is activated and binds PGC-1α, forming a complex that is recruited to pgc-1α promoter to 
regulate its expression (Czubryt MP et al. 2003, Handschin C et al. 2003). The microarray analysis for 
the WT/∆RRM contrast showed that deletion of PGC-1α RRM resulted in decreased levels of Camk2b 
gene for tags located in the 3’UTR region. This observation can reflect both inefficient termination 
and/or inefficient elongation in the absence of the RRM. Furthermore, this regulatory event 
evidences the existence of a retro-regulatory loop of PGC-1α on CAMK2b. However, supporting 
evidence would require further investigation such as luciferase assay or co-immunoprecipitation. 
After looking into the up-regulated genes, the focus was given to genes that have been detected to 
be down-regulated by PGC-1α in a RRM dependent manner in our data set. Three selected examples 
are Solute carrier family 17 (organic anion transporter), member 3 (Slc17a3), inositol polyphosphate-
5-phosphatase J (Inpp5j) and chemokine (C-X-C motif) ligand 1 (Cxcl1) genes. 
Slc17a3 (npt4) was identified as a PGC-1α regulated gene in the two independent microarray assays. 
Exon analysis showed that while some gene regions did not evidence significant variations in gene 
expression for the contrast WT/∆RRM, the region encompassing exons 9 to 11 is more expressed in 
∆RRM PGC-1α hepatocytes, while the 3’ UTR expression does not seem to be highly significantly 
modified by the presence or the absence of PGC-1α. Genomic information available in relevant 
databases indicates that this gene codes for four alternatively spliced mRNAs. These two 
observations might be indicative of an alternative splicing event regulated by PGC-1α in a RRM 
dependent manner. Evidence to support the theory of alternative splicing connected to the PGC-1α-
RRM could be provided by further testing (Section Results 2.5.).  
Taken together, these observations support the idea that deletion of the RRM results both in a 
general reduction in PGC-1α activity and a gene specific alteration in PGC-1α function. This gene 
specific modification seems to involve additional cofactors, like TLS and may be relevant in 
transcripts where alternative processing is involved. Importantly this regulation affects both types of 
genes, those that are positively regulated by PGC-1α and negatively regulated. The evidence 
accumulated so far suggests that promoter sequences are enough to provide RRM dependent 
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regulation by PGC-1α, although other regulatory regions are still possible (Figure 2.19). Elucidation of 
the mechanistic details on how the RRM domain impacts on PGC-1α activity would require further 
investigation. An approach has been selected and is described in Section 3 Results of this study. 
Identification of PGC-1α ligand RNAs  
Once the functional relevance of PGC-1α RRM was established, the aim was to determine if it 
actually function as an RNA binding domain. Most RNA binding proteins have two RRM in tandem. 
One of the RRM provides affinity and the other sequence specificity. PGC-1α has a single RRM. 
Therefore it was unclear whether it was a functional domain and if so, whether it could bind RNA in a 
sequence specific manner. It was found that in cells PGC-1α was bound to a nucleic acid that further 
identified as RNA based on its insensitivity to degradation by DNase I.  Binding to RNA was abrogated 
by deletion of the RRM, suggesting that PGC-1α was in fact a RNA binding protein (Figure 2.30.). 
As an initial test on the capacity of this RRM to bind RNA in a sequence specific manner, we tested in 
vitro the binding affinity of the PGC-1α-CTD for several DNA and RNA molecules. Finding that PGC-
1α-CTD would preferentially bind ssRNA, and would bind RNAs with different affinities, could give 
support to consider PGC-1α as a general RNA-binding protein. The next aim was to establish a 
protocol that would enable the identification of the ligand RNAs. First UV-crosslinking followed by 
RNA labeling and purification was used. As a result, the length of the ligand RNAs of approximately 
40 nt could be defined. . Following adapter ligation and RT-PCR amplification, the purified samples 
were analysed by deep sequencing with a Solexa/Illumina system. This is a variant of the shotgun 
sequencing approach that provides short reads 25-50 nucleotides long. The Illumina sequencing 
approach is built on a very large number of short-sequence reads. The technical challenge was to 
apply this technique to RNA isolated from a protein not previously identified as involved in RNA 
regulation. The first published examples of this type of approach, involved proteins like Dicer and 
Argonaute. These proteins are involved in binding a large number of RNA and involved in major 
processing steps. 
The output of the RNA-seq experiment suggested that PGC-1α ligand RNAs mapped to several sites 
on the mouse genome, and showed a partial sequence homology. Application of bioinformatics tools 
such as ClustaW, BlastN and further Integrative Genomics Viewer (IGV) were used to identify the 
specific genomic locations of the identified RNAs on the mouse genome. Specific targeted regions 
were found on chromosomes 1-2-5-6-10-15 and 17. An RNA-immunoprecipitation assay, followed by 
qRT-PCR, was set up to validate the identified RNAs as specific PGC-1α ligands. Specificity was 
confirmed for the RNA that maps in chromosome 17. Attempts to confirm other locations failed due 
to the technology limitation of small length specific oligonucleotide design to amplify regions 
surrounded by unspecific sequences. The identified sequences are particularly high in CG and bear a 
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small specific signature just 12-25 nt long. To overcome these problems, a novel amplification 
strategy had to be envisioned, similar to the approach used for the specific quantitation of siRNAs. 
Nevertheless, the results clearly suggest that PGC-1α binds not one single but several RNAs 
molecules and does so with restrictive sequence specificity. 
To get further insight into the regulatory mechanisms involved, analysis of genes whose regulation by 
PGC-1α was particularly sensitive to the presence of the RRM was performed. The genes were 
deduced from the array experiments. The presence of CLIP sequences using IGV was performed on 
these particular genes. Interestingly, sequence hits could be identified; possibly suggesting that non-
coding snRNA from these positions would modulate PGC-1α activity on the coding gene. However 
this model assumption would require further validation.  
In summary, the work presented here supports the hypothesis that PGC-1α can regulate gene 
expression not only modulating the efficiency of transcription initiation but can have an impact on 
transcription elongation, RNA processing and UTR selection. These alternative regulatory events can 
be mediated through the interaction with other factors like SirT1 and TLS but can also be the direct 
consequence of PGC-1α activity modulated by the ligand RNAs. Functional validation of the identified 
ligand RNAs and their impact on specific genes regulated by PGC-1α would decide whether 
modification of PGC-1α activity with synthetic ligand RNAs can have a therapeutic potential in 
metabolic diseases where PGC-1α inactivation has been shown to be a relevant feature. 
Future development 
To vision future developments in the field one must first look back 20 years ago and briefly analyse 
how the area of whole genome analysis has evolved. The microarray development could be used as a 
case study. The array technology has almost twenty years of development and had to deal with 
previously unforeseen challenges of changing experimental design, the need for improvements in 
standardisation, accuracy and precision, statistical analysis and the requirement for storage of huge 
amounts of data. All these challenges were faced by the more recently developed mass technologies 
such as ChIP-on-chip and HTS-CLIP. As already mentioned, HTS-CLIP (Jensen KB and Darnell RB 2008) 
was first used successfully in 2008 and has since then been applied to a plethora of well 
characterised RNA binding proteins. The main laboratories (Darnell RB, Tuschl T, Hafner M) that have 
implemented the HTS-CLIP technology have only recently been able to elaborate bioinformatics tools 
to properly analyse the data. The software designs are multiple and have focused on the particular 
experiment requirements for which they were developed. The experiments from the presented 
study, here mentioned, could only be analysed partially by the bioinformatics software available, 
being especially difficult to make a good background correction of the readings. Still, the major 
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drawback of a CLIP assays is the stepwise optimisation of the purification protocol and the low yields 
of material obtained. 
However, the potential of these technological approaches has fostered novel improvements on the 
sample preparation and analysis tools. The most recent technology that deserves to be taken into 
consideration for analysis is the droplet barcoding for single-cell transcriptomics (Klein AM et al. 
2015). The power of analysing a single cell and getting real-time transcription dynamic information is 
about to become a reality. The improvement in RNA sequencing combined with global transcription 
profiling at the single cell level is a tool that can be used to allow RNA inventory at the single-cell 
level. However, although a complete picture of the cell state is not obtained; information about cell 
heterogeneity and dynamic variation can be captured.  This method could overcome artificial 
interactions, low reaction efficiency, as antibody epitope obstacle and could show specific binding 
sites with high accuracy. This approach could be used to analyse the response to stress of cells that 
express wild-type PGC-1α protein. The data could be compared to the ones obtained with the 
protein lacking the RRM under the same stress condition. The information could complete the 
picture of 3’UTR selection and RNA transcripts modulation which was obtained during the present 
study.   
Nevertheless, the novelty of the technique implies that the analysis tools are not yet ready to cope 
with the challenges provided. Additional concerns come from the problem of storing huge sets of 
data for long periods of time. Awareness of this uprising concern is crystalizing in the setting up of 
bioinformatic centers in the hope to provide a global solution. 
An important discovery from this work is the inter-connection of transcription pausing and epigenetic 
and RNA maturation events. Recent publications support this new concept, in particular it has been 
demonstrated that long non-coding RNA can regulate gene expression. A particularly relevant 
example, among others, is the PRC2 complex which is regulated by ncRNAs and the histone code 
(Zhao J et al. 2010).  
Since the discovery of regulation by siRNAs, a plethora of studies have aimed to develop RNA based 
therapies, unfortunately, serious technical problems have so far hampered the successful launching 
of therapies based on small RNAs. Still, the huge potential to develop modulated treatment to a 
broad range of diseases (http://ranarx.com) by targeting regulatory regions or proteins using RNA 
has boosted new technical developments based on targeted delivery. In order to apply the findings 
to the therapeutic market, development of the guidelines by regulatory authorities for biotechnology 
has to be carried out in parallel.  
Therefore work is ongoing on guidelines for new technologies (ncRNA therapy and clinical testing) 
and the scientific community also saw the birth of new scientific journals focusing on these types of 
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therapeutic technologies, for example EMBO Molecular Medicine (Dimmeler S 2011). Prominent 
scientists like Dr. S. Dimmeler stressed at the recent congress of Standardisation of thrombosis and 
haemostasis the importance of ncRNAs as key tools for future developments in cardiovascular 
regenerative medicine. 
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Figure 2.45.: Model of mechanism: 
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1. SirT1 regulates acetylation level, expression and stability of PGC-1α and FoxO3a in endothelial 
cells.  
2. Under oxidative stress conditions SirT1 associates to FoxO3a and PGC-1α to form a ternary 
complex. 
3. The ternary complex associates to specific sites on the promoter regions of the regulated genes.  
4. SirT1 incorparation results in deacetylation of specific promoter regions.  
5. This complex promotes the formation of the RNA PII elongation complex and thereupon gene 
expression of the target genes under oxidative stress conditions.  
 
 
 
6. In the absence of PGC-1α RRM domain, expression of some PGC-1α reguated detoxification 
enzymes is decreased. 
7. Analysis at the genomic level indicate selective gene transcription when PGC-1α RRM domain is 
absent.  
8. PGC-1α RRM domain is binding to RNA on specifc sequences.  
9. The estimated size of PGC-1α RRM domain bound RNAs is about 40 nucleotides after being 
isolated via the HITS-CLIP method.   
10. The bound and isolated RNAs preferably locate in intronic regions.  
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Conclusiones  
 
 
 
 
11. SirT1 regula el estado de acetilación, la expresión y la estabilidad de PGC-1α y de FoxO3a en 
células endoteliales.  
12. En situaciones de estrés oxidativo  SirT1 forma con FoxO3a y PGC-1α un complejo terciario. 
13. El complejo se incorpora a las regiones promotoras de los genes regulados. 
14. La incorporación de SirT1 tiene como resultado la desacetilación de la región promotora. 
15. Este complejo facilita la formación del complejo de elongación y por tanto la expresión del gen 
diana en situaciones de estrés oxidativo. 
 
 
 
16. En ausencia del dominio RRM de PGC-1α la expresión de algunas de las enzimas de 
detoxificación reguladas por PGC-1α esta disminuida. 
17. El análisis a nivel genómico indica una selección de transcritos diferente en ausencia del RRM de 
PGC-1α. 
18. El dominio RRM de PGC-1α se une a RNA de manera específica de secuencia. 
19. El tamaño estimado de los RNA ligados de PGC-1α aislados por HITS-CLIP es de próximamente 40 
nucleótidos. 
20. Los RNA ligados identificados se localizan preferentemente en regiones intrónicas.  
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